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OBJETIVOS 
 
La hipótesis de trabajo de la tesis plantea que la infección por el 
complejo Mycobacterium tuberculosis produce cambios específicos en la 
expresión génica que conducen a la expresión diferencial de genes asociados 
con la infección y respuesta protectora a la enfermedad.  
 
El objetivo general de la tesis es identificar y caracterizar mediante 
técnicas de genómica funcional (genómica y proteómica) los genes 
involucrados en la respuesta celular y la resistencia del hospedador frente a la 
infección por Mycobacterium bovis (complejo Mycobacterium tuberculosis) en 
jabalíes expuestos de forma natural a la micobacteria.  
 
Objetivo 1. Caracterizar la respuesta génica diferencial en tonsilas y 
linfonodos mandibulares de jabalíes tuberculosos y no tuberculosos expuestos 
de forma natural a Mycobacterium bovis. 
 
Objetivo 2. Identificar y caracterizar posibles biomarcadores de infección 
y resistencia a Mycobacterium bovis en jabalí. 
 
Objetivo 3. Proponer a partir de los resultados de los estudios de 
genómica y proteómica herramientas para el estudio de la infección 
micobacteriana y para el diagnóstico y el control de la infección por 
Mycobacterium bovis en jabalí. 
 
 
1
ORGANIZACIÓN DE LA TESIS 
 
Este trabajo de tesis aborda el estudio de la infección por Mycobacterium 
bovis en jabalí mediante técnicas de genómica funcional. Las características 
distintivas de este trabajo son que (i) el trabajo se realiza con animales 
infectados en condiciones naturales para evidenciar similitudes y diferencias 
con los modelos comúnmente empleados con cultivos celulares y animales de 
laboratorio, (ii) la caracterización de la expresión génica diferencial se realiza 
en tejidos que se ven afectados por la infección micobacteriana en jabalí, 
tonsilas y linfonodos mandibulares, (iii) en el trabajo se combinan técnicas de 
genómica funcional (genómica y proteómica) con la determinación de los 
niveles de ARN mensajero y de proteínas mediante RT-PCR en tiempo real y 
métodos inmunoquímicos.  
 
La tesis está estructurada de forma tal que, una vez introducida la 
relevancia del jabalí como reservorio de la tuberculosis en España, se acomete 
primero una fase de descubrimiento de los genes/proteínas afectados por la 
infección, seguida de la caracterización de algunas de estas moléculas como 
biomarcadores de infección, respuesta protectora y resistencia en esta especie. 
El primer capítulo de la tesis expone la problemática actual que supone la 
tuberculosis bovina y el papel que desempeña el jabalí como reservorio de la 
misma en España. En segundo lugar y tras la introducción, se aborda la 
caracterización de la expresión génica diferencial en tonsilas y linfonodos 
mandibulares en jabalíes tuberculosos y no tuberculosos expuestos de forma 
natural a M. bovis. En tercer lugar se caracterizan biomarcadores asociados 
con la respuesta inmune y la resistencia al patógeno. En último lugar y con los 
resultados obtenidos en los apartados anteriores se discute la patobiología de 
la infección por M. bovis en jabalí y se discuten las implicaciones de estos 
resultados para el control de la tuberculosis bovina en España. 
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Esta tesis está dividida en una serie de capítulos que se detallan a 
continuación: 
 
Capítulo 1. Evidencias del papel del jabalí como reservorio de la 
tuberculosis debida al complejo Mycobacterium tuberculosis. 
Capítulo 2. Caracterización de la respuesta génica diferencial en 
tonsilas y linfonodos mandibulares de jabalíes tuberculosos y no tuberculosos 
expuestos de forma natural a Mycobacterium bovis. 
  2.1. Genes expresados diferencialmente en tonsilas y linfonodos 
mandibulares de jabalíes tuberculosos y no tuberculosos expuestos de forma 
natural a Mycobacterium bovis. 
  2.2. Análisis proteómico y transcriptómico de la respuesta de 
estrés e inflamatoria diferencial en  linfonodos mandibulares y tonsilas de 
jabalíes infectados de forma natural con Mycobacterium bovis. 
 Capítulo 3. Caracterización de biomarcadores asociados con la 
respuesta inmunológica y la resistencia a la tuberculosis en jabalí. 
  3.1. Caracterización de genes seleccionados sobreexpresados en 
jabalíes no tuberculosos como posibles marcadores de resistencia a la 
infección por Mycobacterium bovis. 
  3.2. Influencia de los alelos de la metilmalonil CoA mutasa en la 
resistencia a la tuberculosis bovina en el jabalí (Sus scrofa). 
  3.3. Analisis de parámetros bioquímicos séricos en relación con la 
infección por Mycobacterium bovis en jabalí (Sus scrofa) en España. 
 Capítulo 4. Discusión.  
Genómica y proteómica comparativa para estudiar la respuesta 
tisular específica y su función en la infección natural por Mycobacterium 
bovis. 
 Capítulo 5. Conclusiones. 
 
 
  
 
 
3
ABORDAJE DE LOS OBJETIVOS 
 
El objetivo 1 se aborda en el capítulo 2, el cual consta de dos 
apartados. En estos apartados se expone cómo se lleva a cabo la 
caracterización de la respuesta génica diferencial mediante técnicas de 
genómica y proteómica. 
 
El objetivo 2 es tratado en el capítulo 3. En el apartado 1 de este 
capítulo se aborda la caracterización de los genes seleccionados como 
marcadores de resistencia a Mycobacterium bovis. En el apartado 2 del 
capítulo 3 se analiza el caso concreto del gen de la metilmalonil CoA mutasa y 
cómo ciertos alelos de este gen confieren protección frente a la tuberculosis 
bovina en jabalí. Por último, en el apartado 3 de este capítulo, se analizan 
parámetros bioquímicos en suero y su relación con la infección por M. bovis en 
jabalí. 
 
El objetivo 3 se desarrolla en el capítulo 4. En este capítulo se discute 
el impacto de los resultados de la tesis en la patobiología de la infección por M. 
bovis en jabalí y sus implicaciones para el control de la tuberculosis bovina en 
España. 
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Capítulo 1 
 
 
 
 
 
 
 
 
 
Introducción 
 
Evidencias del papel del jabalí como reservorio de tuberculosis 
debida al complejo Mycobacterium tuberculosis 
 
Resumen 
 
La tuberculosis bovina (TBb) causada por Mycobacterium bovis y otras 
micobacterias del complejo Mycobacterium tuberculosis es una zoonosis con 
un extenso rango de hospedadores. El principal obstáculo para la erradicación 
de la TBb en el ganado es la implicación de la fauna silvestre en el ciclo 
natural del patógeno. La identificación de reservorios silvestres es crucial para 
la implementación de medidas efectivas de control. El jabalí (Sus scrofa), a 
menudo no es considerado como un verdadero reservorio, y las evidencias 
científicas son controvertidas fuera de la España mediterránea. El objetivo de 
este trabajo es revisar las evidencias científicas del jabalí como reservorio de 
TBb y subrayar la necesidad de investigar sobre estos aspectos. Las 
evidencias que sostienen que el jabalí es reservorio de TBb incluyen: i) 
presencia de genotipos comunes del complejo M. tuberculosis entre jabalíes y 
animales domésticos, salvajes y personas, ii) alta circulación de M. bovis entre 
jabalíes en áreas cercadas durante décadas en ausencia de contacto con 
ganado domestico y otros ungulados silvestres iii) las lesiones de TBb 
aparecen frecuentemente en linfonodos torácicos y pulmones, lo que sugiere 
la vía respiratoria de infección y excreción y iv) en una alta proporción de 
jabalíes juveniles aparecen numerosas lesiones tuberculosas en más de una 
región anatómica; en consecuencia, este grupo de edad puede suponer la 
principal fuente de excreción de micobacterias. Por consiguiente, las 
evidencias epidemiológicas, patológicas y microbiológicas sugieren que, al 
menos en los ecosistemas mediterráneos españoles, el jabalí es capaz de 
mantener la infección de TBb en su hábitat natural y es, muy probablemente, 
capaz de transmitir la enfermedad a otras especies actuando como un 
verdadero reservorio silvestre. Estos resultados incrementan la lista de 
especies silvestres que actúan como reservorios naturales de TBb en 
diferentes partes del mundo y sugieren la necesidad de controlar la infección 
en poblaciones de jabalí para conseguir la erradicación definitiva de la 
enfermedad en España. 
 
 
 
 
Victoria Naranjo, Christian Gortazar, Joaquín Vicente, José de la Fuente. Evidence of the role of 
European wild boar as a reservoir of tuberculosis due to Mycobacterium tuberculosis complex. Veterinary 
Microbiology, aceptado.
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Evidence of the role of European wild boar as a reservoir of 
Mycobacterium tuberculosis complex 
 
Victoria Naranjo1, Christian Gortazar1, Joaquín Vicente1, José de la Fuente1, 2, * 
 
1Instituto de Investigación en Recursos Cinegéticos IREC (CSIC – UCLM – JCCM), Ronda 
de Toledo s.n., 13071 Ciudad Real, Spain. 
2Department of Veterinary Pathobiology, Center for Veterinary Health Sciences, Oklahoma 
State University, Stillwater, OK 74078, USA. 
 
Abstract 
 
Bovine tuberculosis (bTB) is caused by Mycobacterium bovis and closely related mycobacteria of 
the Mycobacterium tuberculosis complex. They have an extensive host range and may cause 
zoonotic TB. A major obstacle to bTB eradication in livestock is the implication of wildlife in the 
natural cycle of the pathogen. The identification of wildlife reservoir hosts is crucial for the 
implementation of effective control measures. The European wild boar (Sus scrofa) is frequently 
considered a spillover or dead end host rather than a true reservoir, and scientific evidence is 
conflicting outside Mediterranean Spain. The aim of this review is to update current scientific 
evidence of the wild boar as a TB reservoir and to underline those aspects that need further 
research. Evidences supporting that wild boar is a TB reservoir host include: (i) presence of 
common M. tuberculosis complex genotypes in wild boar, domestic and wild animals and humans, 
(ii) high prevalence of M. bovis among wild boar in estates fenced for decades in complete absence 
of contact with domestic livestock, and other wild ungulates (iii) TB lesions are frequently seen in 
thoracic lymph nodes and lungs, suggesting that respiratory infection and excretion may occur, and 
(iv) extensive tuberculous lesions in more than one anatomical region occur in a high proportion of 
juvenile wild boar that probably represents the main source of mycobacterial excretion. Hence, 
epidemiological, pathological and microbiological evidence strongly suggests that, at least in 
Spanish Mediterranean ecosystems, wild boar are able to maintain TB infection in the wild and are 
most probably able to transmit the disease to other species, acting as a true wildlife reservoir. 
These results expand the list of wildlife species that act as natural reservoirs of TB in different parts 
of the world and suggest the need to control the infection in wild boar populations for the complete 
eradication of the disease in Spain.  
 
Keywords: Bovine tuberculosis, Mycobacterium tuberculosis complex, Wildlife, Reservoir host, 
European wild boar  
_______________________________________________________________________________ 
*Corresponding author: José de la Fuente, Instituto de Investigación en Recursos Cinegéticos 
IREC (CSIC – UCLM – JCCM), Ronda de Toledo s.n., 13071 Ciudad Real, Spain. Phone: (34) 
926-295450. E-mail: jose_delafuente@yahoo.com 
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1. Introduction 
 
Bovine tuberculosis (bTB) is 
caused by Mycobacterium bovis and 
closely related mycobacteria of the 
Mycobacterium tuberculosis complex. 
They have an extensive host range 
and may cause zoonotic TB (Gortazar 
et al., 2005; Neill et al., 2005). 
Livestock species of economic 
significance such as cattle, goats and 
pigs are susceptible to infection with 
M. bovis and this has important 
implications for veterinary and public 
health (Amanfu, 2006). In addition, 
losses due to bTB are also relevant 
when endangered wildlife species are 
involved (Briones et al., 2000; Pérez 
et al., 2001; Amanfu, 2006). 
Despite the efficacy of the skin 
test in identifying tuberculous cattle 
(Pollock et al., 2006; Macdonald et 
al., 2006), the disease has not been 
eradicated from many countries 
(Amanfu, 2006; Pavlik, 2006), 
because of the reservoir of M. bovis in 
wildlife (Morris et al., 1994; Cousins, 
2001; Corner, 2006; Collins, 2006; 
Thoen et al., 2006; Amanfu, 2006). 
Therefore, the identification of wildlife 
reservoir hosts is crucial for the 
implementation of effective control 
measures (Gortazar et al., 2007). If 
wildlife species are identified as 
reservoirs of M. bovis infection, 
effective tools for diagnosis of M. 
bovis-infected animals and measures, 
such as field management to avoid 
inter-specific contact or vaccines are 
needed for the control of bTB (Corner, 
2006; Nishi et al., 2006; Michel et al., 
2006; Pollock et al., 2006; Ballesteros 
et al., 2007). 
Tuberculosis is a major 
concern in Spain because prior to 
1995 this country had among the 
highest bTB cattle infection rates in 
the European Union (Caffrey et al., 
1994; Liébana et al., 1995; Pavlik, 
2006). Test and slaughter strategies 
have proven successful and reduced 
bTB prevalence in Spanish cattle from 
1.4% in 1996 to 0.3% in 2005 
(http://rasve.mapa.es/Publica/Progra
mas/NORMATIVA%20Y%20PROGR
AMAS/PROGRAMAS/2007/TUBERC
ULOSIS/PROGRAMA%20NACIONAL
%20DE%20ERRADICACIÓN%20DE
%20LA%20TUBERCULOSIS%20BO
VINA,%20AÑO%202007.PDF; 
Ballesteros et al., 2007). However, 
the disease has not been eradicated 
and regional differences in campaign 
effectiveness have become evident. 
In the regions of southern Spain with 
highest cattle bTB prevalence, wildlife 
species such as European wild boar 
(Sus scrofa) and red deer (Cervus 
elaphus) show high prevalence of 
bTB, which suggests that the disease 
is shared between domestic and wild 
hosts (Gortazar et al., 2005; Vicente 
et al., 2006)? Southern Spain has 
high densities of wild ungulate 
species due to intensive management 
of wild boar and red deer that 
includes artificial feeding and 
watering, containment of populations 
behind high wire fences and 
translocations. This contrasts with 
northern Spain, where bTB 
prevalence is lower and game-
management of wildlife is less 
common (Vicente et al., 2006; 2007). 
In addition, environmental factors 
such as summer draughts and limited 
water availability promote aggregation 
of wildlife at waterholes in the 
Mediterranean habitats of southern 
Spain (Acevedo et al., 2007; Vicente 
et al., 2007).  
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It is known that wild and 
domestic animals share common M. 
tuberculosis complex genotypes thus 
suggesting transmission between 
these animal species (Aranaz et al., 
1996; 2004; Gortazar et al., 2005; 
Hermoso de Mendoza et al., 2006). 
Therefore, the control of TB in wildlife 
species and the avoidance of contact 
between wildlife and livestock, 
particularly in the case of the wild 
boar, is considered a priority for bTB 
control in Spain (Parra et al., 2003; 
2005; Aranaz et al., 2004; Gortazar et 
al., 2005; Vicente et al., 2006; 2007). 
However, wild boar and its relative the 
feral pig are frequently considered 
spillover or dead end hosts rather 
than true reservoirs, and scientific 
evidence is conflicting outside 
Mediterranean Spain (e.g. Serraino et 
al., 1999; Machackova et al., 2003; 
Corner, 2006).  
The aim of this article is to 
review the scientific evidence 
supporting the case for the European 
wild boar as a TB reservoir in 
Mediterranean Spain and to underline 
aspects that need further research. 
 
2. Factors affecting pathogen 
reservoir hosts and transmission 
of M. bovis 
 
Wildlife species can play an 
important role in the epidemiology of 
bTB. For this reason, it is important to 
distinguish between maintenance and 
spillover hosts. Maintenance hosts 
are those that can maintain infection 
in an area in the absence of cross-
transmission from other species of 
domestic or wild animals. Spillover 
hosts need a continuing acquisition of 
infection from other species to 
maintain the infection (Morris et al., 
1994). Both, maintenance and 
spillover hosts may act as a disease 
vector (Corner, 2006). However, a 
true bTB reservoir with 
epidemiological implications for 
disease control is the maintenance 
host with the possibility to transmit the 
pathogen to other species.  
The transmission of M. bovis is 
dependent on a number of factors 
that include (i) the number of infected 
animals, (ii) the number of susceptible 
animals, (iii) the routes of infection, 
(iv) the anatomical location of 
infection and lesions, (v) the structure 
of tuberculous lesions, (vi) the routes 
and levels of pathogen excretion, and 
(vii) the minimum infective dose by 
each infection route (Corner, 2006). 
Direct or indirect contact between 
bTB wild hosts and livestock is 
required and occurs at shared 
pastures, water holes and feeders 
(Garnett et al., 2002). Generally, the 
most effective route of infection 
between wildlife species and from 
wildlife to domestic animals is the 
airborne route (Corner, 2006). 
However, other possible routes 
through sharing of water holes and 
feeding sites and the consumption of 
infected carcases have been 
considered (Corner, 2006; Hermoso 
de Mendoza et al., 2006; Coleman 
and Cooke, 2001; Delahay et al., 
2002, Vicente et al., 2007). 
 
3. Examples of wildlife reservoirs 
for M. bovis  
 
Wildlife species have been 
demonstrated as reservoir hosts for 
M. bovis in different regions of the 
world. Wildlife ruminants such as the 
African buffalo (Syncerus caffer) and 
the Canadian bison (Bison bison) 
have been implicated in the 
epidemiology of bTB in the Kruger 
9
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National Park, South Africa and 
Canada, respectively (De Vos et al., 
2001; Nishi et al., 2006).  
The European badger (Meles 
meles) has been implicated in the 
transmission of M. bovis to cattle and 
is the most important wildlife reservoir 
of bTB in Ireland and the United 
Kingdom (Phillips et al., 2003; 
Delahay et al., 2002). The behaviour 
of infected terminally-ill badgers 
changes, which results in the animals 
loosing fear to cattle and coming in 
close contact with them, thus 
excreting aerosol that constitute a risk 
for transmission of bTB to cattle 
(Corner, 2006).  
The Brushtail possum 
(Trichosurus vulpecula) is the major 
wildlife reservoir of bTB in New 
Zealand and terminally-ill tuberculous 
possums are highly infectious for M. 
bovis (Coleman and Cooke, 2001). As 
with badgers, changes in the behavior 
of terminally-ill tuberculous possums 
increase the risk of contact and TB 
transmission to cattle (Coleman and 
Cooke, 2001). 
The White-tailed deer 
(Odocoileus virginianus) is considered 
a wildlife reservoir of bTB in the 
United States. White-tailed deer 
populations have increased due to 
game-management and aerosol 
transmission is facilitated by high 
animal densities (Corner, 2006). In 
the last years, a significant decrease 
in bTB prevalence in White-tailed 
deer in Michigan has been achieved 
using control strategies such as 
restrictions on supplemental feeding 
and baiting of deer (O’Brien et al., 
2006). Elk (Cervus elaphus) have 
been proposed as a wildlife reservoir 
in Canada (Nishi et al., 2006).  
In summary, several species 
belonging to different taxonomic 
groups are able to act as bTB 
reservoirs depending on the particular 
ecosystem. In those situations where 
true wildlife reservoirs have been 
identified, bTB control has been 
attempted by culling (e.g. badgers; 
Donnelly et al., 2007), limiting 
contacts at the wildlife-livestock 
interface (e.g. banning artificial 
feeding; Brown and Cooper, 2006), 
and more recently with experiments 
for wildlife vaccination with BCG 
(Wedlock et al., 2005; Buddle et al., 
2006; Lesellier et al., 2006) and the 
first delivery of a badger vaccine in 
the wild (Richard Delahay, personal 
communication).  
 
4. Evidence of the role of European 
wild boar as a reservoir for M. 
tuberculosis complex in Spain 
  
In the last decade, research 
groups in Spain have provided 
evidence that support the role of 
European wild boar as a reservoir 
host for M. bovis with important 
implications for the control of the 
disease in the country. The evidences 
discussed below may be relevant for 
the identification of TB reservoirs in 
other European countries where wild 
boar populations may be 
maintenance host for M. bovis 
infection (Pavlik, 2006). 
 
4.1. Number of infected and 
susceptible animals 
 
Wild boar and feral pigs are 
considered important disease 
reservoirs affecting the efforts to 
control infectious diseases (Ruiz-Fons 
et al., 2007a). The geographical 
range and population densities of the 
European wild boar are currently 
increasing in the Iberian Peninsula 
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(Acevedo et al., 2006) and elsewhere 
in Europe (Saez-Royuela and 
Tellería, 1986; Acevedo et al., 2006). 
Artificially high wild boar densities that 
have negative ecological 
consequences are common in 
Mediterranean Spain and contribute 
to the problems associated with 
disease control (Gortazar et al., 
2006).  
Wild boar share M. 
tuberculosis complex genotypes of 
bovine and caprine origin with cattle, 
goats, domestic swine, deer and 
humans (Gortazar et al., 2005; Parra 
et al., 2006; Aranaz et al., 2004). In 
Spain, M. bovis has been circulating 
among wild ungulates in estates 
fenced for over 20 years in complete 
absence of contact with domestic 
livestock (Gortazar et al., 2005). The 
mean prevalence of TB-compatible 
lesions in wild boar from southern 
Spain is 44%, with some local 
populations showing up to 100% 
apparent prevalence (Vicente et al., 
2006). Prevalence estimates based 
on M. bovis isolation from tonsils and 
mandibular lymph nodes reach up to 
60% (unpublished results). In 
southern Spain, spatial aggregation 
due to game-management practices 
such as fencing, feeding and watering 
correlate with high bTB prevalence in 
wild boar (Acevedo et al., 2007; 
Vicente et al., 2007). 
Thus, both the susceptibility to 
the disease and the number of 
infected animals suggest a possible 
reservoir role of the European wild 
boar in southern Spain. 
 
4.2. Anatomical location of 
infection and localization and 
structure of tuberculous lesions 
 
In a recent work, Martín-
Hernando (2007) described the extent 
and distribution of lesions in 127 
culture positive European wild boars.  
Macroscopic TB-compatible lesions 
were found in 82.7% and an 
additional 8.7% had microscopic 
lesions only. In the study, 42.2% of 
wild boar had localized TB lesions 
while 57.8% of the animals had 
generalized TB. Mandibular lymph 
nodes were affected in 92.2% of the 
animals, in agreement with previous 
findings that identified these lymph 
nodes as an important site for TB 
inspection and surveillance in wild 
boar (Gortazar et al. 2003). Moreover, 
pathological studies evidenced TB 
lesions in 51% of the lungs or thoracic 
lymph nodes (Martín-Hernando et al., 
2007). In cases with localized TB, 
granulomas were characterized by a 
mixed inflammatory cell population 
whereas strongly necrotic-calcified 
granulomas were more prevalent in 
cases with generalized TB infection. 
Significantly, tuberculous lesions in 
more than one anatomical region 
were more frequent among juvenile 
wild boar, and mycobacteria were 
most frequently observed in the lung. 
 
4.3. Pathogen infection and 
possible excretion routes 
 
The finding of wild boar with 
thoracic tuberculous lesions only 
(usually bronchial lymph nodes), 
along with wild boar with abdominal 
lesions only (usually mesenteric 
lymph nodes), suggests that both 
respiratory and food-borne 
contamination may occur (Martín-
Hernando et al., 2007). However, the 
data available does not allow 
elucidating whether the respiratory of 
digestive route is more relevant for TB 
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infection in wild boar. Although the 
infection routes in wild boar are 
unknown, we hypothesize that 
mycobacteria enter through oral 
mucosa and tonsils, from where 
infection of mandibular lymph nodes 
and other organs may occur. This 
hypothesis is consistent with 
food/water-borne and direct oro-nasal 
infections. Food/water-borne 
infections could occur at shared water 
and feeding sites that are common in 
game-managed states in Spain. 
Direct oro-nasal contact between 
animals is frequent in wild boar 
behaviour (Ruiz-Fons et al., 2007b). 
Consumption of carrion and discarded 
offal from hunter-killed animals by 
wild boar is probably an important risk 
factor for TB infection in Spain 
(unpublished results). 
In our studies, extensive 
tuberculous lesions in more than one 
anatomical region have been found in 
a high proportion of juvenile wild boar 
that probably represent the main 
source of mycobacterial excretion 
(Martín-Hernando et al., 2007). 
Juveniles are the dispersing age 
group in wild boar, (Truve and Lemel, 
2003) and may therefore contribute to 
the geographical spread of TB. 
Weaners and juveniles (preferably 
females) associate in matriarchal 
groups where intimate contact 
between individuals during social and 
foraging activities are frequent and 
could facilitate pathogen transmission 
directly and/or indirectly. 
The wild boar studied in south-
central Spain present a high 
proportion of lung lesions, sometimes 
with large numbers of mycobacteria 
(Martín-Hernando et al., 2007; Parra 
et al., 2003; 2006). These 
observations suggest that the lung 
has a major role in TB transmission 
from infected wild boar to susceptible 
animals (Palmer et al., 2002). 
Mycobacteria can be excreted either 
as aerosols through the mouth and 
nose, or be swallowed and excreted 
with the faeces. This second route 
could be important because of the 
potential to contaminate food, 
pastures and water, but needs to be 
confirmed in wild boar. Another 
possibility considering the high 
proportion of tuberculous lesions in 
mandibular lymph nodes and tonsils 
of wild boar is the excretion of 
mycobateria through saliva. 
Mycobacteria have been observed in 
the excretory ducts of wild boar 
mandibular salivary glands (Gortazar 
et al., 2003). In contrast, the urinary 
excretion of mycobacteria seems 
unimportant in wild boar, since 
tuberculous lesions and mycobacteria 
were not found in the kidneys. The 
finding of a few sows with TB lesions 
in the mammary glands suggests that 
transmission to the piglets through 
infected milk is possible (Martín-
Hernando et al., 2007). 
In summary, the pathological 
characteristics of the tuberculous 
lesions and the associated tissue 
damage in various organs in wild boar 
indicate that at least those animals 
with large lesions and generalized 
infections have the potential to 
excrete M. bovis by several routes, 
which reinforces the potential for this 
species to be a true TB reservoir 
(Parra et al., 2003; Vicente et al., 
2006; 2007; Martín-Hernando et al., 
2007). 
 
4.4. Minimum infective dose by 
each infection route 
  
Presently, the minimum M. 
bovis infective dose for wild boar is 
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unknown. However, the finding of 
tuberculous lesions with large number 
of mycobacteria in the lungs suggests 
that the minimum infective dose may 
be reached at least through the 
respiratory transmission route. For 
example, the minimum infection dose 
in cattle is five bacilli or less if 
delivered by aerosol to the lungs 
(Corner, 2006). 
 
5. Impact of TB on wild boar 
populations 
 
There is evidence that juvenile 
wild boar with generalized TB are 
under-represented in the population 
and are being lost from the population 
faster than other age groups. These 
evidence include (i) similar 
representation across ages of the 
different stages of granuloma 
development with a high percentage 
of calcified lesions found among 
weaners and juveniles, (ii) the 
proportion of generalized TB was 
constant across ages, (iii) juveniles 
presented the highest proportion of 
large TB lesions, and (iv) lung lesions 
were less frequent in adults (Martín-
Hernando et al., 2007). Limited 
survival of juveniles with large TB 
lesions could be expected since 
healing of large lesions is unlikely. 
However, Bollo et al. (2000) 
described that lesions in wild boar 
could result in nodules of fibrous 
tissue with reduced number of bacilli. 
In a non hunted wild boar population 
with high TB prevalence, prevalence 
was lower in adults than in juveniles, 
again suggesting differential mortality 
of infected juvenile wild boar 
(unpublished results). However, a 
continued exposure to infection may 
occur and adults probably have a 
greater ability to control infection and 
recover from disease (Corner et al., 
1981). 
Recently, Naranjo et al. (2006; 
2007) characterized by proteomic and 
transcriptomic analyses the 
differential stress/inflammatory 
responses in mandibular lymph nodes 
and oropharyngeal tonsils of 
European wild boar naturally infected 
with M. bovis. The results suggested 
that the up-regulation of serum 
amiloid A expression and other 
stress/inflammatory responses in 
mandibular lymph nodes and tonsils 
of infected wild boar may contribute to 
organ damage and death in M. bovis-
infected juvenile wild boar (Segalés et 
al., 2005).  
 
6. Comparative TB pathology and 
epidemiology in wild boar and feral 
pigs 
 
While some previous studies 
found that most wild suids had lesions 
exclusively in mandibular lymph 
nodes (e.g. 62% in Australian feral 
pigs; Corner et al., 1981), findings in 
wild boar showed a high proportion of 
animals with generalized lesions 
affecting more than one anatomical 
region (Martín-Hernando et al., 2007).  
Feral pigs are considered 
spillover (or dead end) hosts for bTB 
in Australia (Corner et al., 1981; 
Corner, 2006). There, feral pig 
densities are almost 10 times lower 
than wild boar densities in Spain 
(Acevedo et al., 2006a; Hone, 1990), 
and several other differences in 
habitat (Acevedo et al., 2006a), 
management (Vicente et al., 2007), 
and even genetic factors (Acevedo-
Whitehouse et al., 2005) may 
contribute to explain these apparently 
contradictory results. 
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In Australia, the low prevalence 
of generalized bTB disease in feral 
pigs, the absence of pulmonary 
lesions, the lack of other obvious 
routes of excretion from infected pigs, 
and the lack of contact between feral 
pigs and other species, particularly 
water buffalo and cattle, lead to the 
conclusion that feral pigs were an end 
host and not a source of bTB infection 
(Corner et al., 1981). This hypothesis 
was subsequently validated when, 20 
years after the above mentioned 
study and after bTB was essentially 
eradicated from the bovid population, 
a survey showed that bTB had almost 
disappeared from the feral pig 
population (Corner, 2006). 
In Mediterranean Spain the 
situation is entirely different. Available 
field and molecular epidemiology and 
histopathological evidence (Gortazar 
et al., 2005; Parra et al., 2006; Aranaz 
et al., 2004; Vicente et al., 2006a; 
2006b; Martín-Hernando et al., 2007), 
document a high proportion of 
generalized TB disease and a 
frequent involvement of the lungs in 
wild boar. Thus, at least in the 
particular ecosystem of 
Mediterranean habitats and 
management systems for wild boar, 
the European wild boar seems 
capable of acting as a true TB 
reservoir (Table 1). 
The finding of 17% of infected 
wild boar without visible macroscopic 
tuberculous lesions (Martín-Hernando 
et al., 2007) further supports the role 
of this species as TB reservoir. Most 
of the previous studies were based on 
wild boar or feral pigs presenting 
macroscopic TB compatible lesions 
(Vicente et al., 2006a; Corner et al., 
1981; Bollo et al., 2000; Gortazar et 
al., 2003). However, the percentage 
of infected wild boar without visible 
macroscopic lesions is similar to that 
reported for other bTB wildlife 
reservoir hosts such as badgers, 
(Gallagher et al., 1998) and lower 
than that reported for possums (de 
Lisle et al., 2005) and white-tailed 
deer (Kaneene et al., 2002).  
 
7. Future research needs 
  
Despite the evidences 
discussed above to support the role of 
European wild boar as a TB wildlife 
reservoir host, several questions need 
further investigations. Presently, the 
minimum infective dose by each 
infection route is unknown and 
controlled experiments are needed to 
clarify this issue. The results 
discussed here were obtained from 
naturally infected wild boar 
populations. However, controlled 
experimental infections are needed 
for a better understanding of the 
pathobiology and immune response 
of wild boar to mycobacterial 
infection. Most of the information 
analyzed in these studies was 
obtained post-mortem. The 
development of rapid test for the 
diagnosis of TB in live animals would 
improve current epidemiological 
studies and control programs. 
Effective vaccines, preferably an oral 
vaccine, are also necessary for the 
control of TB in wild boar and other 
wildlife reservoir species. However, 
vaccination strategies could be 
combined with other control measures 
aimed at reducing risk factors of 
disease transmission identified in 
epidemiological studies. 
 
8. Conclusions 
 
The results discussed herein 
support the role of the European wild 
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boar as a TB reservoir in 
Mediterranean Spain. 
Epidemiological, pathological and 
microbiological evidence strongly 
suggests that, at least in Spanish 
Mediterranean ecosystems, wild boar 
are able to maintain TB infection in 
the wild and are most probably able to 
transmit the disease to other species, 
thus acting as a true wildlife reservoir. 
The finding of European wild boar as 
a TB reservoir host expands the list of 
wildlife species that act as natural 
reservoirs of the infection in different 
parts of the world. These results have 
important implications for the control 
of TB in Spain and suggest the need 
to control the infection in wild boar 
populations if complete eradication of 
the disease is to be achieved. 
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Table 1. Comparative data on feral pig and wild boar ecology and TB epidemiology. 
 
 Australia Spain References 
Animals/km2 < 11 up to 90 Corner et al., 1981; Acevedo et al., 2007 
TB prevalence 0% – 40% 18% - 100% 
Corner et al., 1981; Wakelin and 
Churchman, 1991; Knowles, 
1994; Lugton, 1997; Vicente et 
al., 2006; 2007 
Prevalence trend Decreasing Increasing Parra et al., 2006; Corner, 2006 
Lung lesions Not found 38-52% 
Corner et al., 1981; Gortazar et 
al., 2003; Martín-Hernando et 
al., 2007 
Percent generalized TB 25% 58% Corner et al., 1981; Martín-Hernando et al., 2007 
Host status Spillover Reservoir Corner, 2006; Vicente et al., 2006; 2007 
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Capítulo 2 
 
 
 
 
 
 
 
 
 
Caracterización de la respuesta génica 
diferencial en tonsilas y linfonodos 
mandibulares de jabalíes tuberculosos y no 
tuberculosos expuestos de forma natural a 
Mycobacterium bovis 
Capítulo 2.1  
Genes expresados diferencialmente en tonsilas y linfonodos 
mandibulares de jabalíes tuberculosos y no tuberculosos 
expuestos de forma natural a Mycobacterium bovis 
 
Resumen 
La tuberculosis bovina (TBb), causada por Mycobacterium bovis (Complejo 
Mycobacterium tuberculosis) es una zoonosis que afecta al ganado en todo 
el mundo. Este microorganismo infecta especies animales, tanto 
domésticas como silvestres, abarcando un amplio número de 
hospedadores que complica el control o la erradicación de la enfermedad. 
A pesar de los avances en la caracterización de los mecanismos 
involucrados en las interacciones patógeno-hospedador y en la respuesta 
celular frente al complejo M. tuberculosis en células humanas, bovinas y de 
ratón, la expresión génica diferencial en tejidos de animales tuberculosos y 
no tuberculosos expuestos de forma natural al patógeno ha sido poco 
caracterizada. En este trabajo, la expresión génica diferencial fue analizada 
por hibridación substractiva-supresiva (HSS) en tonsilas y en linfonodos 
mandibulares de jabalíes silvestres tuberculosos y no tuberculosos 
procedentes de una región de España endémica para tuberculosis. Los 
resultados del análisis mediante HSS fueron confirmados por PCR en 
tiempo real y RT-PCR semicuantitativa en genes seleccionados. La 
expresión de proteínas de los genes diferencialmente regulados fue 
analizada por radioinmunodifusión o inmunohistoquímica. La expresión 
diferencial de genes varió tanto entre individuos tuberculosos y no 
tuberculosos como entre tonsilas y linfonodos. Varios mecanismos 
celulares se vieron afectados, incluyendo la transducción de señales, 
respuesta inmune, inflamación, estrés, apoptosis/antiapoptosis, estructura 
celular, adhesión y transporte, metabolismo de ADN/ARN y proteínas y 
procesos enzimáticos. Estos resultados demuestran la modulación de la 
expresión génica por la infección micobacteriana en tonsilas y linfonodos 
de jabalíes expuestos de forma natural a M. bovis y procuran las bases 
para definir las interacciones patógeno-hospedador y el mecanismo de 
protección inmune frente a la infección. 
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Abstract
Bovine tuberculosis, caused by Mycobacterium bovis (Mycobacterium tuberculosis
complex), is a zoonotic disease that affects cattle worldwide. The bacterium infects
other animal species, both domesticated and wild, and this range of hosts
complicates attempts to control or eradicate the disease. Despite advances in the
characterization of the mechanisms involved in host–pathogen interactions and
host cell responses to M. tuberculosis complex in human, bovine and mouse cells,
differentially expressed genes in tissue biopsies of naturally occurring tuberculous
and nontuberculous exposed individuals have been poorly characterized. In this
study, differential gene expression was analysed using suppression-subtractive
hybridization in oropharyngeal tonsils and mandibular lymph nodes of field-
collected tuberculous and nontuberculous European wild boars from a tubercu-
losis-endemic area of Spain. Real-time PCR and semiquantitative reverse-tran-
scriptase PCR of selected genes confirmed the results of the suppression-
subtractive hybridization analysis. Protein expression of selected differentially
expressed genes was analysed by radial immunodiffusion or immunohistochem-
istry. Differential gene expression varied among tuberculous and non-tuberculous
groups and between tonsils and lymph nodes. Single and multiple cellular
mechanisms were affected, including signal transduction, immune response,
inflammation, stress, apoptosis/antiapoptosis, cell structure, adhesion and trans-
port, protein and DNA/RNA metabolism and enzymatic processes. These results
demonstrate the modulation of gene expression by mycobacterial infection in
tonsils and mandibular lymph nodes of European wild boars naturally exposed to
M. bovis, and provide a basis for defining host–pathogen interactions and the
mechanism of protective immunity.
Introduction
Bovine tuberculosis (bTB), caused by Mycobacterium bovis
(Mycobacterium tuberculosis complex), is a well-known
zoonotic disease which affects cattle worldwide (reviewed
by Cousins, 2001). The human health risk of bTB has been
alleviated in many countries by the introduction of pasteur-
ization, but the disease is currently one of the most
important re-emerging zoonoses in Europe (Grange, 2001;
Gibson et al., 2004; Smith et al., 2004), causing major
economic losses to livestock and serious constraints on the
international trade of animals and their products (Milian
Suazo et al., 2003).
The control of bTB continues to be a challenge, and new
vaccines are necessary to control effectively and eventually
eradicate this disease (reviewed by Cousins, 2001; Britton &
Palendira, 2003; Koul et al., 2004; Gilbert et al., 2005).
Mycobacterium bovis has a wide host range, infecting both
domesticated and wild animals, and this increases the
difficulty of control and eradication of the disease. Further-
more, practical treatment or preventive measures other than
control of host density and aggregation currently do not
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exist for free-ranging wildlife. The presence of common
M. bovis genotypes in both cattle and wild boars poses a
threat of interspecies transmission of the pathogen (Serraino
et al., 1999).
Several wildlife species are naturally infected with
M. bovis, and European wild boar (Sus scrofa) is a major
reservoir in some regions of Spain (Gortazar et al., 2003;
Parra et al., 2003; Aranaz et al., 2004). TB was reported for
the first time in wild boar in the 1930s, and since then M.
bovis, M. tuberculosis and Mycobacterium avium have been
described in this species in several countries of Europe,
Oceania and North America (Bollo et al., 2000; Gortazar
et al., 2005). In swine, most of the lesions associated with TB
are formed in the mesenteric or mandibular lymph nodes,
and disseminated lesions are occasionally observed in the
liver, spleen and lungs (Bollo et al., 2000; Gortazar et al.,
2003; Segale´s et al., 2005). Most research on mycobacterial
infections has focused on airborne infections of the lower
respiratory tract of humans, cattle and small laboratory
animals. However, in a variety of animal species, including
European wild boar, mycobacteria apparently enter through
the oropharyngeal tonsils or the lining of the intestine and
then pass into the bloodstream, subsequently causing lesions
in several organs (Windsor et al., 1984; Lugton, 1999;
Gortazar et al., 2003).
Mycobacteria are initially endocytosed by the M cells in
the mucosa-associated lymphoid tissues that present bacilli
to underlying dendritic cells and macrophages, and these
cells constitute the primary target cells of pathogenic myco-
bacteria (Lugton, 1999). The successful infection of macro-
phages by pathogenic mycobacteria involves the inhibition
of several host cell processes, including the fusion of phago-
somes with lysosomes, antigen presentation, apoptosis and
the stimulation of bactericidal responses (reviewed by Koul
et al., 2004).
Increasing evidence suggests that genetic and environ-
mental factors contribute to the pathogenesis and differ-
ences in susceptibility of humans and mice to TB (Gros
et al., 1981; Goto et al., 1984; Motulsky, 1989). Human twin
studies have provided compelling evidence that host genes
affect the outcome of M. tuberculosis infection (Comstock,
1978; Bellamy et al., 2000). The analyses of polymorphisms
in candidate genes have established that, at least in some
populations, variations in the natural resistance-associated
macrophage protein 1 (NRAMP1), the mannose-binding
lectin (MBL), the vitamin D receptor (VDR), the interleu-
kins IL-8 and IL-10, the IL-1 receptor antagonist (IL-1Ra),
and certain human leukocyte antigen (HLA) alleles are
associated with disease susceptibility (Bellamy, 2003; Ma
et al., 2003; Kotb, 2004).
Despite the advances in understanding the mechanisms
involved in host–pathogen interactions and host cell re-
sponses to M. tuberculosis complex in human, bovine and
mouse cells using large-scale microarray analysis (Ehrt et al.,
2001; Ragno et al., 2001; Chaussabel et al., 2003; Wang et al.,
2003; Xu et al., 2003; Keller et al., 2004; Weiss et al., 2004),
the genes differentially expressed in naturally exposed sus-
ceptible and resistant populations have been poorly char-
acterized. The only attempt made to date to analyse
resistance and susceptibility to TB at the gene expression
level was done in mouse macrophages infected with M.
tuberculosis (Keller et al., 2004). Analysis of differentially
expressed genes in tissue biopsies collected from tuberculous
and non-tuberculous animals exposed to the pathogen in
endemic areas would contribute to the understanding of the
cellular response to natural M. bovis exposure.
Herein we report the differential expression of genes in
oropharyngeal tonsils and mandibular lymph nodes of
tuberculous and non-tuberculous European wild boars
naturally exposed to M. bovis. Oropharyngeal tonsils and
mandibular lymph nodes were selected for analysis because
these organs are the entry site and target organ, respectively,
for mycobacteria in swine (Gortazar et al., 2003). For this
analysis we used a subtraction technology, suppression-
subtractive hybridization (SSH), which allows the identifi-
cation of rare and novel differentially expressed genes
(Diatchenko et al., 1996, 1999).
Materials andmethods
Europeanwild boarandsamplepreparation
Six female (Z1 year old) European wild boars were captured
in a 3000 ha hunting estate in Montes de Toledo, Toledo pro-
vince, south central Spain. The habitat is characterized by
scrubland and evergreen oak (Quercus ilex) woodlands, with
scattered pastures and small crops (Gortazar et al., 2005).
The prevalence of TB infections in the European wild boar
population was based on the finding of TB-characteristic
lesions and/or the isolation of mycobacteria, and was higher
than 70% (Gortazar et al., 2003; Vicente, 2004). Animals
were weighed and euthanized by the captive bold method
(Chambers & Grandin, 2001), following European, National
and University of Castilla–La Mancha Ethics Committee re-
gulations. The oropharyngeal tonsils and mandibular lymph
nodes were dissected, and tissue fragments of c. 2 cm3 were
rapidly prepared and stored in liquid nitrogen for RNA
extraction. The rest of the sample was used for culture and
spoligotyping of mycobacteria or stored in 10% neutral
buffered formalin for pathology studies and immunohisto-
chemistry. Blood samples were collected into sterile tubes
with and without anticoagulant (lithium heparin) and main-
tained at 4 1C until plasma and serum were separated after
centrifugation; both products were then stored at  30 1C.
Animals were subjected to detailed necropsy as described
previously (Gortazar et al., 2005; Segale´s et al., 2005).
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Pathologyand immunohistochemistry
Samples for histopathology and immunohistochemistry
were obtained by sagittal cross-section at half the length of
mandibular lymph nodes and oropharyngeal tonsils. During
necropsy, in addition to the tonsils and mandibular lymph
nodes, tissue samples from all organs and from tracheo-
bronchial, hepatic, and mesenteric lymph nodes were fixed
in 10% neutral buffered formalin for 48 h, embedded in
paraffin, and processed routinely for hematoxylin and eosin
staining. Additional sections were stained with a modified
Ziehl Neelsen stain in order to detect the presence of acid-
fast bacilli.
The avidin–biotin–peroxidase complex (ABC) method
was used on paraffin-embedded tissue sections for immu-
nohistochemical staining. Sections were deparaffinized and
hydrated, and endogenous peroxidase activity was inacti-
vated by incubation with 3% hydrogen peroxide in metha-
nol for 30 min at room temperature (20–25 1C). For the
detection of MHC class II (MHC-II) and lysozyme (LYZS),
tissue sections were initially incubated for 5 min at 37 1C
with 20 mg mL1 proteinase K (Sigma, St Louis, MO). For
detection of CD3, sections were pretreated in citrate buffer
(10 mM sodium citrate buffer, 0.05% Tween, pH 6.0) for
30 min at 100 1C using a microwave oven. After three 10-
min rinses in phosphate-buffered saline (PBS; pH 7.4),
sections were incubated with 5% normal goat serum (Vector
Laboratories, Burlingame, CA) for 30 min at room tempera-
ture. Three primary antibodies (1:200 polyclonal anti-LYZS
and anti-CD3, Dako, Glostrup, Denmark; 1:200 monoclonal
anti-MHC-II, Serotec Ltd, Oxford, UK) were applied on
paraffin sections for 12 h at 4 1C. After three 10-min rinses in
PBS, sections were incubated with biotinylated goat anti-
rabbit IgG or goat antimouse IgG (Vector Laboratories)
diluted 1:200 for 30 min at room temperature. After three
10-min rinses in PBS, an avidin-biotin complex (Vector
Laboratories) diluted 1:50 was applied for 1 h at room
temperature. Sections were incubated for 1 min with 3-30-
diaminobenzidine tetrahydrochloride diluted 0.035% in
Tris-buffered saline (pH 7.6) containing 0.01% hydrogen
peroxide as chromogen (Vector Laboratories). All immu-
nostained sections were counterstained with Mayer’s hae-
matoxylin. The specific primary antibodies were replaced by
PBS and by nonimmune rabbit or mouse sera in negative
control tissue sections.
Immunohistochemistry sections were coded and analysed
in a random order by two observers (U.H., M.M.) employ-
ing manual counting as described by Lou et al. (1996) and
Kraan et al. (2000). Antigen expression was evaluated at
 400 magnification under a light microscope based on the
intensity and the frequency of staining. Staining intensity
was scored on a scale from 0 to 4 (0 negative, 4 intense
staining). Ten cells each were scored in three different areas,
and a mean score was calculated from the means of the three
areas. For frequency of staining, positive cells were counted
in 10 randomly selected high-power fields per section using
a 10 mm2 square graticule scale in one eyepiece, and a mean
count of positive macrophages/lymphocytes per 10 mm2
was established.
The intensity of staining and the frequency of stained cells
for antigens in macrophages and lymphocytes were com-
pared between tuberculous and nontuberculous wild boars
and between mandibular lymph nodes and oropharyngeal
tonsils using a Kruskal–Wallis test. The interaction between
both organs and the presence of TB was tested using a two-
tailed ANOVA.
Cultureand spoligotypingofmycobacteria
Pools of lymph-node and tonsil samples were submitted to
culture and spoligotyping of mycobacteria as previously
described (Gortazar et al., 2005).
Suppression-subtractive hybridization
Total RNA was isolated using TriReagent (Sigma) accord-
ing to the manufacturer’s instructions. RNA quality was
checked by gel electrophoresis to verify the integrity
of RNA preparations. After diagnosis of tuberculous and
non-tuberculous individuals by pathology, culture and
spoligotyping of mycobacteria, pools of 20-mg RNA
were made from non-tuberculous (N= 2; 10 mg RNA/each)
and tuberculous (N= 4; 5 mg RNA/each) animals. SSH
was performed at Evrogen JCS (Moscow, Russia) as pre-
viously described (Diatchenko et al., 1996, 1999). Tester and
driver RNAs were subtracted in both directions to construct
four SSH libraries enriched for differentially expressed
cDNAs in tuberculous (reverse-subtracted) and non-tuber-
culous (forward-subtracted) samples for oropharyngeal
tonsils and mandibular lymph nodes. Approximately
100 clones from each library were randomly picked up
and subjected to differential hybridization with subtrac-
ted and non-subtracted probes using the PCR-select differ-
ential screening kit (Clontech, Palo Alto, CA), which re-
sulted in 490% candidate differentially expressed cDNAs.
Then 300 clones from each forward-subtracted library
and 100 clones from each reverse-subtracted library
were sequenced from both ends of the vector with vector-
specific primers.
Sequenceanalysis anddatabase search
Multiple sequence alignment was performed to exclude
vector sequences and to identify redundant sequences
using the program AlignX (Vector NTI Suite V 8.0,
InforMax, Invitrogen, Carlsbad, CA) with an engine based
on the Clustal W algorithm (Thompson et al., 1994).
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Searches for sequence similarity were performed with
the BLASTN 2.2.9 program (http://www.ncbi.nlm.nih.
gov/BLAST; Altschul et al., 1997) against the nonre-
dundant sequence database nr and the database of pig-
specific sequences (http://www.ncbi.nlm.nih.gov/genome/
guide/pig/). Protein ontology was determined using the
human protein reference database (http://www.hprd.org;
Peri et al., 2004).
Real-time-PCRandRT-PCRanalyses
The pooled RNA samples of tuberculous and non-tubercu-
lous European wild boars prepared as described above for
SSH were used for real-time PCR and reverse transcriptase
(RT)-PCR analyses. Two primers were synthesized based on
the sequences determined for selected candidate differen-
tially expressed genes (Table 1). RT-PCR was performed
using the Access RT-PCR system (Promega, Madison, WI)
and a Techne (Cambridge, UK) PCR machine (model TC-
512). RNA (0.2 mg) was reverse-transcribed in a 50 mL
reaction mixture (1.5 mM MgSO4, 1 avian myeloblastosis
virus (AMV) RT/Thermus flavus (Tfl) reaction buffer,
0.2 mM each dNTP, 5 U AMV RT, 5 U Tfl DNA polymerase
(Promega), 10 pmol of each primer) at 45 1C for 45 min.
After 2 min incubation at 94 1C, PCR was performed for 30
cycles in the same reaction mixture with specific primers
and amplification conditions (Table 1). Control reactions
were performed using the same procedures, but without RT
to control for DNA contamination in the RNA preparations
and without RNA added to control contamination of the
PCR reaction. PCR products were electrophoresed on 1%
agarose gels to check the size of amplified fragments by
comparison with a DNA molecular weight marker (1-kb
DNA Ladder, Promega).
Real-time PCR was performed with the RNA samples and
gene-specific primers described above using the QuantiTec
SYBR Green RT-PCR kit (Qiagen, Valencia, CA) and a
Cepheid Smart Cycler II (Sunnyvale, CA) following the
manufacturer’s recommendations. PCR conditions were as
described above for RT-PCR, except that annealing was set
at 60 1C when the annealing temperature in the RT-PCR
reaction was above 60 1C.
The expression of selected genes was quantified by real-
time PCR except for LYZS and actin-related protein 3
(ARP3), for which the amount (ng) of RT-PCR bands in
the gels was determined in comparison with known
amounts of DNA standards to calculate the non-tuberculous
to tuberculous mRNA ratio. Amplification efficiencies were
validated and normalized against S. scrofa b-actin (ACT)
(GenBank accession number U07786). Real-time PCR and
RT-PCR experiments were repeated at least three times, with
similar results.
Complement componentC3andC7radial
immunodiffusionassays
Radial immunodiffusion (RID) (Wu et al., 1986) was
performed to compare the C3 and C7 serum levels between
tuberculous and nontuberculous European wild boar. One
percent agarose (Biotools MB Labs, S.A., Spain) plates
(VWR International, Barcelona, Spain) 55 mm in diameter
containing sheep polyclonal antibodies to C3c or C7 (Ab-
cam, Cambridge, UK) in 10 mM sodium phosphate pH 6.8
were used. The antibody solution was added to the agarose
at 42 1C before pouring the plates. Five microlitre wells were
made in the agarose gel to fill with boar serum samples in
duplicate. Plates were incubated upright on a flat surface at
room temperature for 24 h in a humidity chamber. After
incubation, plates were washed 2 times in PBS for 2 h each
with agitation. The gel was then dried with hydrophilic
paper, stained with Coomassie blue stain R-250 (0.5 g R-250,
90.8 mL H2O, 90.8 mL methanol, 18.4 mL glacial acetic acid)
for 10 min and destained with a solution containing 200 mL
glacial acetic acid, 20 mL glycerol, 1 L H2O and 1 L ethanol.
Finally, the gel was left to dry at room temperature and the
diameters of the precipitation areas were measured in
millimetres using Adobe Photoshop 5.5 with an error of
0.35 mm. The diameters of the precipitation areas were
compared between tuberculous and nontuberculous wild
boar samples by a Mann–Whitney U two-tailed test (http://
eatworms.swmed.edu/leon/stats/utest.html).
Nucleotide sequenceaccessionnumbers
The nucleotide sequences of the expressed sequence tags
(ESTs) reported in this paper have been deposited in the
GenBank database under accession numbers DN837257
–DN837576.
Results
Selectionand characterizationoftuberculous
andnontuberculousEuropeanwild boars
naturallyexposed toMycobacteriumbovis
Adult European wild boars were collected from a hunting
estate with a high (70%) prevalence of TB in this species, in
order to select animals that were naturally exposed to
Mycobacterium bovis. Wild boars in this area shared com-
mon water and food supplies, which increased animal
interaction and exposure to M. bovis. Wild boars collected
for this study were subjected to detailed necropsy and
pathology studies, and tissue samples were submitted for
culture and spoligotyping of mycobacteria. Individual wild
boars were classified as tuberculous or nontuberculous
based on the presence or absence of the following criteria:
(1) the presence of lesions characteristic of TB; and (2) the
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identification of positive mycobacterial cultures and M.
bovis spoligotypes. According to these criteria, two wild
boars were considered nontuberculous, and four were
classified as tuberculous.
In tuberculous animals, macroscopic lesions charac-
teristic of TB were found in tonsil (n= 1) and in mandibular
(n= 4), bronchial (n= 4), hepatic (n= 3) and mesenteric
(n= 2) lymph nodes. In three of the tuberculous animals,
Table 1. Primer sets and PCR conditions used for this study
Gene description Upstream/downstream primer sequences (50–30) PCR conditions
Vitamin D receptor-interacting protein complex (VDR) VITD5: GAATCATAACATGCGATTTTATGC 62 1C, 30 s/
VITD3: GTTGCCTGTGGTCATGCCATA 68 1C, 1 min
Annexin I (ANX) ANEX5: GAATTCCTTAAGCAGGCCTGG 62 1C, 30 s/
ANEX3: AGCCCTTGCATCTGTATCAGC 68 1C, 1 min
Lysosomal-associated protein (LAP) LAM5: CATTTATTTTCAAACACTAACAAGC 54 1C, 30 s/
LAM3: AGCTGAAAACTTCAGATCTTA 68 1C, 1 min
Calmodulin 2 (CALM) CAL5: CTTCATAGTTTACTTGACCATCAC 64 1C, 30 s/
CAL3: CTGAGTGGTTGTGTGGTCGCG 68 1C, 1 min
Vascular cell adhesion molecule 1 (VCAM) VCAM5:CTTTGGAGCCTCAAATATACTTTGG 53 1C, 30 s/
VCAM3: ACTGAGGGCTGACCATCAATG 68 1C, 1 min
Chemokine receptor 4 (CXCR4) CXC5: ATGGACGGGTTCCGTATATTC 58 1C, 30 s/
CXC3: GAACACCACTAACCACAGGTC 68 1C, 1 min
MHC-I SLA-31 SLA31/2F:GACCCTGGCCCTGACTGGT 62 1C, 30 s/
SLA31R:GGAGCCACTCCACACACGC 68 1C, 1 min
MHC-I SLA-32 SLA31/2F:GACCCTGGCCCTGACTGGT 62 1C, 30 s/
SLA32R: GGAGCCACACCACACACGC 68 1C, 1 min
MHC-I SLA-1 SLA1F: CCTCTTCCTGCTGCTGTCG 58 1C, 30 s/
SLA1/2R: AGCGTGTCCTTCCCCATCT 68 1C, 1 min
MHC-I SLA-2 SLA1/2R: AGCGTGTCCTTCCCCATCT 58 1C, 30 s/
SLA2F: GCCATCCTCATTCTGCTGTC 68 1C, 1 min
b2-microglobulin (B2M) BETA25: GTGGCCTTGGTCCTGCTCGG 62 1C, 30 s/
BETA23:GGTAACATCAATACGATTTCTGAT 68 1C, 1 min
MHC-II SLA-DRA MCII5: CCTCCCAGAGACTACAGAGAAC 62 1C, 30 s/
MCII3: CACCTAAGGCCCACTCAAAGT 68 1C, 1 min
Complement component 3 (C3) C35: TGTGGTCAAGGTCTTCGCTATGG 66 1C, 30 s/
C33: TGGGCCAAGGCTTGGAACACC 68 1C, 1 min
Complement component 7 (C7) C75: CAAAACGGTGGCATGGCCAG 62 1C, 30 s/
C73: TGAACAGGAAAAGGTCACCTTCTC 68 1C, 1 min
Lysozyme (LYZS) LYS5: GGCCAAGTGGGAAAGTAATTTTAAC 62 1C, 30 s/
LYS3: GAGATAACTGAACAGATGAAGAC 68 1C, 1 min
Arginase I (ARG) ARG5: GACTGGCTGGAGGACTCTGG 64 1C, 30 s/
ARG3: CTGCAGGGTCCACGTCTCTC 68 1C, 1 min
Heat shock protein gp96 GP965: GCTGAAGGGGAAGTTACCTTCAAG 68 1C, 30 s/
GP963: GCAGTATTCGTCCACAGGTTCTG 68 1C, 1 min
Cathepsin S (CAT) CAT5: CAGGAGGGGTCATAGTAGACAC 64 1C, 30 s/
CAT3: GCTGTGGGAGCTCTGGAAGC 68 1C, 1 min
Secreted phosphoprotein 1, osteopontin (OPN) OST5: CTGCCTCTGGGGCTTCGCCT 66 1C, 30 s/
OST3: ACGTGCAGGCGCTGGGCAAC 68 1C, 1 min
Clathrin heavy polypeptide (CLTC) CLA5: ACTATCAGGATCGTGGATATTTTG 62 1C, 30 s/
CLA3: TGCTCCCTCATTTTCTGTGGC 68 1C, 1 min
Cullin 1 (CUL) CUL5: TAAGGATTGCCGCACTGGAC 60 1C, 30 s/
CUL3: CTCTCATCCATCAGATCTTCTC 68 1C, 1 min
Actin related protein 3 (ARP3) ARP5: GTACAATTCAAGCATTATAGAG 56 1C, 30 s/
ARP3: GTACAAGTCATTACACACCACA 68 1C, 1 min
Methylmalonyl-CoA mutase (MUT) MUT5: GGTCAACAAGGATTATCAGTTGC 64 1C, 30 s/
MUT3: GCTGTATATTGGAAGATGTCAGC 68 1C, 1 min
E1A binding protein p300 P3005: CTTTCCCAGCCAGCTGTAAGC 64 1C, 30 s/
P3003: GTACTTGGCTGGTCTTCTTCCTC 68 1C, 1 min
Beta actin (ACT) ACTIN5: ATGTTTGAGACCTTCAACACGCCG 68 1C, 30 s/
ACTIN3: ACATCTGCTGGAAGGTGGACAGCG 68 1C, 1 min
PCR conditions are shown as annealing/extension in reverse transcriptase PCR analysis.
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nodular lesions, 1–10 mm in diameter, were caseous
with a calcified centre and surrounded by a fibrous capsule.
The fourth tuberculous animal had nodular lesions
0.5–20 mm in diameter that contained caseous material
that were also present in the spleen and adrenal gland.
This animal also had a fibrinous pericaditis. All tuber-
culous and nontuberculous wild boars had a moderate
parasitic pneumonia and Metastrongylus spp. were identi-
fied in the bronchi. All animals were in fair to good body
condition.
Histologically, the TB-compatible lesions described in
tuberculous wild boars consisted of granulomas that were
characterized by a necrotic, frequently calcified core area
surrounded by macrophages and lymphocytes. Langerhans-
type multinucleated giant cells were present among the
macrophages, and the granulomas were generally sur-
rounded by a prominent fibrous capsule. Acid-fast bacilli
were sparsely detected in these lesions using the modified
Ziehl Neelsen stain.
The expression of macrophage (MHC-II and LYZS) and
lymphocyte (CD3) cell markers was confirmed by immuno-
histochemistry (data not shown). Macrophages labelled for
MHC-II were equally (P4 0.05) dispersed throughout the
oropharyngeal tonsils and mandibular lymph nodes of
tuberculous and nontuberculous wild boars. Labelling of
MHC-II was also observed in the crypt epithelium of the
tonsils. In the tuberculous granulomas, more than 60% of
the macrophages strongly expressed MHC-II. Interfollicular
lymphocytes and occasionally follicular lymphocytes were
identified as CD31 by immunohistochemistry. Most of the
lymphocytes present among the macrophages surrounding
tuberculous granulomas expressed CD3, as did those located
peripherally. The number of CD31 lymphocytes did not
differ between tuberculous and non-tuberculous wild boars
(P4 0.05). However, significantly more CD31 positive
lymphocytes were found in the mandibular lymph nodes
than in the tonsils (Po 0.05). LYZS appeared to be ex-
pressed in the majority of macrophages and epithelial cells
found in the oropharyngeal tonsils and mandibular lymph
nodes of tuberculous and nontuberculous animals, but
labelling appeared to be more intense in macrophages
around tuberculous granulomas.
Positive mycobacterial cultures were obtained from
all the tonsil and lymph-node samples from tuberculous
boars but in none of the tissues derived from nontubercu-
lous animals. Spoligotyping of mycobacteria confirmed the
presence of two spoligotypes in tuberculous wild boar. The
spoligotype M corresponded to M. bovis and was isolated
from 3/4 of the tuberculous animals. The spoligotype C
was isolated from one boar and corresponded to M. bovis
subsp. caprae, which is considered by some authors to
be a new species within the M. tuberculosis complex (Aranaz
et al., 2003).
Identificationof candidate differentially
expressedgenesbySSH
Candidate differentially expressed genes were identified by
SSH and analysis of ESTs in oropharyngeal tonsils and
mandibular lymph nodes of tuberculous and nontubercu-
lous European wild boars naturally exposed to M. bovis
(Tables S1–S4 in the Supplementary Material). Candidate
differentially expressed genes may be components of single
or multiple cellular mechanisms such as signal transduction,
immune response, inflammation/stress, apoptosis/antia-
poptosis, cell structure, adhesion and transport, protein
and DNA/RNA metabolism and enzymatic processes.
In the global SSH analysis, 156 and 170 candidate
differentially expressed genes were characterized in orophar-
yngeal tonsils and mandibular lymph nodes, respectively
(Fig. 1). Of the 326 candidate differentially expressed genes,
160 (49%) did not have identity to previously published
sequences or were identical to genes of unknown function
(Tables S1–S4). Sixteen genes were represented more than
once in SSH analysis of tonsils and/or lymph nodes (Tables
S1–S4). The MHC class I (MHC-I) SLA genes were repre-
sented six times in tonsils and lymph nodes of nontubercu-
lous wild boars (three times in each), the translation
elongation factor 1a (EF-1a) was represented four times in
lymph nodes and once in tonsils of non-tuberculous wild
boars, the S. scrofa CB475401 EST and LYZS were repre-
sented five and three times, respectively, in lymph nodes of
tuberculous animals, and 12 other genes were represented
twice in various samples.
Although multiple cellular mechanisms were affected by
exposure to mycobacteria, the gene expression profile char-
acterized by SSH differed between tuberculous and non-
tuberculous individuals, and between tonsils and lymph
nodes with some distinctive features (Tables S1–S4). For
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Fig. 1. Candidate unique and commonly differentially expressed genes
in oropharyngeal tonsils and mandibular lymph nodes of European wild
boars naturally exposed to Mycobacterium bovis. Results are expressed
as the number of unique genes differentially expressed by suppression-
subtractive hybridization in tissues of nontuberculous (black area) and
tuberculous (white area) animals.
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example, the heat shock response was found to be differen-
tially expressed in all samples, but this effect was more
pronounced in tonsils of tuberculous animals (Table S1),
while the ubiquitin system was differentially expressed in
tonsils of nontuberculous animals (Table S3). Genes in-
volved in apoptosis, antigen presentation and phagocytosis/
endocytosis were also differentially expressed in the tonsils
and lymph nodes of wild boars naturally exposed to M. bovis
(Tables S1–S4). The MHC-I SLA and EF-1a genes were the
only candidate differentially expressed genes identified by
SSH in both tonsils and lymph nodes of non-tuberculous
animals (Fig. 1).
ValidationofSSH resultsbyRT-PCRand real-time
PCR
Twenty-four candidate differentially expressed genes were
selected based on their putative role during mycobacterial
infection to validate the SSH results by real-time PCR and
RT-PCR. Real-time PCR and semiquantitative RT-PCR were
done on a pool of the RNA samples used in the SSH analysis.
The results of real-time PCR and RT-PCR differed because
of the variations in the relative sensitivities of the techni-
ques, but provided similar differential expression trends in
tonsils and lymph nodes. In addition, the expression of these
24 genes was analysed in the tissues in which they were not
originally identified by SSH, confirming differences in the
differential expression of some genes in tonsils and lymph
nodes (Fig. 2). Of the 24 genes analysed, 17 were confirmed
to be differentially expressed by Z1.5-fold in tonsils or
lymph nodes of wild boars exposed to M. bovis and were
selected for discussion (Table 2).
Analysisof protein levels of selected
differentiallyexpressedgenes
Protein levels of selected differentially expressed genes were
analysed by RID or immunohistochemistry. The C3 and C7
mRNAs were found to be differentially expressed in the
lymph nodes of nontuberculous animals (Table 2), and C3
was found to be highly overexpressed in this tissue (Fig. 2).
Serum C3 and C7 levels were determined in tuberculous and
nontuberculous wild boars by RID. The results of RID
demonstrated that C3 serum levels were higher (P= 0.02)
in nontuberculous wild boars (Average SD; 12 2) than
in tuberculous ones (9 1). C7 levels, although not statisti-
cally significant (P= 0.2), were also higher in non-tubercu-
lous (13 4) than in tuberculous (10 2) animals.
Although immunohistochemical labelling was difficult to
quantify, the levels of MHC-II and LYZS, differentially
Fig. 2. mRNA ratios of selected candidate genes differentially expressed in non-tuberculous (Non-Tb) and tuberculous (Tb) European wild boars
naturally exposed to Mycobacterium bovis. The expression of selected genes was analysed by reverse-transcriptase (RT)-PCR (upper and lower panels)
and quantified by real-time PCR in oropharyngeal tonsils (white bars) and mandibular lymph nodes (black bars), except for LYZS and ARP3, for which the
amount (ng) of RT-PCR bands was determined in the gels by comparison with known amounts of DNA standards and was used to calculate the non-
tuberculous to tuberculous mRNA ratio. Amplification efficiencies were validated and normalized against Sus scrofa ACT (GenBank accession number
U07786). Abbreviations are given in Table 1.
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Table 2. Genes differentially expressed in oropharyngeal tonsils and mandibular lymph nodes of tuberculous and non-tuberculous European wild boars
exposed to Mycobacterium bovis
EST
No. of
identical
ESTsw
GenBank
accession
number Host tissuez
Gene
description References‰
Signal transduction
T21P4 2 DN837413 Non-Tb lymph node Vitamin D receptor-
interacting protein
complex
Xu et al. (2003), Selvaraj et al. (2004)
T11C4 2 DN837322 Tb tonsil Annexin I Majeed et al. (1998)
Non-Tb lymph node
T11H5 1 DN837352 Tb tonsil Lysosomal-associated
protein
Koul et al. (2004), Clemens & Horwitz
(1995)
Non-Tb lymph node
T21P14 1 DN837420 Non-Tb lymph node Vascular cell adhesion
molecule 1
Ragno et al. (2001), Keller et al. (2004),
Feng et al. (2000)
G23C8 1 DN837548 Non-Tb lymph node Chemokine receptor 4 Chaussabel et al. (2003), Keller et al.
(2004), Shalekoff et al. (2001)
Immune response
G21H12 6 DN837485 Non-Tb lymph node MHC class I SLA31 Weiss et al. (2001), Noss et al. (2000),
Gercken et al. (1994), Flynn et al. (1992),
Rolph et al. (2001)
G22H6 1 DN837528 Non-Tb lymph node b2-microglobulin Flynn et al. (1992), Rolph et al. (2001)
G21B5 1 DN837465 Non-Tb lymph node MHC class II SLA-DRA Weiss et al. (2001), Noss et al. (2000),
Gercken et al. (1994)
T22E5 1 DN837432 Non-Tb lymph node Complement
component 3
Velasco-Velazquez et al. (2003), Ferguson
et al. (2004)
G21H4 1 DN837483 Non-Tb lymph node Complement
component 7
Barroso et al. (2004)
G23E7 1 DN837559 Non-Tb lymph node Heat shock protein
gp96
Zu¨gel et al. (2001), Doody et al. (2004),
Cho et al. (2004)
Inflammation/stress
G11D12 3 DN837282 Tb lymph node Lysozyme Yu & Irwin (1996), Aggeli et al. (2000),
Mishra et al. (2000)
Non-Tb tonsil
G11A6 2 DN837260 Tb lymph node Arginase I Keller et al. (2004), Hesse et al. (2001),
Denis (1991)
Tb tonsil
G11A2 2 DN837258 Tb lymph node Secreted
phosphoprotein 1,
osteopontin
Ragno et al. (2001), Nau et al. (1999),
Koguchi et al. (2003)
Protein metabolism
T21H5 1 DN837405 Non-Tb lymph node Cullin 1 Deshaies (1999)
Structural proteins
T21P13 1 DN837419 Non-Tb tonsil Actin-related protein 3 Stamm et al. (2003)
Enzymes
G21B6 1 DN837466 Non-Tb lymph node Methylmalonyl-CoA
mutase
Kambo et al. (2005)
EST denotes expressed sequence tag
Summary of differential expression results of suppression-subtractive hybridization and real-time-PCR/reverse-transcriptase (RT)-PCR analyses for
selected genes.
wNumber of redundant sequences identified by suppression-subtractive hybridization.
zDifferential expression determined in oropharyngeal tonsils (tonsil) and mandibular lymph nodes (lymph node) of tuberculous (Tb) and non-tuberculous
(Non-Tb) European wild boars exposed to Mycobacterium bovis from suppression-subtractive hybridization and real-time PCR/RT-PCR.
‰References to literature used in the Discussion to provide more information on gene function.
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expressed in tonsils and lymph nodes of tuberculous and
nontuberculous animals, were determined in macrophages
by immunohistochemistry. Tuberculous wild boars had
significantly more macrophages in their mandibular lymph
nodes and tonsils that expressed MHC-II than nontubercu-
lous animals (Po 0.05). However, significant differences
were not observed in the intensity of MHC-II labelling
between macrophages of the two groups. Significant differ-
ences were not found in the number of macrophages that
labelled positively for LYZS between tuberculous and non-
tuberculous wild boars, although a marginally significant
tendency to more intense LYZS labelling was observed in
macrophages in the mandibular lymph nodes of tuberculous
animals (P= 0.06).
Discussion
One of the novel approaches of this study was the analysis of
gene expression profiles in wild animals exposed to Myco-
bacterium bovis infection under natural conditions. The
identification of genetic factors associated with resistance
to TB in this European wild boar population presented a
unique opportunity for the study of differential gene
expression in tissue biopsies of naturally occurring indivi-
duals with different susceptibilities to TB (Acevedo-White-
house et al., 2005). This approach did, however, have some
disadvantages. The infection conditions were not controlled,
and therefore wild boar exposure to M. bovis was assumed
based on the fact that animals were Z1 yr old, living in a
highly prevalent TB-endemic area and sharing common
water and food supplies, which increased animal interaction
and exposure to M. bovis. Another problem of working with
wild populations was the presence of mixed infections in the
animals. However, it was possible to minimize the effect of
these mixed infections on differential gene expression ana-
lysis because they were equally present in all the non-
tuberculous and tuberculous animals. For this study, six
female wild boars were captured and characterized. Of them,
four were tuberculous and two were non-tuberculous,
closely resembling the 70% prevalence of TB established for
this population (Gortazar et al., 2003; Vicente, 2004). The
RNAs were pooled for SSH analysis to homogenize samples
and increase the probability of detecting common differen-
tially expressed genes. The criteria to define tuberculous and
non-tuberculous animals were based on the characterization
of TB lesions and the culture and spoligotyping of myco-
bacteria in analysed tissues. Macroscopic lesions character-
istic of TB were found in all tuberculous animals. Although
these lesions were not distributed equally in all tissues
analysed, mycobacterial cultures were obtained from all the
oropharyngeal tonsils and mandibular lymph nodes of
tuberculous animals and in none of the nontuberculous
individuals. The extremely detailed necropsies performed,
in parallel with the complete histopathology and the im-
mediate culture of fresh lymphoid and nonlymphoid tissues,
warrant an optimal sensitivity to detected mycobacterial
infections in mammals that almost rules out infection in the
non-tuberculous animals (Corner, 1994; Rohonczy et al.,
1996).
The differential gene expression in response to pathogen
infection has been reported from SSH in various animal and
plant cells (Begum et al., 2004; Cramer & Lawrence, 2004;
Munir et al., 2004; Nowak et al., 2004; Tanguy et al., 2004).
SSH allows the detection of rare and novel differentially
expressed genes (Diatchenko et al., 1996, 1999). The infor-
mation derived from SSH has provided a basis for defining
host–pathogen interactions and for the identification of
correlates of protective immunity (Begum et al., 2004;
Cramer & Lawrence, 2004; Munir et al., 2004; Nowak et al.,
2004; Tanguy et al., 2004; Tsoi et al., 2004).
In this study, some of the candidate differentially ex-
pressed genes that were identified by SSH in oropharyngeal
tonsils and mandibular lymph nodes of tuberculous and
nontuberculous European wild boars naturally exposed to
M. bovis constitute new findings. Herein, we selected for
discussion those genes that were confirmed differentially
expressed in Z1.5-fold by real-time PCR/RT-PCR analyses
(Table 2).
Some of the differentially expressed genes identified in
wild boars were reported previously in other organisms
using different experimental approaches. Among these
genes was the lysosomal-associated protein (LAP), which is
involved in phagosomal maturation and is negatively regu-
lated by pathogenic mycobacteria in human and mouse
macrophages (Clemens & Horwitz, 1995; Koul et al., 2004).
The results reported in this work identified that this gene
was differentially expressed in the tonsils and lymph nodes
of tuberculous and nontuberculous wild boars, respectively.
Annexin I (ANX), which participates in the endocytic path-
way involved in phagocytosis of mycobacteria (Majeed et al.,
1998), was differentially expressed in lymph nodes of non-
tuberculous wild boars and in tonsils of tuberculous ani-
mals. Altogether, these results suggest that the regulation of
genes involved in endocytosis of mycobacteria in wild boars
is a complex mechanism in which some genes are differen-
tially expressed in tissues of tuberculous and nontubercu-
lous animals and may differ from the response observed in
other host species.
Ubiquitination of proteins requires a multienzyme sys-
tem of which cullin 1 (CUL) is an example (Deshaies, 1999).
The ubiquitin system, involved in protein degradation and
regulation of the cell cycle, was differentially expressed in
tonsils of nontuberculous wild boars, as reported previously
for human (Chaussabel et al., 2003; Wang et al., 2003) and
cattle (Weiss et al., 2004) macrophages. Arginase (ARG),
induced by Th2-type cytokines in mice, plays an important
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role in the regulation of inflammation and bacteriostatic
ability of interferon-g(IFN-g) (Denis, 1991; Hesse et al.,
2001). ARG was differentially expressed in tonsils and lymph
nodes of tuberculous wild boars and is induced in mouse
macrophages infected with M. tuberculosis (Keller et al.,
2004). The cytokine osteopontin (OPN) was differentially
expressed in tonsils of tuberculous wild boars. OPN, in-
volved in cell migration and homing, is induced by myco-
bacterial infection and may be involved in the pathologic
process associated with active pulmonary TB (Nau et al.,
1999; Ragno et al., 2001; Koguchi et al., 2003). LYZS was
another inflammation/stress protein differentially expressed
in wild boars naturally exposed to M. bovis. LYZS, which is
encoded by a single gene expressed in both stomach and
non-stomach tissues of pigs (Yu & Irwin, 1996), was
differentially expressed in tonsils of non-tuberculous wild
boars and in lymph nodes of tuberculous animals. LYZS
levels are increased in tuberculous effusions with diagnostic
value in humans (Aggeli et al., 2000; Mishra et al., 2000), a
process that, as shown here, may be regulated in lymph
nodes at the mRNA level.
Keller et al. (2004) identified, by microarray analysis,
genes specifically regulated in M. tuberculosis-infected
macrophages derived from susceptible and resistant mouse
strains. The vascular cell adhesion molecule 1 (VCAM-1),
involved in leukocyte–endothelial cell interactions and asso-
ciated with immunity to M. tuberculosis through the recruit-
ment of Th1-type T cells to the site of infection (Feng et al.,
2000), was found to be differentially expressed in lymph
nodes of nontuberculous wild boars. However, incongruent
results were reported for VCAM-1 gene expression in M.
tuberculosis-infected mouse (Keller et al., 2004) and human
(Ragno et al., 2001) macrophages.
Mycobacterial infections induce suppression of cellular
antibacterial responses through the inhibition of signal
transduction, cell maturation, immune response and anti-
gen presentation, among other mechanisms (reviewed by
Koul et al., 2004). In the SSH analysis described in this work
we identified several candidate differentially expressed genes
involved in the regulation and execution of antibacterial
responses.
The expression of signal transducers such as VDR and the
chemokine receptor 4 (CXCR4) were affected in wild boars
naturally exposed to M. bovis. Deficiencies in vitamin D, a
modulator of macrophage function, as well as polymorph-
isms in VDR, have been associated with higher risks of TB
infection (Selvaraj et al., 2004). Downregulation of VDR has
been reported in human macrophages infected with M.
tuberculosis and may be associated with unresponsiveness
to vitamin D(3) in pulmonary TB patients (Xu et al., 2003;
Selvaraj et al., 2004). Increased expression of VDR in certain
human genotypes may be associated with improved im-
mune response to mycobacterial infections (Selvaraj et al.,
2004). Differential expression of VDR in lymph nodes of
nontuberculous wild boars reinforces the role of VDR in
mycobacterial pathogenesis, and suggests that polymorph-
isms in the VDR gene may also be associated with resistance
to TB in wild boar.
The upregulation of chemokine receptor expression was
described during mycobacterial infection (Chaussabel et al.,
2003; Keller et al., 2004). However, the results reported on
the expression of CXCR4, differentially expressed in lymph
nodes of nontuberculous wild boars, are in agreement with
our results. Although M. tuberculosis infection of macro-
phages in vitro increases CXCR4 surface expression, expres-
sion of CXCR4 is significantly reduced in persons with
pulmonary TB (Shalekoff et al., 2001).
Antigen presentation was differentially regulated in wild
boars in this study. The MHC-I and MHC-II pathways,
which play a central role in innate as well as in acquired
immunity, may be one of the target molecules for the
immune evasion by mycobacteria and other intracellular
bacteria (Zu¨gel et al., 2001; Cho et al., 2004; Doody et al.,
2004). Infection with mycobacteria affects MHC-I and
MHC-II antigen processing (Gercken et al., 1994; Noss
et al., 2000; Weiss et al., 2001). MHC-I restricted CD81
and T cells b2-microglobulin (B2M), are required for the
development of resistance to TB (Flynn et al., 1992; Rolph
et al., 2001). These results support why heat shock protein
gp96, a chaperone of both MHC-I and MHC-II restricted
epitopes for in vivo antigen presentation (Doody et al.,
2004), B2M, MHC-II SLA-DRA and certain MHC-I SLA
alleles were differentially expressed in lymph nodes of
nontuberculous wild boars. These results support an im-
portant role for MHC-I and MHC-II restricted antigen
presentation during mycobacterial infections in European
wild boar.
The complement system has been shown to be involved in
mycobacterial pathogenesis. M. tuberculosis activates the
alternative pathway of complement and binds C3 protein,
resulting in enhanced phagocytosis by complement recep-
tors (CR3) on human alveolar macrophages (Velasco-Velaz-
quez et al., 2003; Ferguson et al., 2004). This mechanism of
C3 opsonophagocytosis of M. tuberculosis by macrophages
may result in the inhibition of bactericidal responses and
pathogen survival (Velasco-Velazquez et al., 2003). The
differential expression of C3 in lymph nodes and tonsils of
nontuberculous wild boars may contribute to a protective
mechanism against mycobacterial infection. Higher levels of
C3 may allow increased binding of C3 to CR3 to promote
phagocytosis and effective killing of bacteria, while inter-
fering with CR3-mediated opsonic and nonopsonic phago-
cytosis of mycobacteria (Velasco-Velazquez et al., 2003).
Different genetic mutations have been described in C7
deficiency, a molecular defect clinically associated with an
increased susceptibility to recurrent neisserial infections
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(Barroso et al., 2004). Although the role of C7 in
TB is presently unknown, the differential expression of
C7 in lymph nodes of non-tuberculous wild boars con-
stitutes an interesting finding that warrants further charac-
terization.
Genes affecting cellular processes, such as protein and
DNA/RNA metabolism and cytoskeleton, were differentially
expressed in wild boars from this study. These genes
included ones encoding for CUL, ARP3 and methylmalo-
nyl-CoA mutase (MUT).
Some intracellular bacteria, including M. marinum, have
been shown to escape from phagosomes by recruiting host
cell cytoskeletal factors, such as ARP3. These host factors
induce actin polymerization, resulting in intracellular moti-
lity and direct cell-to-cell spread (Stamm et al., 2003).
However, the differential expression of ARP3 in tonsils of
non-tuberculous wild boar is difficult to explain because this
mechanism of bacterial motility has not been determined
for the M. tuberculosis complex.
Methylmalonyl-CoA mutase was differentially expressed
in lymph nodes of nontuberculous wild boars. This protein,
a key enzyme in intermediary metabolism, was shown
recently to be inhibited by nitric oxide, perhaps linked to
the severe metabolic acidosis observed in children with
deficiencies in MUT activity (Kambo et al., 2005). Although
the role of MUT during TB is unknown, it has been
associated with resistance to TB in European wild boar
(Acevedo-Whitehouse et al., 2005).
Presently, the exact role of apoptosis in mycobacterial
pathogenesis is unclear and differences have been reported
in the levels of apoptosis caused by M. tuberculosis in human
macrophages and alveolar epithelial cells (Danelishvili et al.,
2003). While mycobacteria were hypothesized to prevent
apoptosis in the early phase of infection to allow for efficient
bacterial replication, they may induce or be unable to
prevent cell death in later phases, which would contribute
to their systemic dissemination via infection of immune cells
(Weinrauch & Zychlinsky, 1999; Koul et al., 2004). The
results of the SSH analysis supported this hypothesis.
Candidate differentially expressed genes in tonsils and
lymph nodes of nontuberculous wild boars included syn-
leurin, a leucine-rich repeat protein that increases the
intensity of pleiotropic cytokine responses (Wang et al.,
2003), cisplatin, a resistance-associated overexpressed pro-
tein that could be involved in the formation of the spliceo-
some (Umehara et al., 2003), and caprin-1, a cytoplasmic
protein associated with the proliferation of lymphocytes
(Grill et al., 2004). The expression of these genes may have
antiapoptotic activity and thus correlate with protective
responses to mycobacteria. On the other hand, the apopto-
sis-specific protein p45ASP gene, differentially expressed in
tonsils of tuberculous wild boars, constitutes an apoptotic
protein (Yung et al., 2002).
Other genes reported to be regulated in macrophages and
dendritic cells in response to mycobacterial infections (re-
viewed by Koul et al., 2004) were not found differentially
expressed in the SSH analysis of European wild boars
naturally exposed to M. bovis, which may have resulted from
variations in the methodological approach, global expres-
sion analysis vs. SSH, or from the use of different mycobac-
terial strains, tissues, and stage and condition of infection.
However, these results also suggest that the response in
European wild boars to natural mycobacterial infection
could differ from human and mouse cell responses reported
previously in experimental studies.
Conclusions
The profile of candidate differentially expressed genes in
response to Mycobacterium bovis in European wild boars
under natural infection conditions has similarities to and
differences from reports for other host species and for
different experimental conditions. The results of the differ-
ential expression analysis by SSH were different for tonsils
and lymph nodes, suggesting that these organs play different
roles during TB infection and progression. Differential
expression in tonsils and lymph nodes of tuberculous wild
boars had some common features evidenced by the inhibi-
tion of phagosomal maturation and/or endocytosis and by
OPN expression, which correlates with pathologic processes.
However, evidence of apoptosis in tuberculous animals was
found in tonsils only, whereas correlates of Th2 and inflam-
matory responses were found exclusively in lymph nodes.
Tonsils and lymph nodes of nontuberculous animals also
presented common differentially expressed genes including
VDR, C3, as well as other genes that participate in key
cellular processes relevant for TB pathogenesis such as Th1
response, antigen presentation and prevention of apoptosis.
The genes differentially expressed in nontuberculous wild
boars may represent downregulation as a result of mycobac-
terial infection in tuberculous animals and/or upregulation
in nontuberculous individuals as a result of individual
resistance and/or protective response to infection. The
experimental design of the study reported herein did not
permit selection among these possibilities. Differentially
expressed genes in nontuberculous wild boars could be the
result of genetic polymorphisms at loci associated with
disease susceptibility. Some of the genes differentially ex-
pressed in nontuberculous animals, such as VDR, MUT, and
certain MHC-I alleles, have been associated with resistance
to TB in human, mouse and/or European wild boar popula-
tions (Bellamy, 2003; Ma et al., 2003; Kotb, 2004; Acevedo-
Whitehouse et al., 2005).
In summary, the results presented in this manuscript
demonstrate that SSH analysis provides fundamental infor-
mation towards the elucidation of mechanisms involved in
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mycobacteria–cell interactions in naturally exposed Eur-
opean wild boars. Specific candidate genes whose expression
was shown by SSH analysis to be affected by mycobacterial
infection were verified by real-time PCR, semiquantitative
RT-PCR, and at the protein level by RID or immunohisto-
chemistry. Some of the differentially expressed genes identi-
fied by this study have not been reported previously in
mycobacteria-infected cells, thus expanding the existing
information on the response of mammalian host cells to
mycobacterial infections under natural conditions. These
results suggest possible correlates of protective immunity to
TB, and provide evidence of the manner in which mycobac-
teria modulate gene expression in tonsils and lymph nodes.
The expression of genes reported here was associated with
the regulation of important cellular mechanisms such as
signal transduction, immune response, inflammation/stress,
apoptosis/antiapoptosis, cell structure, adhesion and trans-
port, protein and DNA/RNA metabolism and enzymatic
processes, some of which are used by the pathogen for
infection and multiplication in the host cells.
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Table S1. Candidate genes differentially expressed by SSH in oropharyngeal tonsils of 
tuberculous European wild boar infected with M. bovis. 
EST  Sequence identity E value Short description 
Structural proteins 
T11A1 Human LOC129285  0.0 Smooth muscle myosin heavy 
chain 
T11E10 Bovine KERIV 9e-79 Epidermal cytokeratin (type II) 
component IV 
 
Protein metabolism 
T11D8 Human RPL14 1e-112 Ribosomal protein L14 
 
Signal transduction 
T11A5 Human ANGPTL1 1e-107 Angiopoietin 1 
T11A11 Human SLC35A1 1e-164 CMP-sialic acid transporter 
T11B10 Human ASB3 0.0 Adapter molecule 
T11C1 Human CALM2 0.0 Calmodulin 2 
T11C4/T11F10 Swine annexin I 0.0 Annexin I 
T11C6 Human PA26 0.0 p53 regulated nuclear protein 
T11D5 Human RAB7 2e-61 Ras oncogene family 
T11E12 Human CAP1 0.0 Adenylate cyclase-associated 
protein 1 
T11G3 Human NS 1e-71 Nucleostemin 
T11G10 Human PARD6B 8e-64 Par-6 partitioning defective 6 
homolog beta (C. elegans) 
T11H5 Bovine LAPTM4a 6e-77 Lysosomal-associated protein 
T11E11 Human ROBO2 7e-86 Roundabout, axon guidance 
receptor 
T11G11 Swine LOC396559 1e-127 Membrane steroid receptor 
 
Apoptosis/anti-apoptosis 
T11A7 Human APG5L 0.0 Apoptosis specific protein 
T11E2/T11F12 Swine myostatin 0.0 Growth factor 8 
 
DNA/RNA affecting 
T11A8 Human DEAD/H (Asp-
Glu-Ala-Asp/His) box 
polypeptide 5 
0.0 RNA helicase 
T11A12 Human zinc finger 
protein 297B 
0.0 Transcription factor 
T11B12 Human zinc finger 
protein 207 
 Transcription factor 
T11C3 Human MGC23908 1e-69 RNA polymerase B transcription 
factor 3 
Supplementary Material: Tables S1-S4
T11E4 Human SRp40 1e-136 Splicing factor 
T11E5 Human TZP 9e-95 Transcription factor 
    
Enzymes    
T11B7 Human AD-017 0.0 Glycosyltransferase 
T11B11 Swine cytb 0.0 Cytochrome b 
T11D7 Human TARS 1e-133 Threonyl-tRNA synthetase 
T11E9 Human ACSL3 1e-127 Acyl-Coa synthetase long-chain 
family member 3 
T11F9 Human NQO1 2e-45 NADPH dehydrogenase, quinine 1 
T11H9 Swine NADH1 1e-177 NADH dehydrogenase 
    
Inflammation/stress 
T11B6 Bovine hsp90 beta 0.0 Hsp90 beta chaperone 
T11F6 Human HSPA8 1e-96 Hsp70 protein 8 chaperone 
T11F11 Human DNAJC10 1e-148 DnaJC110 (Hsp40) chaperone 
 
Immune response 
T11C8 Swine Igκ 2e-73 Immunoglobulin kappa variable 
region 
 
Miscellaneous 
T11A6 S. scrofa BM083219 1e-87 Function unknown 
T11A10 S. scrofa BP166374 0.0 Function unknown 
T11B2 S. scrofa BI118293 6e-97 Function unknown 
T11B4 S. scrofa BI119022 1e-90 Function unknown 
T11C7 S. scrofa BI132958 0.0 Function unknown 
T11E1 S. scrofa BM659058 e-108 Function unknown 
T11E8 None --- Function unknown 
T11F2 S. scrofa CK461065 0.0 Function unknown 
T11F4 None --- Function unknown 
T11F5 S. scrofa BP162350 0.0 Function unknown 
T11F7 S. scrofa BX920390 0.0 Function unknown 
T11G2 S. scrofa CN164751 0.0 Function unknown 
T11G6 None --- Function unknown 
T11G7 S. scrofa CB477955 0.0 Function unknown 
T11G8 Rat Ns5atp9 1e-50 Function unknown 
T11H7 S. scrofa BF712156 0.0 Function unknown 
T11H8 S. scrofa CN158180 9e-63 Function unknown 
T11H10 None --- Function unknown 
T11H12 None --- Function unknown 
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Table S2. Candidate genes differentially expressed by SSH in mandibular lymph nodes of 
tuberculous European wild boar infected with M. bovis. 
EST  Sequence identity E value Short description 
Structural proteins 
G11B6 Bovine LUM 7e-63 Lumican: keratin sulfate 
proteoglycan isoform 37B 
    
Protein metabolism 
G11B9 Human RPLP0 1e-170 60S ribosomal protein P0 
G11B11 Swine RPN1 1e-129 Ribophorin 1 
G11E11 Bovine RPL3 1e-121 Ribosomal protein L3 
    
Signal transduction 
G11C3 Bovine CATS 1e-110 Cathepsin S 
    
DNA/RNA affecting 
G11A8 Human MBNL1 6e-72 Muscleblind-like transcript variant 
1 
G11D8 Human RNF103 1e-149 Transcriptional regulator kf-1, ring 
finger protein 103 
G11F3 Human GABPB2 3e-99 GA binding protein transcription 
factor, β subunit 2 
    
Enzymes 
G11E9 Swine HEXB 1e-166 B-N-acetyl-hexosaminidase 
G11G3 Human cytb5 5e-48 Cytochrome b5 outer mitochondrial 
membrane precursor 
    
Inflammation/stress 
G11A6/G11H3 Swine ARG1 0.0 Arginase I 
G11D12/G11E3
G11G9 
Swine LYZS 0.0 Lysozyme 
G11H4 Swine HSP90 7e-58 Hsp90 chaperone 
G11A1/G11E8 Bovine SAA3 2e-48 Amyloid A 
G11A2/G11B8 
 
Swine SPP1 0.0 Secreted phosphoprotein 1, 
osteopontin 
    
Immune response 
G11H2 Swine SLA-DRB 1e-108 MHC class II antigen 
    
Miscellaneous 
G11B3 Human H3F3A 6e-72 H3 histone, family 3A 
G11G7 Human MOSPD1 9e-47 Motile sperm domain containing 1 
G11A3  S. scrofa BE013165 1e-155 Function unknown 
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G11A12 S. scrofa CK454169 1e-144 Function unknown 
G11B5/G11B10 
G11C11/G11H7 
G11H10 
S. scrofa CB475401 1e-126 Function unknown 
G11C1 None --- Function unknown 
G11C5 S. scrofa BX922403 9e-96 Function unknown 
G11C6 None --- Function unknown 
G11C9 None --- Function unknown 
G11C10 S. scrofa BI118474 6e-97 Function unknown 
G11C12 S. scrofa BQ597664 0.0 Function unknown 
G11D1 S. scrofa BX922928 0.0 Function unknown 
G11D2 S. scrofa BP161957 1e-130 Function unknown 
G11D3 None --- Function unknown 
G11D4 S. scrofa AJ657908 8e-95 Function unknown 
G11D7 S. scrofa BP158145 1e-117 Function unknown 
G11D11 None --- Function unknown 
G11E12 S. scrofa AJ666799 1e-134 Function unknown 
G11E2 S.scrofa AW486662 1e-85 Function unknown 
G11E6 None --- Function unknown 
G11E7 None --- Function unknown 
G11F7 None --- Function unknown 
G11F8 S. scrofa BQ599228 0.0 Function unknown 
G11F9 S. scrofa CF366987 0.0 Function unknown 
G11F10 S. scrofa BQ603358 0.0 Function unknown 
G11F11 S. scrofa CK460791 e-147 Function unknown 
G11F12 S. scrofa BI400395 e-116 Function unknown 
G11G10 None --- Function unknown 
G11G12 S. scrofa BP143985 e-150 Function unknown 
G11H5 S. scrofa BP436764 e-134 Function unknown 
G11H9 S. scrofa BX919389 e-111 Function unknown 
G11H11 S. scrofa BP460593 e-127 Function unknown 
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Table S3. Candidate genes differentially expressed by SSH in oropharyngeal tonsils of 
non-tuberculous European wild boar exposed to M. bovis. 
EST  Sequence identity E value Gene description 
Structural proteins 
T21P13 Human ACTR3 0.0 Actin related protein 3 
 
Protein metabolism 
T21A6 Swine RPL32 1e-112 60S ribosomal protein L32 
T21B6 Bovine eEF-1α 0.0 Translation elongation factor 1α 
T22E10/T22E11 Human EEF1B2 1e-173 Translation elongation factor 1β 2 
T21D4 Human FLJ32109 1e-176 Similar to ubiquitin-protein ligase 1 
T21E4 Human FBXO11 1e-152 F-box protein 11 
T22C10 Human FBXO3 e-139 F-box protein 3 
T21F1 Swine CAST 0.0 Protease inhibitor calpastatin 
T21H5 Bovine CUL1 1e-123 Cullin 1 
T21H9 Human NEDD4L 1e-104 Ubiquitin ligase 
T22F6 Human RNF20 1e-179 Ring finger protein 20 
T23A9 Human PSARL  1e-124 Metalloprotease 
T23B3 Human RPL22 1e-150 Ribosomal protein L22 
T23C4 Human MRPS36 2e-95 Mitochondrial ribosomal protein 
S36 
T23C5 Swine PSME1 1e-156 Proteasome activator 28 alpha 
subunit 
 
Signal transduction 
T21C2 Human RTN4IP1 9e-87 Reticulon 4 
T21C9 Human CCNB2 0.0 Cyclin B2 
T21P4/T23A10 Human DRIP205 0.0 Vitamin D receptor-interacting 
protein complex 
T21P14 Swine VCAM1 0.0 Vascular cell adhesion molecule 1 
T22B12 Human PLEK 0.0 Pleckstrin 
T22C3 Maize PCO116159 1e-139 Triose phosphate/phosphate 
translocator 
T23D9 Human ARHGAP15 0.0 Rho GTPase activating protein 15 
T23H4 Human ITPR1 1e-110 Inositol 1,4,5-triphosphate receptor 
type 1 
T23H10 Human SDCBP 1e-127 Syntenin 
T21C8 Human LAMR1 1e-112 Laminin receptor 1 
T21A3 Human EEA1 0.0 Endosome-associated protein 
T21D3/T22H11 Bovine CLTC 1e-111 Clathrin heavy polypeptide  
    
Apoptosis/anti-apoptosis 
T23F8 Human LUC7A 0.0 Cisplatin resistance-associated 
overexpressed protein 
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Transport 
T21E5 Human SEC24D 0.0 Protein transport protein 
T21H4 Human TIMM23 1e-130 Mitochondrial import inner 
membrane translocase subunit 23 
T23E5 Swine FTH1 1e-141 Ferritin heavy chain 1 
 
DNA/RNA affecting 
T21D10 Human TARDBP 0.0 TAR DNA binding protein 
T21E2 Human Nrf2 1e-132 NF-E2-like basic leucine zipper 
transcriptional activator 
T21E11 Human WDHD1 1e-140 WD repeat and HMG-box DNA 
binding protein 1 
T21G10 Human MBNL1 0.0 Muscleblind-like RNA binding 
protein 1 
T21G7 Human NCBP1 1e-131 Nuclear cap binding protein subunit 
1 
T23B10 Human MIER1 1e-177 Mesoderm induction early response 
1 N3-beta-ii transcription factor 
T23D3 Human DDX3X 1e-130 RNA binding protein 
T23G5 Human SF3B3 5e-56 Splicing factor 3 subunit b 
 
Enzymes    
T21A5/T22C12 Human 
sialyltransferase 8D  
6e-77 Alpha-2, 8-polysialyltransferase 
T21B8 Human ATP5B 1e-135 ATP synthase, H+ transporting, 
mitochondrial F1 complex, β-
polypeptide 
T21D6 Swine LDH-B 0.0 Lactate dehydrogenase B 
    
Inflammation/stress 
T21F11 Human SGK 0.0 Serum/glucocorticoid regulated 
kinase 
T23F7 Swine CYP11A1 1e-159 Cytochrome P450 (CYP11A1) 
T23D6 Human RRM2B 1e-113 p53-inducible ribonucleotide 
reductase M2 
T22A8 Human HSPA4 1e-107 Hsp70 protein 4 chaperone 
T23F12 Bovine HSP90 1e-107 Hsp 90 beta 
 
Adhesión 
T21E6 Swine SELE 0.0 E-selectin 
 
Immune response 
T21F6/T21G11/ 
T23E12 
Swine SLA 0.0 MHC class I SLA, haplotype H01 
T22E5 Swine C3 0.0 Complement component 3 
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Miscellaneous 
T21A9 Human HPS5 0.0 Hermansky-Pudlak syndrome 5 
protein 
T21D1 Human XTP3TBP 1e-135 Gene 3 transactivated by hepatitis B 
virus X antigen 
(XTP3)transactivated protein 
T23C11 Human MAGED2 1e-111 Function unknown 
T23D12 Human PRKA 1e-55 Kinase anchor protein (yotiao) 9 
T21A7 S. scrofa  CK453550 0.0 Function unknown 
T21A8 S. scrofa AJ746964 e-160 Function unknown 
T21A12 S. scrofa CD572010 8e-85 Function unknown 
T21B1 S. scrofa BX671944 9e-74 Function unknown 
T21B2 None --- Function unknown 
T21B5 None --- Function unknown 
T21B7 None --- Function unknown 
T21B10 S. scrofa CN153712 0.0 Function unknown 
T21B11 S. scrofa BF709892 1e-143 Function unknown 
T21B12 S. scrofa BP159612 1e-140 Function unknown 
T21C1 None --- Function unknown 
T21C12 S. scrofa BF703469 0.0 Function unknown 
T21D7 S. scrofa BP157293 1e-152 Function unknown 
T21E1 None --- Function unknown 
T21E3 S. scrofa CK452033 0.0 Function unknown 
T21E8 S. scrofa CK453696 8e-74 Function unknown 
T21E9 S. scrofa AC092874 0.0 Function unknown 
T21F3 None --- Function unknown 
T21F4 None --- Function unknown 
T21F9 None --- Function unknown 
T21G2 None --- Function unknown 
T21G3 S. scrofa CK451014 1e-126 Function unknown 
T21G9 S. scrofa CN157412 1e-114 Function unknown 
T21G12 S. scrofa BP162709 1e-160 Function unknown 
T21H6 None --- Function unknown 
T21H8 S. scrofa BQ600803 2e-77 Function unknown 
T21H10 S. scrofa AJ746886 1e-119 Function unknown 
T21H12 S. scrofa CK465325 0.0 Function unknown 
T21P1 S. scrofa CB479238 0.0 Function unknown 
T21P2/T21P3 S. scrofa BP158145 1e-125 Function unknown 
T21P5 None --- Function unknown 
T21P7 S. scrofa BP147794 0.0 Function unknown 
T21P8 S. scrofa AJ660272 0.0 Function unknown 
T21P10 S. scrofa BQ603166 0.0 Function unknown 
T21P11 S. scrofa CK456652 0.0 Function unknown 
T22A9 S. scrofa AJ657306 1e-140 Function unknown 
T22A12 S. scrofa BQ599322 1e-103 Function unknown 
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T22B4 S. scrofa CK464205 1e-135 Function unknown 
T22B5 S. scrofa AJ659243 1e-136 Function unknown 
T22B8 S. scrofa CN157536 1e-180 Function unknown 
T22C4 S. scrofa BF701977 1e-136 Function unknown 
T22D10 S. scrofa AJ654824 1e-157 Function unknown 
T22F10 None --- Function unknown 
T22F12 S. scrofa CN160977 1e-164 Function unknown 
T22H7 S. scrofa CF789476 2e-85 Function unknown 
T23A8 None --- Function unknown 
T23H12 S. scrofa C94734 1e-151 Function unknown 
T23G12 None --- Function unknown 
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Table S4. Candidate genes differentially expressed by SSH in mandibular lymph nodes of 
non-tuberculous European wild boar exposed to M. bovis. 
EST  Sequence identity E value Gene description 
Protein metabolism 
G21D9 Human RPLP0 1e-142 Ribosomal protein P0 
G21E10/G23A7 Swine RPL11 1e-179 60S ribosomal protein L11 
G22H2/G23B12/ 
G21H7/G22H9 
Human/Bovine eEF-
1α 
0.0 Translation elongation factor 1α 
G21H9 Human RPS16 1e-49 Ribosomal protein S16 
G22D2 Human EIF3S4 4e-92 Eukaryotic translation initiation 
factor 3, subunit 4 delta 
G22F2 Swine HBP15/L22 1e-134 Ribosomal protein L22/heparin 
binding protein 
G23C2 Human RPL34 4e-42 Ribosomal protein L34 
G23G7 Human FBXW7 4e-52 F-box and WD-40 domain protein 
7 
G22H3 Swine NTAN1  5e-83 N-terminal asparagine 
amidohydrolase  
G22H12 Human ITM1 0.0 Integral membrane protein 1 
    
Signal transduction 
G21A9 Human YWHAQ 1e-140 Tyrosine 3-
monooxygenase/tryptophan 5-
monooxygebase activation protein, 
theta polypeptide 
G21E9 Human AP3M1 0.0 Adaptor-related protein complex 3, 
mu 1 subunit 
G21G7 Human ROCK1 8e-94 Rho-associated protein 
serine/threonine kinase 
G21G8 Human HINT1 1e-67 Histidine triad nucleotide binding 
protein 1 
G22B4 Human SHIP-2 1e-121 Signaling inositol polyphosphate 
phosphatase 
G22C4 Human MAPRE1 8e-58 Microtubule-associated protein, 
RP/EB family, member 1 
G21G9 Human unr 3e-91 Upstream of N-ras 
G22D12 Human LAX 7e-43 Membrane associated adaptor 
protein 
G23A5 Human DMXL1 1e-79 Dmx-like 1 
G23A11 Swine CYC511 1e-149 Cyclin B1 
G23B9 Human PRKCN 1e-160 Protein kinase C 
G23C4 Swine PPP1CB 0.0 Protein phosphatase 1 
G23E4 Human CCNG2 2e-77 Cyclin G2 
G22F10 Human LEPROTL1 6e-49 Leptin receptor 
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G23C8 Swine CXCR4 0.0 Chemokine receptor 4 
    
Apoptosis/anti-apoptosis 
G21F12 Human caprin-1 1e-173 Cytoplasmic 
activation/proliferation-associated 
protein 1 
G22A4 Human PCNT1 2e-74 Pericentrin 1 
G22B5 Human synleurin 
 
4e-62 Leucine-rich repeat protein that 
increases the intensity of 
pleiotropic cytokine responses 
 
Transport 
G22C5 Human SYP 1e-127 Synaptophysin 
G22F8 Human XPO6 1e-173 Exportin 6 
 
DNA/RNA affecting 
G21F10/G22F11 Human HNRPF 0.0 Heterogeneous nuclear 
ribonucleoprotein F 
G22A11 Human RBM7 1e-132 RNA binding motif protein 7 
G22D7 Human HNRPC 1e-150 Heterogeneous nuclear 
ribonucleoprotein C (C1/C2) 
G22D11 Human FKBP4 1e-126 FK506 binding protein 4 
interacting with IRF-4 
G23A9 Human DDX39 1e-180 DEAD box polypeptide 39 
G23B5 Human ZNF638 3e-75 Zinc finger protein 638 
G23D7 Mouse HNRPH1 6e-62 Heterogeneous nuclear 
ribonucleoprotein H1 
G23D11 Human EP300 1e-113 E1A binding protein p300 
G23F7 Human TRIP15 1e-128 Thyroid receptor interacting 
protein 15 
G23G10 Human GZP1 1e-152 GC-box DNA binding zinc finger 
protein 
G23H9 Human SET 5e-53 SET translocation (myeloid 
leukemia-associated) 
 
Enzymes 
G21A12 Human 2966655 4e-75 Coenzyme Q3 homolog 
methyltransferase 
G21B6 Swine MUT 0.0 Methylmalonyl-CoA mutase 
G23B4 Human ACAT1 2e-66 Acetyl-CoA acetyltransferase 1 
G23H8 Swine COX7A1 2e-71 Cytochrome c oxidase subunit 
VIIa-M 
    
Immune response 
G21B5 Swine SLA-DRA 0.0 MHC class II antigen 
G21F7 Swine LOC396781 2e-82 IgG heavy chain 
46
G21H4 Swine C7 0.0 Complement component 7 
G21H12/G22E12 
G23E11 
Swine SLA  0.0 MHC class I SLA, haplotype H01  
G22H6 Swine B2M 0.0 β2-microglobulin 
G23C7 Human CD20 4e-60 B lymphocyte antigen 
G23E7 Swine TRA1 1e-170 Heat shock protein gp96  
 
Miscellaneous 
G21A3 None --- Function unknown 
G21A8 Human NM_006083 7e-55 IK cytokine, down-regulator of 
HLA II 
G21A10 S. scrofa CN165360 1e-101 Function unknown 
G21A11 Human 4830384 1e-175 Similar to EMSY protein 
G21B8 None --- Function unknown 
G21B9 None --- Function unknown 
G21C7 None --- Function unknown 
G21C8 None --- Function unknown 
G21E11 None --- Function unknown 
G21E12 None --- Function unknown 
G21F8 None --- Function unknown 
G21F11 None --- Function unknown 
G21H2 None --- Function unknown 
G22A7 None --- Function unknown 
G22A12 None --- Function unknown 
G22B1 None --- Function unknown 
G22B7 None --- Function unknown 
G22B8 None --- Function unknown 
G22B9 None --- Function unknown 
G22B11 None --- Function unknown 
G22C9 None --- Function unknown 
G22C10 None --- Function unknown 
G22D5 None --- Function unknown 
G22D9 None --- Function unknown 
G22D10 None --- Function unknown 
G22E2 Human DNA 
sequence from clone 
RP11-175019 
2e-82 Function unknown 
G22E4 None --- Function unknown 
G22E10 None --- Function unknown 
G22F3 Human FLJ22965 2e-53 Function unknown 
G22F7 Human TXNL2 9e-69 Function unknown 
G22F9 None --- Function unknown 
G22F12 None --- Function unknown 
G22G3 None --- Function unknown 
G22G5 None --- Function unknown 
G22G8 Human clone 0.0 Function unknown 
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CS0DG006YB11 of 
B cells 
G22G10 None --- Function unknown 
G22G11 None --- Function unknown 
G22G12 None --- Function unknown 
G22H4 Human FLJ35630 1e-90 Function unknown 
G22H10 None --- Function unknown 
G22H11 None --- Function unknown 
G23A4 None --- Function unknown 
G23A8 None --- Function unknown 
G23B7 None --- Function unknown 
G23B10 Bovine 
NM_001002885 
1e-99 Thymosin beta 4 
G23B11 None --- Function unknown 
G23C5 None --- Function unknown 
G23C11 None --- Function unknown 
G23C12 None --- Function unknown 
G23D2 Sea hare ek435 gene 3e-89 Cytolytic cyplasin S  
G23D5 None --- Function unknown 
G23D6 None --- Function unknown 
G23D8 Human BX537823 7e-80 Function unknown 
G23D10 None --- Function unknown 
G23E10 None --- Function unknown 
G23F1 None --- Function unknown 
G23F6 None --- Function unknown 
G23F9 None --- Function unknown 
G23F10 None --- Function unknown 
G23F11 None --- Function unknown 
G23G2 None --- Function unknown 
G23G4 None --- Function unknown 
G23G12 None --- Function unknown 
G23H4 None --- Function unknown 
G23H7 None --- Function unknown 
G23H11 Human KIAA0058 0.0 Function unknown 
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Capítulo 2.2 
 
Análisis proteómico y transcriptómico de la respuesta de 
estrés e inflamatoria diferencial en  linfonodos mandibulares y 
tonsilas de jabalíes infectados de forma natural con 
Mycobacterium bovis 
 
Resumen 
 
La respuesta diferencial de estrés e inflamatoria fue caracterizadas a nivel 
de ARNm y proteínas en linfonodos mandibulares y tonsilas de jabalíes 
(Sus scrofa) infectados de forma natural con Mycobacterium bovis. La 
hibridación substractiva-supresiva en combinación con inmunohistoquímica 
y RT-PCR cuantitativa en tiempo real se usaron para identificar y 
caracterizar las secuencias más abundantes de genes de 
estrés/inflamación expresados de forma diferencial en jabalíes 
tuberculosos. Los genes identificados en linfonodos mandibulares y 
tonsilas fueron amiloide sérico A, arginasa I, osteopontina, lisozima, 
anexina I y proteínas de choque térmico. Los patrones de proteínas 
globales en linfonodos y tonsilas fueron comparados entre jabalíes 
tuberculosos y no tuberculosos mediante 2-DE y MALDI-TOF MS. Cinco 
proteínas incluyendo las proteínas de estrés/inflamación anexina V, 
albúmina sérica y apolipoproteína A fueron encontradas en bajos niveles 
en jabalíes tuberculosos. La manganeso superóxido dismutasa se encontró 
sobreexpresada en linfonodos de jabalíes tuberculosos. Cinco proteínas, 
entre ellas la creatina kinasa y antígenos del MHC clase II aparecieron 
sobreexpresados en tonsilas de jabalíes tuberculosos. Estos resultados 
demuestran una respuesta diferencial de estrés e inflamatoria en jabalíes 
infectados de forma natural con M. bovis y sugieren posibles marcadores 
de tuberculosis en esta especie que podrían resultar útiles para futuros 
estudios sobre interacciones patógeno-hospedador y para el desarrollo de 
nuevas herramientas de diagnóstico y vacunas. 
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Proteomic and transcriptomic analyses of differential
stress/inflammatory responses in mandibular lymph
nodes and oropharyngeal tonsils of European wild boars
naturally infected with Mycobacterium bovis
Victoria Naranjo1*, Margarita Villar2*, Ma Paz Martín-Hernando1,
Dolors Vidal1, Ursula Höfle1, 3, Christian Gortazar1, Katherine M. Kocan4,
Jesús Vázquez2 and José de la Fuente1, 4
1 Instituto de Investigación en Recursos Cinegéticos IREC (CSIC-UCLM-JCCM), Ciudad Real, Spain
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3 Centro de Investigación Agraria El Dehesón del Encinar, Junta de Comunidades de Castilla – La Mancha,
Oropesa, Spain
4 Department of Veterinary Pathobiology, Center for Veterinary Health Sciences,
Oklahoma State University, Stillwater, OK, USA
Differential stress/inflammatory responses were characterized at the mRNA and protein levels in
mandibular lymph nodes (MLN) and oropharyngeal tonsils of European wild boars (Sus scrofa),
naturally infected with Mycobacterium bovis. Suppression-subtractive hybridization combined with
immunohistochemistry and/or quantitative real-time RT-PCR were used to identify and character-
ize abundant stress/inflammatory gene sequences differentially expressed in tuberculous (TB1)
wild boars. Genes identified in MLN and tonsils corresponded to serum amyloid A, arginase I,
osteopontin, lysozyme, annexin I, and heat shock proteins, respectively. Global protein patterns in
MLN and tonsils were compared between TB1 and nontuberculous (TB2) boars by 2-DE and
MALDI-TOF MS. Five proteins, including stress/inflammatory proteins annexin V, serum albu-
min, and apolipoprotein A1 were found at lower levels in MLN of TB1 boars. Manganese super-
oxide dismutase was found up-regulated in MLN of TB1 boars. Five proteins, including creatine
kinase and MHC class II antigens were found up-regulated in tonsils of TB1 boars. These results
demonstrated differential stress/inflammatory responses in wild boars naturally infected with M.
bovis and suggest possible markers of tuberculosis in this species that may prove useful for future
studies of host–pathogen interactions and for diagnostics and vaccine development.
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1 Introduction
Mycobacterium bovis (M. tuberculosis complex) causes bovine
tuberculosis, a well known reemerging zoonotic disease
which affects cattle worldwide [1–5]. Several wildlife species
are naturally infected with M. bovis, but European wild boar
(Sus scrofa) is a major reservoir in some regions of Spain [6–
11]. In this species, most of the lesions associated with
tuberculosis occur in the mandibular lymph nodes (MLN),
while disseminated lesions are occasionally observed in the
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liver, spleen, lungs, and other organs [6, 12]. The presence of
common M. bovis genotypes in both cattle and wild boars
suggests a threat of interspecies transmission of the patho-
gen [7].
Control of bovine tuberculosis continues to be a chal-
lenge, and new interventions and vaccines are needed to
effectively control and eventually eradicate this disease [1, 13,
14]. The wide host range of M. bovis that includes both
domesticated and wild animals has impacted the effective-
ness of the eradication and control programs [15–18]. Fur-
thermore, since identification of infected wildlife is difficult
because of the lack of reliable tests, biomarkers of infection
would greatly enhance the implementation of effective con-
trol programs for bovine tuberculosis [19].
Despite recent advances in understanding the mech-
anisms of host–pathogen interactions and host cell
responses to M. tuberculosis complex in human, bovine,
and mouse cells [20], expression of genes differentially
regulated in naturally infected wild animal populations
has been poorly characterized. Analysis of differentially
regulated genes in tissue biopsies collected from tubercu-
lous (TB1) and nontuberculous (TB2) wild animals
would contribute to the understanding of the cellular re-
sponse to natural mycobacterial infection and may con-
tribute to identification of biomarkers of bovine tubercu-
losis in these species.
Recently, we identified genes differentially expressed in
MLN and tonsils of TB1 and TB2 European wild boars
naturally exposed to M. bovis [21]. Herein, we report the pro-
teomic and transcriptomic characterization of differential
stress/inflammatory responses in MLN and tonsils of wild
boars naturally infected with M. bovis in order to identify
possible biomarkers of bovine tuberculosis in this wild host
reservoir.
2 Materials and methods
2.1 European wild boars and tissue sample
preparation
For mRNA expression and protein profile analyses, seven
adult (1 year old) female European wild boars (TB1, n = 4;
TB2, n = 3) were captured in hunting estates in South Cen-
tral Spain, euthanized and subjected to detailed necropsy as
described previously [21]. TB1 and TB2 individuals were
diagnosed by pathology, culture, and spoligotyping of myco-
bacteria [7, 21]. All TB1 animals and none of the TB2 boars
had M. bovis infection and granulomatous MLN character-
istic of tuberculosis [21]. Samples of dissected MLN and ton-
sils were obtained by sagittal cross-section at half the length,
and tissue fragments of approximately 2 cm3 were rapidly
prepared and stored in liquid nitrogen for RNA extraction.
The remaining portion of the sample was used for culture
and spoligotyping of mycobacteria or stored in 10% neutral
buffered formalin for histopathology [21].
2.2 Suppression-subtractive hybridization (SSH)
Total RNA was isolated from MLN and tonsil tissue samples
using TriReagent (Sigma, St. Louis, MO, USA) according to
manufacturer’s instructions. RNA quality was checked by gel
electrophoresis to verify the integrity of RNA preparations.
After diagnosis of TB1 and TB2 individuals, pools of 20 mg
RNA were made from TB2 and TB1 animals. SSH was
performed at Evrogen JCS (Moscow, Russia) as described
previously [21]. For the analysis reported in this paper, we
analyzed 152 and 97 sequences differentially expressed in
MLN and tonsils of TB1 wild boars, respectively.
2.3 Sequence analysis and database search
Multiple sequence alignment was performed using the pro-
gram AlignX (Vector NTI Suite V 8.0, InforMax, Invitrogen,
Carisbad, CA, USA) to exclude vector sequences and to
identify redundant (not unique) sequences. Searches for
sequence similarity were performed with the BLASTN pro-
gram (http://www.ncbi.nlm.nih.gov/BLAST) against the
nonredundant sequence database nr and the database of pig-
specific sequences (http://www.ncbi.nlm.nih.gov/genome/
guide/pig/). Protein ontology was determined using the
protein reference database (http://www.proteinlounge.com).
2.4 Quantitative real-time RT-PCR
Individual RNA samples of TB1 and TB2 European wild
boar MLN and tonsils were prepared as described above for
SSH and used for real-time RT-PCR analysis. Two primers
were synthesized based on the sequences determined for
selected stress/inflammatory response of differentially
expressed genes serum amyloid A (SAA; SAA5: 50-CACAAT-
GAAGCTTTTCACAG, SAA3: 50-ATTGGCTTCTCTCATG-
TCCG), arginase I (ARG1; AR5: 50-TAGTGAAGAATCC-
AAGGTCT, AR3: 50-GGCATGGCCAGAGATGCT), osteo-
pontin (SPP1; SP5: 50-TCACGCTGACGACGCTGACC, SP3:
50-CGCGGCCATCATTGGGGTCT), lysozyme (LYZS; LY5:
50-AGCTACAAACTACAATCCTG, LY3: 50-CATCGTCCAG-
CAAAACTTTG), annexin I (ANXI; ANEX5: 50-GAATTCCT-
TAAGCAGGCCTGG, ANEX3: 50-AGCCCTTGCATCTG-
TATCAGC), manganese superoxide dismutase (MnSOD;
SOD5: 50-CACATCAACGCCCAGATCATG, SOD3: 50-GCA-
GGCTGCAGAGCTACCTG), and apolipoprotein A1 (ApoA1;
APOA15: 50-GCTCTTCCTCACAGGGAGCC and APOA13:
50-CAAACTGGGCCACATAATCT). Real-time RT-PCR was
performed using the QuantiTec SYBR Green RT-PCR kit
(Qiagen, Valencia, CA, USA) and a Cepheid Smart Cycler II
(Sunnyvale, CA, USA) following manufacturer’s recom-
mendations.
Expression of selected genes was quantified in MLN
(SAA, ARG1, SPP1, LYZS, ApoA1, MnSOD) or tonsils
(ANXI) by real-time RT-PCR. Amplification efficiencies were
validated and normalized against S. scrofa b-actin and
expressed as transcript copy numbers [21]. mRNA expres-
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sion levels were compared between TB1 and TB2 wild
boars by one-tailed Student’s t-test for samples with unequal
variance (p = 0.05). Real-time RT-PCR experiments were
repeated at least two times with similar results.
2.5 Histopathology and immunohistochemistry
Tissue samples of MLN were fixed for 48 h in 10% neutral
buffered formalin, embedded in paraffin, and processed
routinely for hematoxylin and eosin staining. Additional
sections were stained with Crystal violet to detect the pres-
ence of amyloid deposits as described previously [22].
Rabbit polyclonal anti-LYZS antibodies (1:200, Dako,
Glostrup, Denmark) were used on paraffin-embedded MLN
tissue sections for immunohistochemistry as reported pre-
viously [21]. Controls for immunohistochemistry studies
included use of preimmune rabbit sera and PBS and by
reaction of test sera on sections from uninfected animals.
Immunohistochemistry sections were coded and analyzed in
a random order by two observers (UH, MM) employing
manual counting as described by Kraan et al. [23]. Antigen
expression was evaluated at 4006magnification under a
light microscope based on the intensity of staining reaction.
Stain intensity was scored on a scale from 0 to 4 (0, negative;
4, intense staining). Ten cells each were scored in three dif-
ferent areas and a mean score was calculated from the means
of the three areas. The intensity of stained macrophages was
compared between TB1 and TB2 wild boars using a two-
tailed ANOVA test (p = 0.06).
2.6 Sample preparation for 2-DE
Cytoplasmic proteins were prepared using a subcellular
fractionation method. After diagnosis of TB1 and TB2
individuals, pools of 300–500 mg of MLN and tonsil tissue
were made from TB2 and TB1 animals for protein extrac-
tion in order to reduce variance from individual-to-individual
variation. Tissues were homogenized on ice with a Polytron
(PT 3000, Kinematica AG, Luzern, Switzerland) at
11 000 rpm in five volumes of homogenization buffer
(20 mM HEPES pH 7.4, 250 mM sucrose, 1 mM EDTA,
1 mM PMSF, 1 mM Na3VO4, 1 mM benzamidin, 1 mM pep-
statin, and 10 mM leupeptin). The homogenates were centri-
fuged at 10 0006g for 10 min at 47C to remove cell debris,
nuclei, and mitochondria. The supernatant was centrifuged
at 200 0006g for 1 h at 47C, and the protein concentration of
the resulting supernatant was determined by the Bradford
method using BSA as standard [24]. Cytosolic proteins were
precipitated with acetone and stored at 2807C in aliquots of
300 mg until use.
2.7 2-DE and image analysis
IPG strips (pH 3–10; Amersham Biosciences, Piscataway,
NJ, USA) were used for IEF of acetone-precipitated samples.
IPG strips were loaded with 200 mg protein in 340 mL of the
rehydration buffer containing 7 M urea, 2 M thiourea, 0.5%
ampholite (pH 3–10), 4% CHAPS, and 1 mM DTT. The
sample was focused for 24 h for a total of 100 000 V?h per
IPG strip using IPGphor (Amersham Biosciences).
Focused IPG strips were first incubated in equilibration
buffer containing 6 M urea, 2% SDS, 130 mM DTT, 20%
glycerol, and 375 mM Tris-HCl (pH 8.8) for 15 min, and
then with 135 mM iodoacetamide instead of DTT for another
15 min. These strips were placed onto 10% homogeneous
SDS-polyacrylamide gels. The running buffer contained
25 mM Tris-HCl, pH 8.3, 192 mM glycine, and 0.1% SDS.
The second dimensional SDS-PAGE was run at a constant
voltage of 70 V for 2 h and 400 V for 6 h. The gels were
incubated for 30 min twice in 50% methanol, 10% acetic acid
with continuous mixing and stained with SYPRO Ruby
(Molecular Probes, Invitrogen, Eugene, OR, USA) for 12 h,
following the conditions recommended by the manufacturer.
The gels were washed twice with 10% methanol, 7% acetic
acid for 30 min in order to reduce background fluorescence
and increase sensitivity. Destained gels were rinsed with
distilled water to remove methanol and acetic acid, and were
then allowed to return to the original size. Proteins were vis-
ualized by fluorescence using a Typhoon 9410 scanner
(Amersham Biosciences) at 532 nm excitation with the 610
BP 30 emission filter, and gel images were acquired.
The analysis of differentially regulated proteins was done
by eye using the ImageMaster 2D Platinum software package
(version 5.0, Amersham Biosciences). To minimize the con-
tribution of experimental variations, four gels were analyzed
for each of the four samples derived from MLN and tonsils
from TB1 and TB2 wild boars. SYPRO Ruby-stained spots
were quantified on the basis of their relative volumes (the
spot volume divided by the total volume over the whole set of
gel spots, according to the instructions provided by the
manufacturer). Matching of protein profiles was done be-
tween TB2 and TB1 samples in MLN and tonsils, respec-
tively. Statistical analysis was done using the Student’s t-test
(p,0.05), and this allowed the identification of differentially
regulated proteins in each pair of samples. A factor greater
than 3-fold difference in the average spot volume between
TB2 and TB1 boars was reported as up- (or down)-regula-
tion at protein level.
2.8 In-gel protein digestion
2-DE-stained gels were washed twice for 10 min with dis-
tilled water. Protein spots of interest were excised from the
gels, ground to small pieces, transferred to Eppendorf tubes,
and covered with ACN. After dehydration, the gels were
allowed to dry (Savant SpeedVac, mod SPD, 121 P, equipped
with a vacuum pump OFP-400), after which they were re-
hydrated and digested in situ with trypsin (Promega, Madrid,
Spain) as described by Shevchenko et al. [25] with minor
modifications. Briefly, stained protein gel spots were incu-
bated in 25 mM NH4HCO3 with trypsin (12.5 ng/mL) for 1 h
in an ice bath. The digestion buffer was removed and gels
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were covered again with 12.5 mM NH4HCO3 and incubated
at 377C for 12 h. Whole supernatants were allowed to dry,
and then stored at 2207C until MS.
2.9 MALDI-TOF MS analysis
Digested and dried samples were resuspended in 5 mL of
30% ACN, 0.1% TFA. Samples (0.5 mL) were then analyzed
by MALDI-TOF MS using an Autoflex™ (Bruker Daltonics,
Bremen, Germany) equipped with a reflector and employ-
ing 2,5-dihydroxybenzoic acid as matrix and an
AnchorChip™ surface target (Bruker Daltonics). Peak iden-
tification and monoisotopic peptide mass assignation were
performed automatically using Flexanalysis™ software (Bru-
ker Daltonics). Database searches were performed using
MASCOT (http://matrixscience.com) [26] and ProFound
software (http://129.85.19.192/prowl-cgi/ProFound.exe) [27]
against an NCBI nonredundant protein sequence database
(www.ncbi.nih.gov), allowing two missed cleavages and set-
ting peptide tolerance to 100 ppm after close-external cali-
bration. A match was considered successful when the pro-
tein identification score was located out of the random
region of MASCOT and scored in first position in both
algorithms.
2.10 Determination of SAA and ApoA1 serum levels
For the determination of ApoA1 serum levels, 15 hunter-
harvested adult European wild boars (TB1, n = 8; TB2,
n = 7) were analyzed. For SAA protein level determinations,
90 hunter-harvested adult European wild boars (TB1, n = 45;
TB2, n = 45) were analyzed. Blood samples were collected in
sterile tubes with and without anticoagulant (lithium
heparin) and maintained at 47C until plasma and serum
were separated after centrifugation and stored at 2307C.
The ApoA1 serum levels were analyzed by turbidimetry
using an automatic biochemical analyzer (A25, Biosystems,
Barcelona, Spain) and manufacturer diagnostic reagents.
ApoA1 in the sample precipitated in the presence of goat
antihuman ApoA1 antibodies. The detection limit of the
assay was 1.9 mg ApoA1 per dL serum.
The SSA assay was performed using a commercial
solid-phase sandwich ELISA test (Tridelta Development,
Kildare, Ireland) and a 1:500 serum dilution following
manufacturer’s recommendation. The absorbance was
determined using a microtiter plate reader (Sunrise™,
Tecan, Zurich, Switzerland) at 450 nm. The SAA con-
centration in each serum sample was determined by com-
parison with a standard curve constructed with two-fold
serial dilutions of a porcine SAA standard supplied by the
manufacturer. The sensitivity of the assay was 1.9 ng SAA
per mL serum.
Serum protein levels were compared between TB1 and
TB2 wild boars by use of a one-tailed Student’s t-test for
samples with unequal variance (p = 0.06).
2.11 Determination of SOD levels
For the determination of SOD levels in MLN, 64 hunter--
harvested European wild boars (TB1, n = 32; TB2, n = 32)
were analyzed. SOD levels were determined using the
Superoxide dismutase (SOD) Detection kit (Bachem, Cali-
fornia, USA) and following manufacturer’s recommenda-
tions. Tissue samples were homogenized using a Diax 900
homogenizer (Heidolph Instruments, Schwabach, Ger-
many). Total protein was determined using the method
described by Bradford [28]. SOD levels were compared be-
tween TB1 and TB2 wild boars by use of a one-tailed Stu-
dent’s t-test for samples with unequal variance (p = 0.05).
2.12 Nucleotide sequence accession
numbers
The nucleotide sequences of the ESTs reported in this paper
have been deposited in the GenBank database under
accession numbers DN837257-DN837576 and DQ437856-
DQ437869.
3 Results
3.1 Identification and characterization of abundant
differentially expressed sequences in MLN and
tonsils of TB1wild boars
Twenty-six redundant (not unique) sequences were found to
be differentially expressed in MLN and tonsils of TB1 wild
boars using SSH and analysis of ESTs. Gene ontologies could
be assigned to 25 clones containing genes involved in cell
structure, protein metabolism, signal transduction, cell
growth, inflammation, stress and immune response (Table
1). The most abundant sequences identified by SSH in MLN
represented 33% (50/152) of analyzed sequences, and corre-
sponded to stress/inflammatory response genes SAA3,
ARG1, SPP1, and LYZS (Table 1). In tonsils, the most abun-
dant sequences identified by SSH corresponded to stress/
inflammatory response genes also, such as ANXI and heat
shock protein (HSP) 90 that represented 20% (19/97) of
analyzed sequences (Table 1).
Analysis of mRNA levels by real-time RT-PCR demon-
strated that SAA3, ARG1, SPP1, LYZS, and ANXI genes were
expressed at significantly higher levels (p,0.05) in MLN or
tonsils of wild boars infected with M. bovis (Fig. 1). Further-
more, LYZS immunostaining and amyloid deposits were
detected in MLN of TB1 boars (Fig. 2) that had higher
(p = 0.057) SAA serum levels (Ave 6 SE, 56.4 6 19.4 mg/mL)
when compared to TB2 animals (21.4 6 9.9 mg/mL). The
accumulation of a homogeneous eosinophilic substance
appeared in the MLN follicular center of TB1 boars (Fig. 2a)
that was absent in the TB2 animals (Fig. 2b). Amyloid
deposits were evident by Crystal violet staining in the MLN
follicular center of TB1 boars (Fig. 2c) when compared to
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Table 1. Redundant (not unique) sequences differentially expressed in MLN and tonsils of European wild boars infected with M. bovis
EST No. of clones
with identical
sequences (%)a)
Sequence identity E-value Short description
MLN
Cell structure
G12C4 2 (1.3) B. taurus PRG1 2e-82 Proteoglycan 1 precursor
G12D2 2 (1.3) S. scrofa TubA 0.0 Tubulin-a
G13G1 2 (1.3) H. sapiens spectrin 1e-102 a, nonerythrocytic 1 (a-fodrin)
Protein metabolism
G13G3 6 (3.9) S. scrofa 18S rRNA 0.0 18S ribosomal RNA
G13C1 2 (1.3) H. sapiens APOLLON 1e-173 Ubiquitin-conjugating BIR-domain enzyme
Signal transduction
G12F10 2 (1.3) C. familiaris FN1 1e-82 Fibronectin 1
G12A2 2 (1.3) S. scrofa CCR3, CCR2, CCR5, CCRL2, LTF 1e-40 CC chemokine receptor genes
Enzymes
G12G2 4 (2.6) S. scrofa CYTB 0.0 Mitochondrial cytochrome b
G13D3 2 (1.3) S. scrofa NADH5 0.0 Mitochondrial NADH dehydrogenase subunit 5
Inflammation/stress
G11A6 12 (7.9) S. scrofa ARG1 0.0 ARG1
G11D12 7 (4.6) S. scrofa LYZS 0.0 LYZS
G11A1 22 (14.5) B. taurus SAA3 2e-48 SAA
G11A2 9 (5.9) S. scrofa SPP1 0.0 Secreted phosphoprotein 1, SPP1
Immune response
G11C3 2 (1.3) B. taurus CTSS 1e-110 Cathepsin S
G13F6 2 (1.3) S. scrofa CD45 0.0 CD45 antigen isoform 5 precursor
G12C10 2 (1.3) S. scrofa CD163 0.0 Monocyte-macrophage CD163 antigen
G12B6 2 (1.3) S. scrofa CLU 0.0 Complement cytolysis inhibitor
Miscellaneous
G11G7 2 (1.3) H. sapiens MOSPD1 9e-47 Motile sperm domain containing 1
G11B5 5 (3.3) S. scrofa CB475401 1e-126 Function unknown
G13A1 2 (1.3) S. scrofa PLAT 1e-146 T-plasminogen activator
G13G7 2 (1.3) H. sapiens NY-BR-84 1e-30 Serologically defined breast cancer antigen
Tonsils
Cell growth
T11E2 4 (4.1) S. scrofa myostatin 0.0 Growth factor 8
Inflammation/stress
T11C4 8 (8.2) S. scrofa ANXI 0.0 ANXI
T11B6 11 (11.3) B. taurus HSP90 b 0.0 HSP90 b chaperone
T11F6 2 (2.1) H. sapiens HSPA8 1e-96 HSP70 protein 8 chaperone
T11F11 2 (2.1) H. sapiens DNAJC10 1e-148 DnaJC110 (HSP40) chaperone
a) For each redundant EST, the number of clones with identical sequences and the percent that they represent of the 152 and 97 clones
analyzed from the MLN and tonsil-subtracted cDNA libraries, respectively, is shown.
TB2 animals (Fig. 2d). LYZS immunostaining was denser in
MLN macrophages of TB1 boars (p = 0.059; Fig. 2e) when
compared to TB2 animals (Fig. 2f).
3.2 Characterization of protein profiles in MLN and
tonsils of TB1 and TB2wild boars
Global protein patterns in MLN and tonsils were compared
between TB1 and TB2 boars by 2-DE (Fig. 3). The protein
profiles differed between MLN and tonsils, but were very
similar in samples of TB2 and TB1 animals. However, dif-
ferences in some proteins were observed consistently in all
replicates in both MLN and tonsils. Five protein spots were
found to be differentially down-regulated in the MLN of TB1
individuals in comparison with TB2 boars, whereas one
protein was up-regulated in TB1 boars (Fig. 3A). In the ton-
sils, differences were found in five proteins that were repro-
ducibly differentially up-regulated in TB1 boars with respect
to TB2 boar samples (Fig. 3B). Table 2 lists the proteins
identified after in-gel digestion, MALDI-TOF MS analysis,
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Figure 1. Expression of stress/
inflammatory response genes dif-
ferentially regulated in granulo-
matous MLN or tonsils of Europe-
an wild boars infected with M.
bovis. The mRNA expression
levels of SAA, ARG1, SPP1,
MnSOD, andLYZSandANXIwere
quantified by real-time RT-PCR in
MLN and tonsils, respectively.
Amplification efficiencies were
validated and normalized against
S. scrofa b-actin. mRNA expres-
sion levels were compared be-
tweenTB1andTB2wildboarsby
one-tailed Student’s t-test for
sampleswith unequal variance (*,
p,0.05; **,p,0.005).
Figure 2. Histopathological characteristics of
TB1 and TB2wild boar MLN. (a, b) Hematoxylin
and eosin staining demonstrated an accumula-
tion of a homogeneous eosinophilic substance
(arrows) in the MLN follicular center of TB1
boars (a), which was not present in the TB2
animals (b). (c, d) Staining with Crystal violet
revealed amyloid deposits (shown in pink by
arrows) in the MLN of TB1 boars (c) that were
not apparent in TB2 animals (d). (e, f) Immuno-
staining with anti-LYZS antibodies (dark brown
areas pointed by arrows) was more intense in
MLN macrophages of TB1 boars (e) than in TB2
animals (f). Magnification a–d, 106; e–f, 406.
Bars = 50 mm.
and database searches. Protein identification was unambig-
uous in all cases as judged by peptide mass accuracy and
sequence coverage, and protein score was always significant
with p,0.05.
The up-regulated proteins identified in the MLN sample
of TB2 boars included the stress/inflammatory proteins,
annexin V (ANXV), albumin, and ApoA1. The other two
spots identified in MLN of TB2 boars corresponded to g-actin
and enolase 1. The up-regulated protein spot identified in
gels of MLN of TB1 animals corresponded to the oxidative
stress-response protein, MnSOD (Table 2). SOD levels were
then determined in MLN from 64 wild boars. SOD levels
were higher (p = 0.049) in MLN of TB1 (0.71 6 0.20 U/mg)
than in TB2 (0.36 6 0.06 U/mg) animals. Analysis of
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Figure 3. Representative 2-D gels of cytoplasmic
proteins from MLN (A) and tonsil (B) samples of
(a) TB2 and (b) TB1 European wild boards. IEF
at pH 3–10 was carried out at the first dimension
using IPG strips, and a 10% SDS gel electro-
phoresis was followed at the second dimension
as described in Section 2. Gels were done in a
minimum of triplicate in order to confirm repre-
sentative differences. Proteins of interest, circled
and numbered on the figures, were analyzed by
MS. Arrows indicate truncated polypeptides that
correspond to proteins specified as fragments in
Table 2.
MnSOD mRNA levels by real-time RT-PCR demonstrated
that the mRNA levels for this gene were significantly higher
(p,0.05) in MLN of wild boars infected with M. bovis (Fig. 1).
The analysis of the tonsil proteome identified proteins
involved in the stress/inflammatory response such as two
isoforms of creatine kinase (CK), NADP-dependent isocitrate
dehydrogenase (IDP), and MHC class II antigens (MHC II)
as differentially up-regulated in TB1 boars (Table 2). The
other protein identified in the tonsils of TB1 boars corre-
sponded to g-actin.
Four protein spots belonged to cleaved or truncated poly-
peptides as they appeared in areas of the 2-D gels with
molecular weights lower than the matched full-length pro-
teins. Two of these polypeptides were fragments of g-actin,
which appeared cleaved in both tissues analyzed (Fig. 3A (a),
spot 3 and Fig. 3B (b), spot 4). The other two truncated poly-
peptides were identified as fragments of serum albumin pre-
cursor in MLN of TB2 boars (Fig. 3A (a), spot 4) and MHC II
antigen in tonsils of TB1 animals (Fig. 3B (b), spot 5).
Serum ApoA1 levels were also significantly higher
(p = 0.031) in TB2 (Ave 6 SE, 14.52 6 0.71; range, 10.87–
16.14 mg/dL) than in TB1 boars (7.486 2.98; range, 1.00–
25.18 mg/dL). However, the ApoA1 mRNA levels were higher
(p = 0.037) in TB1 boars (Ave6 SD, 24 6 4 ng/mg total
RNA) than in TB2 animals (126 1 ng/mg total RNA) (Fig. 1).
4 Discussion
In this research, we focused our analysis on the stress/
inflammatory responses that were identified as being dif-
ferentially regulated in MLN and tonsils of TB1 and TB2
wild boars at the mRNA (SAA, ARG1, SPP1, LYZS, ANXI,
HSP90, HSP70, HSP40, ApoA1, and MnSOD) and protein
(ANXV, albumin, ApoA1, MnSOD, CK, IDP, MHC II,
SAA, and LYZS) levels. For these studies, samples were
pooled for SSH and proteomic analysis to homogenize
samples and increase the possibility of detecting common
differentially regulated molecules. This approach does not
allow detection of subject-to-subject variations in response
to M. bovis. However, real-time RT-PCR data and ApoA1,
SAA and SOD protein levels were analyzed in individual
animals to confirm the results of SSH and proteomic
analyses.
The stress/inflammatory response is the animal re-
sponse to homeostatic disturbances caused by infection, tis-
sue injury, neoplastic growth, or immunological disorders,
and results in a series of systemic reactions which induce
changes in the expression of several proteins such as the
plasma acute-phase proteins (APP) [29]. In pigs, increased
concentrations of haptoglobin, C-reactive protein, SAA, and
pig major APP are well-known indicators of positive APP re-
sponse, and their validity as markers of infection or inflam-
mation has been confirmed [30]. Negative APP response in
pigs has been associated with decreases in albumin, trans-
ferrin, and ApoA1 concentrations [31, 32].
The differentially regulated molecules described in this
study in MLN and tonsils of TB2 and TB1 wild boars
infected with M. bovis may be involved in stress/inflam-
matory responses to mycobacterial infection. This result is
not surprising given the known immunopathogenesis of
tuberculosis [20]. We briefly summarize the function of
these molecules and their putative role during tubercu-
losis:
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Table 2. Results of MALDI-TOF mass spectra and database searching for protein identification in MLN and tonsils of TB1 and TB2 Euro-
pean wild boars
Tissue Spot
no.a)
Protein
ID
MW/pIb) Protein
scorec)
Number
of
matched
peptides
Mass
accuracy
of matched
peptides
(ppm)
Sequence of identified peptidesd) Sequence
coverage
(%)
Acces-
sion
numbere)
Average
fold-change
6 SEf)
MLN
TB2 1 Enolase 1 47.7/6.4 94 10 27 YNQILR 25 27806645 212.8 6 2.3
AVEHINK
EALELLK
IEEELGSK
NFRNPLAK
SGKYDLDFK
IGAEVYHNLK
VVIGmDVAASEFYR
AAVPSGASTGIYEALELR
DATNVGDEGGFAPNILENK
2 ANXV 35.8/4.8 81 7 18 WGTDEEK 18 999937 24.2 6 0.6
FITIFGTR
LYDAYELK
SEIDLFNIR
SEIDLFNIRK
NFATSLYSmIK
GTVTDFPGFDER
3 g-Actin
(fragment)
41.8/5.3 77 8 50 IIAPPER 23 54036676 24.7 6 1.5
IIAPPERK
DLTDYLMK
DLTDYLmK
GYSFTTTAER
QEYDESGPSIVHR
SYELPDGQVITIGNER
TTGIVmDSGDGVTHTVPIYEGYAL-
PHAILR
4 Serum
albumin
precursor
(fragment)
71.9/5.9 84 7 35 LCVLHEK 9 71152981 23.9 6 0.3
YLYEIAR
NDNPDIPK
DLGEQYFK
DTYKSEIAHR
FKDLGEQYFK
ECCHGDLLECADDR
5 ApoA1 30.3/5.4 78 6 30 MAPLGAEFR 21 164359 25.4 6 0.4
mAPLGAEFR
EGGGSLAYQAK
LSPLAEELRDR
QQLAPYSDDLR
DYVAQFEASALGK
TB1 1 MnSOD 11.7/7.5 72 4 48 DFGSFEK 29 15082142 13.5 6 0.9
RDFGSFEK
GELLEAIKR
KGDVTAQVALQPALK
Tonsil
TB1 1 Muscle CK 43.0/6.7 127 11 26 HNNHMAK 31 54111517 14.8 6 0.7
IEEIFKK
FEEILTR
PFGNTHNK
DLFDPIIQDR
SFLVWVNEEDHLR
LNFKAEEEYPDLSK
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Table 2. Continued
Tissue Spot
no.a)
Protein
ID
MW/pIb) Protein
scorec)
Number
of
matched
peptides
Mass
accuracy
of matched
peptides
(ppm)
Sequence of identified peptidesd) Sequence
coverage
(%)
Acces-
sion
numbere)
Average
fold-change
6 SEf)
GGDDLDPNYVLSSR
LGSSEVEQVQLVVDGVK
GTGGVDTAAVGSVFDVSNADR
RGTGGVDTAAVGSVFDVSNADR
2 Muscle CK 43.0/6.7 126 11 34 HNNHMAK 33 54111517 14.6 6 1.2
IEEIFKK
FEEILTR
PFGNTHNK
GGNMKEVFR
DLFDPIIQDR
SFLVWVNEEDHLR
LNFKAEEEYPDLSK
GGDDLDPNYVLSSR
LGSSEVEQVQLVVDGVK
GTGGVDTAAVGSVFDVSNADR
3 IDP 46.7/6.4 88 11 56 RVEEFK 23 3641398 13.3 6 0.9
DLAACIR
LGENLKIK
HAYGDQYR
NILGGTVFR
FKDIFQEIYDK
SDYLNTFEFMDK
TVEAEAAHGTVTR
FKDIFQEIYDKQYK
SIEDFAHSSFQMALSK
SIEDFAHSSFQmALSK
4 g-Actin
(fragment)
41.8/5.3 118 7 32 IIAPPERK 28 54036676 14.2 6 0.2
DLTDYLMK
GYSFTTTAER
QEYDESGPSIVHR
SYELPDGQVITIGNER
DLYANTVLSGGTTMYPGIADR
TTGIVmDSGDGVTHTVPIYEGYAL-
PHAILR
5 MHC II
antigen
(fragment)
29.1/7.8 70 3 40 FDSNVGEYR 14 75062804 13.9 6 0.8
VQPTVTISPSK
VEHSSLQSPILVEWR
a) Spot numbers refer to the 2-D gel proteins of interest that were analyzed by MS (Fig. 3).
b) Abbreviations: MW, molecular weight (kDa); pI, isoelectrical point.
c) Protein score is210*log(P), where p is the probability that the observed match is a random event, it is based on NCBInr database using
MASCOT PMF searching program.
d) m: oxidized methionine.
e) Protein name and accession number are listed according to the NCBInr database.
f) ‘1’ indicates an increase in protein expression in TB1 samples, ‘2’ indicates a decrease in protein expression in TB1 samples.
(i) SAA3. SAA is dramatically induced by pro-inflamma-
tory mediators during the acute-phase response to infection
or injury [33] and is induced during inflammatory conditions
such as tuberculosis [12]. Furthermore, the expression of SAA
has been shown to be induced in zebrafish and mice infected
with M. marinum and M. tuberculosis, respectively [34, 35].
The findings reported here suggest that the up-regulation of
SAA expression in MLNof TB1wild boars may increase SAA
concentrations and amyloid deposits which could contribute
to organ damage in M. bovis-infected animals [36].
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(ii) ARG1. As discussed previously [21], ARG1 is induced
by Th2-type cytokines and plays an important role in the
regulation of inflammation and bacteriostatic ability of
interferon-g [37]. ARG1 was differentially up-regulated in
MLN of TB1 wild boars and is induced in mouse macro-
phages infected with M. tuberculosis [38].
(iii) SPP1. The cytokine SPP1, involved in cell migration
and homing, was also differentially up-regulated in MLN of
TB1 wild boars. SPP1 is induced by mycobacterial infection
and may be involved in the pathologic process associated
with active pulmonary tuberculosis [39, 40].
(iv) LYZS. LYZS was another inflammation/stress pro-
tein differentially up-regulated in TB1 wild boars. LYZS
levels increase in tuberculosis effusions with diagnostic
value in humans [41, 42], a process which, as demonstrated
in this research, may be regulated in lymph nodes at the
mRNA level.
(v) Albumin. Albumin protein levels were higher in MLN
of TB2 boars, probably reflecting decreased concentrations
in TB1 animals. The role of albumin in tuberculosis is
unknown. However, low serum albumin levels have been
associated with poor prognosis in pulmonary tuberculosis
patients [43] and with acute-phase response in pigs [30]. Fur-
thermore, amyloid deposits can occur in the intestine of
TB1 wild boars, which may reduce absorption and decrease
serum albumin levels [12]. These results suggest that albu-
min protein levels may be an indicator of body condition and
health status in wild boars infected with M. bovis.
(vi) ANXI and ANXV. ANXs are calcium-dependent
phospholipid-binding proteins with a potential role in cel-
lular signal transduction, inflammation, growth, and differ-
entiation, some of which have been implicated in exocytotic
and endocytotic pathways affected by mycobacterial infection
[20]. ANXI is an endogenous anti-inflammatory mediator
[44]. Differential up-regulation of ANXI in tonsils of TB1
boars may represent a protective mechanism against myco-
bacterial-induced inflammation in this species. ANXV, with
phospholipase A2 (PLA2) and protein kinase C inhibitory
activity, was down-regulated in MLN of TB1 boars. PLA2 is
involved in inflammation. The properties of high-density
lipoprotein (HDL) in cytokine production, lipid oxidation,
cholesterol efflux, and reverse cholesterol transport con-
tribute to HDL being a protective agent in inflammation-
induced organ damage [45, 46]. However, inflammation
causes a decrease in HDL-cholesterol concentrations and
impairs HDL function by increasing the activities of endo-
thelial lipase and soluble PLA2 and by replacing ApoA1 in
HDL with SAA, a process which may lead to inflammation-
induced organ damage and death [45]. The lower levels of
ANXV in MLN of TB1 boars may prevent inhibition of PLA2
and thus contribute to mycobacterial-induced inflammation
and organ damage.
(vii) ApoA1. ApoA1 was also down-regulated in MLN of
TB1 boars. ApoA1 is one of the APP that decreases during
acute-phase processes such as infections in pigs [31].
Changes in the ApoA1 concentration have been suggested to
be involved in the modulation of some of the reactions that
occur during inflammation. As discussed previously, this
protein is associated with HDL protective properties in
inflammatory processes [45, 46]. The relative lower con-
centration of ApoA1, together with the up-regulation of SAA
expression and serum protein levels in TB1 boars may
impair HDL function and result in inflammation-induced
organ damage in TB1 wild boars [45].
(viii) MnSOD. The proteomic analysis also revealed
higher levels of the oxidative stress-response protein MnSOD
in TB1 boars. The role of SOD is to scavenge increased
superoxide anions (O2
2) produced during the oxidative burst,
triggered by stimulation of macrophages [47]. Protein levels
of MnSOD are induced in macrophages infected with
M. tuberculosis [48]. The induction of MnSOD may protect
the cell against O2
2-mediated cytotoxicity, but could also
promote the survival of mycobacteria within macrophages by
providing protection against O2
2 killing.
(ix) HSPs. The heat shock response was found to be
activated in tonsils of TB1 boars. HSPs perform diverse
functions during septic inflammation which protects
humans from environmental pathogens [49]. The differ-
ential expression of HSP genes in tonsils of TB1 boars sug-
gests a role for these genes in response to mycobacterial
infection in this species.
(x) MHC II. Evidence was found in this study for the dif-
ferential regulation of MHC II antigen presentation in ton-
sils of TB1 boars that correlates with differences reported
previously at the transcriptional level [21]. Mycobacterial
infection activates macrophages which express enhanced
cytotoxicity, proinflammatory cytokines, and MHC II anti-
gens [20]. The MHC II pathway, which plays a central role in
inflammation and innate as well as acquired immunity, may
be one of the target molecules for the immune evasion by
mycobacteria [50, 51] and may have an important role during
mycobacterial infections in European wild boars.
(xi) CK. CK isozymes are involved in maintaining intra-
cellular ATP levels, particularly in tissues that have high
energy demands, and elevated CK levels have been asso-
ciated with pathologic processes, including carcinoma,
inflammatory muscle disease, and tuberculosis [52, 53]. The
up-regulation of CK in tonsils of TB1 boars may reflect
active tuberculosis and tissue inflammation in these ani-
mals.
(xii) IDP. IDP was identified as one of the proteins up-
regulated in the tonsils of TB1 boars. The control of redox
balance and the cellular defense against oxidative damage is
one of the primary functions of mitochondrial and cytosolic
IDPs through the supply of NADPH for antioxidant systems
[54, 55]. Although the role of these enzymes during tubercu-
losis is unknown, they may constitute a response mechan-
ism against mycobacterial-induced oxidative stress and
apoptosis.
Proteomic and transcriptomic analyses provide com-
plementary approaches to the study of the host response to
infection. The results of our study demonstrate that different
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stress/inflammatory response molecules were identified by
mRNA and protein characterization. In agreement with our
results, most of the stress/inflammatory responses are regu-
lated at the transcriptional level [29]. However, the results of
this study suggest that expression of ApoA1 in MLN of wild
boars may be regulated post-transcriptionally at the level of
protein glycosylation, degradation, and/or secretion.
Although stress/inflammatory responses were char-
acterized in MLN and tonsils of wild boars infected with
M. bovis, tissue-specific differences were evidenced. The
heat shock response was activated in tonsils of TB1 boars,
while the APP response was increased in MLN of infected
animals. These results may reflect differences in the role of
MLN and tonsils during mycobacterial infection in boars.
Oropharyngeal tonsils may be one of the infection routes
for mycobacteria in boars, and the heat shock response in
this tissue may be induced to protect boars from environ-
mental mycobacteria. MLN are the most affected tissues
during the formation of granulomatous lesions during
tuberculosis in wild boars [6, 12], where the APP response
may reflect tissue injury in the granulomas. In general, the
findings reported here suggest that the up-regulation of
SAA and other stress/inflammatory responses in MLN of
TB1 wild boars may contribute to organ damage in
M. bovis-infected animals.
Some of the stress/inflammatory responses character-
ized in this study, such as SAA, ARG1, SPP1, MnSOD, and
MHC II, have been previously described in macrophages
during in vitro and in vivo experimental infections with
mycobacteria [20, 34, 35, 38–42, 48]. Other molecules such as
ApoA1, HSPs, CK, and IDP constitute new findings. As pre-
viously discussed [21, 56], differences in gene expression
may occur between bone marrow-derived macrophages and
peripheral blood monocytes in comparison to tissues natu-
rally infected with mycobacteria. Therefore, the selection of
biological samples may be crucial to identify biomarkers and
correlates of pathology and protection in tuberculosis. This
information will contribute to the design of novel interven-
tion strategies [57].
In summary, the differentially regulated molecules
described herein in MLN and tonsils of TB2 and TB1 wild
boars infected with M. bovis are involved in stress/inflam-
matory responses to mycobacterial infection and may repre-
sent biomarkers for identification and analysis of TB1 wild
boars. These results, although encouraging, should be con-
firmed in individual samples to study subject-to-subject var-
iations using a larger number of animals. Furthermore,
controlled infections with different pathogens should be
characterized to understand differential stress/inflammatory
responses specific to M. bovis before markers are proposed as
diagnostic tools for bovine tuberculosis in European wild
boars. Finally, these results contribute to the understanding
of host–pathogen interactions during mycobacterial infec-
tions and expand the existing information on the response of
mammalian host cells to mycobacterial infections under
natural conditions.
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Capítulo 3 
 
 
 
 
 
 
 
 
 
Caracterización de biomarcadores 
asociados con la respuesta inmunológica y 
la resistencia a la tuberculosis en jabalí 
 
Capítulo 3.1 
Caracterización de genes seleccionados sobreexpresados en 
jabalíes no tuberculosos como posibles marcadores de 
resistencia a la infección por Mycobacterium bovis 
 
Resumen 
 
La tuberculosis bovina (TBb) causada por Mycobacterium bovis (Complejo 
Mycobacterium tuberculosis) es una zoonosis que afecta al ganado y a la 
fauna silvestre en todo el mundo. Estos hospedadores pueden actuar como 
reservorios de la infección incrementando de esta forma el riesgo de 
exposición e infección en humanos. En este estudio se cuantificaron 
mediante hibridación fluorescente de “macro-arrays” de ARN y RT-PCR en 
tiempo real los niveles de mRNA de genes expresados de forma diferencial 
en tonsilas y linfonodos mandibulares en tres y siete jabalíes no 
tuberculosos y tuberculosos, respectivamente, expuestos de forma natural 
a M. bovis. Estos resultados demostraron la sobre-expresión de dos genes, 
el componente 2 del complemento (C3) y la metilmalonil CoA-mutasa 
(MUT) en los jabalíes no tuberculosos. Estos genes sobre-expresados 
pueden contribuir a la resistencia de jabalíes a TBb modificando la 
inmunidad innata, la cual limita la capacidad de la micobacteria para 
infectar y persistir en los macrofagos. Los genes C3 y MUT, por tanto, 
parecen ser buenos candidatos para ser estudiados como marcadores de 
resistencia a TBb usando genómica funcional en modelos animales. La 
identificación de genes sobre-expresados en animales silvestres 
resistentes a TBb contribuye a la comprensión de los mecanismos de 
inmunidad protectora y resistencia  a micobacterias. 
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Veterinary Microbiology 116 (2006) 224–231AbstractBovine tuberculosis (bTB), caused by Mycobacterium bovis (Mycobacterium tuberculosis complex), is a zoonotic disease
that affects cattle and wildlife worldwide. These animal hosts can serve as reservoirs of infection, thus increasing the risk of
human exposure and infection. In this study we quantified by RNA macroarray fluorescent hybridization and real-time RT-PCR
the mRNA levels of genes differentially expressed in oropharyngeal tonsils and mandibular lymph nodes of three and seven
individual non-tuberculous and tuberculous wild boars naturally exposed to M. bovis, respectively. These results demonstrated
upregulation of two genes, complement component 3 (C3) and methylmalonyl-CoAmutase (MUT), in the non-tuberculous wild
boars. These upregulated genes may contribute to resistance of wild boars to bTB by modifying the innate immunity, which
limits the ability of the mycobacterium to infect and persist within macrophages. The C3 andMUT genes, therefore, are likely to
be good candidates to study as markers of bTB resistance using functional genomics in animal model systems. Identification of
genes upregulated in wild animals resistant to bTB contributes to our understanding of the mechanisms of protective immunity
and resistance to mycobacterial organisms.
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641. Introduction
Bovine tuberculosis (bTB), caused by Mycobac-
terium bovis (Mycobacterium tuberculosis complex),.
V. Naranjo et al. / Veterinary Microbiology 116 (2006) 224–231 225is an established zoonotic disease, which affects cattle
worldwide (reviewed by Cousins, 2001). Recently,
Smith et al. (2006) suggested that the M. tuberculosis
complex may be described as a series of host-adapted
ecotypes that have the propensity to adapt to new host
species. The control of bTB has been complicated by
the host range of M. bovis, which infects both
domesticated and wild animals (Serraino et al., 1999;
Aranaz et al., 2004), the variable response to M. bovis
BCG protection (Suazo et al., 2003; Britton and
Palendira, 2003) and the absence of predictive
correlates of protective immunity (Gilbert et al., 2005).
The European wild boar (Sus scrofa) is a major
reservoir of M. bovis in some regions of Spain
(Gortazar et al., 2003, 2005; Parra et al., 2003; Aranaz
et al., 2004; Vicente et al., 2006). In this species,
mycobacteria apparently enter through the orophar-
yngeal tonsils (T) or the lining of the intestine and then
pass into the bloodstream, subsequently causing
lesions in several organs including the mandibular
lymph nodes (MLN) (Gortazar et al., 2003; Segale´s
et al., 2005).
Substantial evidence suggests that genetic and
environmental factors contribute to the pathogenesis
and differences in susceptibility of humans and mice
to M. tuberculosis (Fernando and Britton, 2006). In
European wild boar, genetic factors have been
associated with resistance to bTB (Acevedo-White-
house et al., 2005).
Recently, we demonstrated by suppression-sub-
tractive hybridization (SSH) of pooled RNA samples
differential gene expression in T and MLN of
tuberculous and non-tuberculous European wild boar
exposed to natural M. bovis infection (Naranjo et al.,
2006). Herein, we characterized selected genes
upregulated in T and MLN of individual non-
tuberculous wild boars exposed to M. bovis as
possible correlates of resistance to bTB in this species.2. Materials and methods
2.1. Animals and sample preparation
Ten female (1-year old) European wild boars
were captured in a hunting estate in South Central
Spain. The prevalence of TB infections in the
European wild boar populations was based on the65finding of TB characteristic lesions and/or the
isolation of mycobacteria and was higher than 70%
(Gortazar et al., 2003; Vicente et al., 2006).
The wild boar were weighted and euthanized by
the captive bold method (Chambers and Grandin,
2001) following European, National and University
of Castilla—La Mancha Ethics Committee regula-
tions. The T and MLN were dissected and tissue
fragments of approximately 2 cm3 were rapidly
prepared and stored in liquid N for RNA extraction.
The rest of the sample was used for culture and
spoligotyping of mycobacteria (Gortazar et al., 2005)
or stored in 10% neutral buffered formalin for
histopathologic studies. Animals were subjected to
detailed necropsy as described previously (Naranjo
et al., 2006). Seven wild boars were classified as
tuberculous and three as non-tuberculous based on
the presence or absence of lesions characteristic of
TB and positive mycobacterial cultures and M. bovis
spoligotypes, respectively.
Total RNAwas isolated from boar T and MLN and
from mouse (strain C3H/HeJ, which constitutively
express intracellular pathogen resistance 1 (IPR-1)
gene; Pan et al., 2005) liver and spleen samples using
TriReagent (Sigma, St. Louis, MO, USA) according to
manufacturer’s instructions.
2.2. Selection of genes
Genes that were candidate correlates with resis-
tance to M. bovis infection in European wild boars
were selected based on their putative role during
mycobacterial infection and/or for their association
with resistance to tuberculosis in human, mouse and/
or wild boar populations (Naranjo et al., 2006). The
analyzed genes herein included vitamin D receptor-
interacting protein complex (VDR), vascular cell
adhesion molecule 1 (VCAM-1), chemokine receptor
4 (CXCR4), MHC class I (MHC-I), complement
components 3 and 7 (C3 and C7), actin related
protein 3 (ARP3) and methylmalonyl-CoA mutase
(MUT).
2.3. RNA macroarray analysis
2.3.1. Preparation of RNA macroarrays
The preparation of RNA macroarrays and fluor-
escent hybridization was done following the procedure
V. Naranjo et al. / Veterinary Microbiology 116 (2006) 224–231226described by Yadetie et al. (2004) with some
modifications.
RNA samples were dissolved in 3 SSC (20
SSC, 3 M NaCl and 0.3 M Na citrate in RNase free
water) at a concentration of 0.25 mg/ml. For spotting
RNAs, the array pattern was drawn on a paper in a
rectangular sketch with dimension of a glass slide
(25 mm  75 mm) indicating the positions of all spots
and blocks. Gamma amino propyl silane coated GAPS
II glass slides (Corning Inc., Acton, MA, USA) were
positioned on the rectangular sketch and fixed to the
paper at each corner using a piece of adhesive tape.
Then, 0.5–2 ml of each RNA solution was taken up by
capillary action, and manually spotted, in triplicate, by
gently touching the slide surface at the spot positions
indicated by the sketch on the paper underneath using
narrow-bore gel loading pipet tips (Prot/Elec Tips;
Bio-Rad Laboratories, Hercules, CA, USA). The slide
was allowed to dry at room temperature before the
RNAwas immobilized by baking in an oven at 80 8C
for 12 h.
2.3.2. Preparation of fluorescent probes
Plasmids containing wild boar cDNA inserts of the
selected genes were collected from the 96-well plates
that were prepared for sequencing differentially
expressed genes after SSH (Naranjo et al., 2006).
Probe cDNA fragments were amplified by PCR using
vector-specific primers PAL95: 50-CGCTCAAGAC-
GACAGAAGTACGC-30 and PAL93: 50-CAGTGG-
TAACAACGCAGAGTACGC-30 flanking the cDNA
inserts. Themouse IPR-1 (GenBank accession number
AY845948) probe was prepared by reverse transcrip-
tion (RT)-PCR of mouse spleen RNA using gene-
specific primers IPR5: 50-TTCACTCTGACCAAAG-
CCTTGG-30 and IPR3: 50-TGAATTGGATGTCTG-
GGCACGC-30. Reactions were performed in a 50 ml
volume employing the Access RT-PCR system
(Promega, Madison, WI, USA) and an automated
DNA thermal cycler (Eppendorf Mastercycler1
personal, Westbury, NY, USA) for 35 cycles. The
PCR products were purified using the Wizard PCR
Preps DNA purification system (Promega) and labeled
with Cy3-dCTP or Cy5-dCTP (Amersham Bios-
ciences, Little Chalfont, UK) using random priming
method as described by Yadetie et al. (2004) but
omitting the concentration step of the labeled
probe.662.3.3. Hybridization of RNA macroarrays and
data analysis
The RNA array slides were pre-hybridized in 1%
BSA, 3.5 SSC, 0.1% SDS at 65 8C for 20 min, then
washed by dipping in ddH2O (5) and finally dipped
in isopropranol (2) and air dried. The Cy3-labeled
probe (5 ml) spiked with 1 ml of the Cy5-labeled 18S
rRNA probe was added to 10 ml hybridization solution
(0.5 MNaH2PO4, 2 mMEDTA, 9% SDS, 2 SSC, 4
Denhardt’s solution, 30 mg tRNA), 2 ml L-DNA dT
blocker (Genisphere Inc., Hatfield, PA, USA) and 2 ml
ddH2O for a final volume of 20 ml. The probe was
denatured by incubating for 2 min at 98 8C, cooled to
room temperature, transferred onto the array and
covered by a cover slip. The slide was then put in a
hybridization chamber (Corning) with 10 ml of 1
hybridization solution on each side to avoid drying.
The hybridization chamber was assembled and
submerged in a water bath at 65 8C for hybridization
for 4 h. Post-hybridization washes were done once in
2 SSC, 0.2% SDS at 65 8C for 10 min, then in 2
SSC at 55 8C for 10 min, and finally with 0.2 SSC at
55 8C for 10 min. After the final wash, the slide was
dried by centrifuging at 1000 rpm for 3 min.
Hybridization signals were measured using a
ScanArray Express (Perkin-Elmer, Boston, MA,
USA) at 10 mm resolution and the images where
processed as standard microarray images using
GenePix Pro version 4.0 (Axon, Union City, CA,
USA). The values were normalized to correct for the
amount of RNA deposited in individual spots by
dividing the mean signal of cDNA probe (Cy3 signal)
by the mean signal of 18S rRNA gene probe (Cy5
signal) for each spot. For 18S rRNA, 1 ml of the Cy5-
labeled probe resulted in fluorescent signals within the
dynamic range. RNA ratio values were then averaged
from three biological replicates for each cDNA probe
and compared by Student’s t-test between samples
from non-tuberculous and tuberculous animals.
2.4. Real-time RT-PCR analysis
Real-time RT-PCR was performed with C3 and
MUT gene-specific primers and conditions described
previously (Naranjo et al., 2006) using the QuantiTec
SYBR Green RT-PCR kit (Qiagen, Valencia, CA,
USA) and a Cepheid Smart Cycler II (Sunnyvale, CA,
USA) following manufacturer’s recommendations.
V. Naranjo et al. / Veterinary Microbiology 116 (2006) 224–231 227Amplification efficiencies were validated and normal-
ized against S. scrofa b-actin (ACT) (GenBank
accession number U07786). Average RNA values
were compared between samples from non-tubercu-
lous and tuberculous animals by Student’s t-test.3. Results
3.1. Characterization of genes upregulated in
non-tuberculous wild boars
The results of RNA macroarray fluorescent
hybridization were similar to the SSH analysis results
in which all genes analyzed were upregulated in
tissues of non-tuberculous animals (Fig. 1). However,
upregulation of C3 andMUT genes were the only ones
in which the differences were statistically significant
(P < 0.05) between non-tuberculous and tuberculous
animals (Fig. 1).
The mouse IPR-1 probe was studied to determine if
this gene, recently discovered to be associated with
resistance to TB in mice, was detected in wild boars.
The hybridization signal of wild boar RNA with the
mouse IPR-1 probe was at the same level of that
obtained with mouse liver and spleen RNA (data notFig. 1. Quantitative gene expression analysis in lymph nodes and tonsils of
using RNA macroarray fluorescent hybridization. RNA samples were prep
glass slide and hybridized to fluorescent cDNA probes. The values were n
spots by dividing the mean signal of cDNA probe (Cy3 signal) by the mean
values were then averaged from three biological replicates for each cDNA
tuberculous animals by Student’s t-test (*P < 0.05). Bars show non-Tb to
67shown) and suggested upregulation of this gene in
non-tuberculous wild boars (Fig. 1).
3.2. Validation of RNA macroarray results by
real-time RT-PCR.
Expression of the C3 and MUT genes, found to be
significantly different by RNA macroarray fluorescent
hybridization in non-tuberculous wild boars, were
analyzed by real-time RT-PCR using the same samples
studied in the RNA macroarrays. The results of the
real-time RT-PCR corroborated the results of the RNA
macroarray analysis and confirmed that C3 and MUT
were upregulated in MLN and T of non-tuberculous
animals (P < 0.05) (Fig. 2A). The IPR-1 gene
expression was not analyzed by real-time RT-PCR
because the sequence of the S. scrofa gene homologue
is unknown and therefore primers could not be
designed for its amplification.
The analysis of C3 and MUT expression in MLN
and T of wild boars by real-time RT-PCR indicated a
higher variability in tuberculous animals (Fig. 2B).
The clearest distinction between gene expression
levels in non-tuberculous and tuberculous animals was
made for C3 in MLN and for MUT in T (Fig. 2B).
Some animals had undetectable levels of C3 (N = 4 innon-tuberculous (non-Tb) and tuberculous (Tb) European wild boars
ared from 10 animals (seven Tb and three non-Tb), arrayed onto a
ormalized to correct for the amount of RNA deposited in individual
signal of the 18S rRNA probe (Cy5 signal) for each spot. RNA ratio
probe and compared between samples from non-tuberculous and
Tb average  S.D. mRNA ratios.
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mRNA in tuberculous animals (Fig. 2C). Of these
animals, three had undetectable levels of both C3 and
MUT mRNAs in MLN (Fig. 2C).4. Discussion
Little is known about the genes differentially
expressed in susceptible and resistant animal popula-
tions naturally exposed to mycobacterium. Keller et al.
(2004) analyzed the resistance and susceptibility to
TB at the gene expression level in mouse macrophages
infected with M. tuberculosis using mouse micro-
arrays. Analysis of genes differentially expressed in
tissue biopsies collected from tuberculous and non-
tuberculous animals exposed to mycobacteria in
endemic areas would contribute to the understanding
of the cellular response to natural mycobacterial
exposure, thus providing information on genes that
may correlate with resistance to mycobacterial
infections (Naranjo et al., 2006).
The results reported herein demonstrated that C3
and MUT expression is upregulated in non-tubercu-
lous wild boars naturally exposed to M. bovis. As
previously discussed (Naranjo et al., 2006), the work
with natural animal populations has the disadvantage
that the infection conditions were not controlled and
therefore wild boar exposure to M. bovis was assumed
based on the fact that animals were1-year old, living
in a highly prevalent bTB endemic area and sharing
common water and food supplies, which increased
animal interaction and exposure to M. bovis.
Furthermore, the suggestion that C3 and MUT are
putative markers of resistance to M. bovis was based
on the finding that (a) non-tuberculous animals had
very similar elevated levels of C3 and MUT mRNAs,
consistent with these genes being markers of
resistance and not exposure to M. bovis, (b)
individuals with different susceptibility to bTB occur
in the wild boar population (Acevedo-Whitehouse
et al., 2005), (c) MUT has been associated with
resistance to bTB in genetic studies of the wild boar
population (Acevedo-Whitehouse et al., 2005), and (d)
the expression of mRNAs that hybridized to mouse
IPR-1, known to be associated with resistance to
tuberculosis in mice, was also upregulated in non-
tuberculous wild boars.69The complement system has been shown to be
involved in mycobacterial pathogenesis (Velasco-
Velazquez et al., 2003; Ferguson et al., 2004). The
upregulation of C3 in non-tuberculous wild boars may
contribute to a protective mechanism against myco-
bacterial infection (Naranjo et al., 2006). C3 was
previously shown to be induced by M. marinum
infection of zebrafish (Meijer et al., 2005). The role of
MUT during TB is unknown. However, upregulation of
MUT gene in non-tuberculous wild boars may interfere
withmycobacterial infection bydepletingmacrophages
of cholesterol, thus limiting the ability of mycobacteria
to infect and survive within macrophages (Chua and
Deretic, 2004; Kaul et al., 2004; Mansoorabadi et al.,
2005). Additionally, upregulation of MUT may be a
mechanism by which macrophages counteract the
inhibition of MUT by the production of nitric oxide
(Kambo et al., 2005) as part of the macrophage
bactericidal response tomycobacterial infections (Kaul
et al., 2004). Although the homolog for the mouse IPR-
1 has not been discovered in S. scrofa, the results
reported here suggested that IPR-1, overexpressed in
mouse macrophages resistant to M. tuberculosis
infection (Pan et al., 2005), may also be present and
upregulated in non-tuberculous wild boars.
The results reported herein suggest that the upre-
gulation of C3 and MUT gene expression in non-
tuberculous wild boars may correlate with resistance to
bTB. The putativemechanism bywhich upregulation of
C3 and MUT contributes to resistance to bTB in non-
tuberculous wild boarsmay be through themediation of
innate immunity in which the ability of mycobacterium
to infect and persist within the macrophage in T and
MLN is limited. Given the importance of innate
immunity, both in resisting mycobacterial challenge
and shaping adaptive immunity, genetic variation
favoring innate responses are likely to have a major
impact on resistance to tuberculosis (Koul et al., 2004).
The experiments reported herein resulted in the
selection of genes that are likely candidates to be tested
in functional genomic studies as correlates of resistance
to bTB in pigs and other animal model systems.Acknowledgments
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Capítulo 3.2 
 
Influencia de los alelos de la metilmalonil CoA mutasa en la 
resistencia a la tuberculosis bovina en el jabalí (Sus scrofa) 
 
Resumen 
Se llevó a cabo un estudio para examinar la influencia del polimorfismo en 
el gen de la metilmalonil CoA mutasa (MUT) en la susceptibilidad para 
desarrollar tuberculosis bovina (TBb) en una población de jabalíes bien 
definida del sur de España. Para este propósito se examinaron 37 jabalíes 
con TBb y 36 individuos no infectados. Nuestro estudio caso-control mostró 
que el alelo MUT-B estaba asociado con la enfermedad de forma 
dominante (odds ratio = 3.36; 95 % IC = 1.05-10.72; p = 0.04), mientras 
que el genotipo MUT A/A parece tener un efecto protector frente a la 
infección por TBb (odds ratio = 4.33; 95 % CI = 1.20-14.96; p = 0.02). De 
manera interesante, los jabalíes infectados heterocigotos para MUT A/B 
tienen una ventaja 11 veces mayor para contener la extensión sistémica de 
la enfermedad en comparación con otros genotipos, lo que sugiere que hay 
un polimorfismo balanceado en la población. Estos resultados refuerzan 
observaciones previas sobre la importancia del gen MUT en TBb en 
jabalíes y sugieren que los polimorfismos en este locus influyen en el 
riesgo de adquisición y mantenimiento de la TBb en la población estudiada. 
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Summary 
 
An association study was carried out to examine the influence of methylmalonyl-CoA 
mutase (MUT) polymorphisms on the susceptibility to develop bovine tuberculosis (bTB) in 
a well-defined wild boar population from southern Spain. To this purpose, 37 wild boars 
with bTB and 36 non-infected individuals were examined. Our case-control study showed 
that MUT-B allele was associated with disease in a dominant pattern (odds ratio = 3.36;  
95 % CI = 1.05-10.72; p = 0.04), while MUT A/A genotype appeared to have a protective 
effect against bTB infection (odds ratio = 4.33; 95 % CI = 1.20-14.96; p = 0.02). 
Interestingly, infected wild boars heterozygous for MUT-A/B are at an advantage (11-fold) 
to contain the systemic spread of the disease when compared to other genotypes, 
suggesting a balanced polymorphism occurring in the population. These results strengthen 
previous observations on the importance of MUT gene on bTB in wild boars and suggest 
that polymorphisms at this locus will influence the risk of acquiring and maintaining bTB in 
the studied population. 
 
Keywords: Balanced polymorphism, European wild boar, Reservoir, Sus scrofa, Tuberculosis, 
Genetics, methylmalonyl-CoA mutase, MUT 
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Introduction 
 
Bovine tuberculosis (bTB) due to 
Mycobacterium tuberculosis complex 
is a worldwide disease that affects a 
wide range of domestic and wildlife 
animals and humans (Gibson et al. 
2004; Smith et al. 2004; Naranjo et al. 
2007a). The control of bTB has been 
complicated by the existence of 
pathogen reservoirs among wildlife 
species, including European badgers, 
African buffalo, Canadian bison, 
white-tailed deer, brushtail possum 
and European wild boar (Roper 2003; 
Scantlebury et al. 2004; Naranjo et al. 
2007a), the variable response to M. 
bovis BCG protection (Milian Suazo et 
al. 2003; Britton & Palendira 2003) 
and the absence of predictive 
correlates of protective immunity 
(Gilbert et al. 2005). 
Populations of the European wild boar 
(Sus scrofa Linnaeus, 1758) are 
currently increasing in Spain and 
other European countries (Acevedo et 
al. 2006). This is relevant for public 
and veterinary health, as they are a 
major reservoir of bTB in some 
regions of Spain (Gortazar et al. 
2003; 2005; Parra et al. 2003; Aranaz 
et al. 2004; Vicente et al. 2006; 
Naranjo et al. 2007a) and they co-
share M. tuberculosis complex strains 
of bovine and caprine origin with 
cattle, goats, domestic pigs, deer and 
humans (Gortazar et al. 2005; Parra 
et al. 2006; Aranaz et al. 2004). In this 
context, understanding the factors 
that determine resistance to bTB 
become increasingly important. 
Substantial evidence suggests that 
genetic and environmental factors 
contribute to the pathogenesis and 
differences in susceptibility of 
humans, mice and cattle to M. 
tuberculosis and M. bovis (Phillips et 
al. 2002; Fernando & Britton, 2006). 
Similarly, genetic factors have been 
found to influence resistance to bTB 
in the European wild boar (Acevedo-
Whitehouse et al. 2005), but clear 
evidence of the contribution of 
specific genes in the pathogenesis of 
this disease is still lacking. 
Recently, we demonstrated by 
genomics and proteomics analyses in 
combination with real-time RT-PCR 
the differential gene expression in 
European wild boar exposed to 
natural M. bovis infection (Naranjo et 
al. 2006a; 2006b; 2007b). In these 
studies, we identified methylmalonyl-
CoA mutase (MUT) to be 
overexpressed in oropharyngeal 
tonsils and mandibular lymph nodes 
of non-tuberculous wild boar exposed 
to natural mycobacterial infection, 
thus suggesting that MUT contributes 
to resistance of wild boars to bTB by 
enhancing innate immune 
mechanisms which limit the ability of 
the mycobacterium to infect and 
persist within macrophages (Naranjo 
et al. 2006a; 2006b). MUT is 
synthesized as a propeptide 
containing a mitochondrial targeting 
sequence to direct the holoenzyme 
homodimer formation in the 
mitochondrial matrix (Jansen et al. 
1989) and is a cobalamin (B12)-
dependent enzyme which catalyses 
the isomerization of methylmalonyl-
CoA to succinyl-CoA (Nham et al. 
1990). This reaction is required for the 
catabolism of odd fatty acids and 
several amino acids. The MUT gene 
was assigned to pig chromosome 
1q13-q14 and a (AT)3 ACATAC (AT)8 
dinucleotide repeat microsatellite was 
localized in the second intron, 
suggesting linkage with the gene 
(Duscher et al. 1999; 2000).  
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Herein, we characterized genetic 
polymorphisms of MUT in the 
European wild boar and searched for 
correlations of particular alleles with 
resistance to bTB. Our results may 
provide a tool for the evaluation of 
infection risk in naïve populations and 
selective breeding of wild boar and 
pigs (Naranjo et al. 2007c). 
 
Materials and methods 
European wild boar 
 
DNA was extracted from tissue 
samples from 73 (36 tuberculous and 
37 non-tuberculous) hunter-harvested 
wild boars collected between 2000 
and 2003 in the provinces of Ciudad 
Real and Toledo, in south-central 
Spain (38°55´N, 0°36´E to 39°25´ N, 
0°22´E; 600–850 m above sea level). 
Genomic DNA was isolated using a 
modified Proteinase 
K/SDS/Chelex100™ protocol 
(Acevedo-Whitehouse et al. 2005). 
The prevalence of bTB infections in 
the European wild boar population 
had been determined previously for 
the study region, and ranged from 
29% to 72% between sites (Acevedo-
Whitehouse et al. 2005). Individual 
wild boars were classified as 
tuberculous or non-tuberculous based 
on the presence or absence of the 
following criteria: (a) lesions 
characteristic of bTB and (b) the 
identification of positive mycobacterial 
cultures and M. bovis spoligotypes 
(Naranjo et al. 2006a). Complete 
post-mortem data concerning 
systemic spread of tuberculous 
lesions was available for a subset (n = 
21) of the wild boars included in this 
study. 
 
 
 
Analysis of MUT polymorphism 
 
MUT polymorphisms were analyzed 
using oligonucleotide primers 
(forward:  
5´-FAM-TCCTTTCACACCATGTGC-
3´ and reverse: 5´-
AGTACTGTGGAAGAGAGC-3´) that 
amplify a polymorphic microsatellite 
located within the second intron of the 
MUT gene (Genbank accession 
number AJ277795; Duscher et al. 
2000). PCRs were done in 50-µl 
volume (1.5 mM MgSO4, 1 X avian 
myeloblastosis virus (AMV) 
RT/Thermus flavus (Tfl) reaction 
buffer, 0.2 mM each deoxynucleoside 
triphosphate (dNTP), 5 u Tfl DNA 
polymerase and 0.2 µM of each 
oligonucleotide primer) employing the 
Access RT-PCR system (Promega, 
Madison, WI, USA). Reactions were 
performed in an automated DNA 
thermal cycler (Techne model TC-
512, Cambridge, England, UK). The 
PCR consisted of an initial step of 5 
min at 95oC followed by 35 cycles of a 
denaturing step of 30 sec at 94oC 
and annealing step of 30 sec at 54 ºC 
and an extension step of 60 sec at 68 
ºC. The reaction was terminated after 
a final extension at 68ºC for 5 min. 
Control reactions were done using the 
same procedures, but without DNA 
added to check for contamination of 
the PCR reaction. PCR products were 
electrophoresed on 1% agarose gels 
to check the size of amplified 
fragments by comparison to a DNA 
molecular weight marker (1 Kb Plus 
DNA Ladder, Promega, Madison, WI, 
USA). Fragments were separated 
using an ABI 3730 authomated DNA 
sequencer (Applied Biosystems, Inc. 
Foster City, CA, USA) and sized 
relative to a ROX-labeled internal size 
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standard (GeneScan-500LIZ, 
Applera, Norwalk, CT, USA). The 
data were analyzed using program 
Peak Scanner (Applied Biosystems). 
For each allele size detected, 
amplicons from three PCR reactions 
were resin purified (Wizard, Promega) 
and cloned into the pGEM-T vector 
(Promega) for sequencing both 
strands by double-stranded dye-
termination cycle sequencing 
(Secugen SL, Madrid, Spain). At least 
two independent clones were 
sequenced for each PCR. Multiple 
sequence alignment was performed 
using the program AlignX (Vector NTI 
Suite V 5.5, InforMax, North 
Bethesda, MD, USA) with an engine 
based on the ClustalW algorithm 
(Thompson et al. 1994).  
 
Statistical analysis 
 
Tests for deviation from Hardy-
Weinberg equilibrium (HWE) were 
conducted in GENEPOP (Raymond & 
Rousset 1995). Significance of the 
case-control study was analyzed 
using a binary logistic regression 
model with correction for sampling 
site as a covariate (Crawley 2002). All 
analyses were performed in R (The R 
Foundation for Statistical Computing, 
version 2.1.1).  
 
Results and discussion 
 
The MUT microsatellite was not highly 
polymorphic in our study population, 
with only three distinct alleles showing 
different repeat structure and size 
(allele A: (AT)5 (AC)2, 271 bp; allele 
B: (AT)3 ACATAC (AT)8, 285 bp, and 
allele C: (AT)3 ACAT (AC)2 (AT)8, 
287bp). This finding was unexpected 
as no less than 11 alleles have been 
described for this locus in domestic 
pigs (Duscher et al. 2000). The 
genotypic and allelic frequencies of 
healthy (non-infected) and bTB-
afflicted wild boars are shown in 
Table 1. Case-control tests using the 
genotypic and allelic frequencies 
between the bTB-infected and control 
groups demonstrated a protective role 
of MUT-AA genotype against bTB, 
where AA wild boars had a 4-fold 
decrease in risk of bTB infection 
compared with AB, BB, BC or CC 
genotypes (OR = 4.33; 95 % CI = 
1.20-14.96; p = 0.02). In contrast, 
allele B was associated with a 3-fold 
increase in risk of infection (OR = 
3.36; 95 % CI = 1.05-10.72; p = 0.04). 
Interestingly, both ‘protective’ A and 
‘detrimental’ B alleles were highly 
prevalent in the wild boar population, 
suggesting occurrence of a balanced 
polymorphism.  
Disease-related balanced 
polymorphisms can occur when two 
different versions of a gene are 
maintained in a population because 
individuals carrying both versions are 
better able to survive than those who 
have two copies of either version 
alone (Harpending & Cochran 2006), 
even when some of the variants can 
increase the risk of debilitating 
inherited diseases or increase 
susceptibility to infectious diseases. 
An elevated frequency of some of 
these harmful variants can be 
explained by a beneficial effect that 
confers a selective advantage owing 
to disease resistance in carriers of 
such mutations during an infectious 
disease outbreak (Dean et al. 2002). 
In the case of bTB, following infection, 
a relatively large number of 
individuals do not progress through 
several stages from mild 
granulomatous dissemination to 
severe disease spread and never 
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develop clinical disease (Cassidy et 
al. 1999; Mackintosh et al. 2000). 
Thus, we tested our a posteriori 
hypothesis by analyzing genotypes 
among bTB-infected animals. We 
found MUT-A allele to be present in 
every single wild boar that 
successfully contained infection, thus 
avoiding systemic granulomatous 
dissemination (Table 2). The most 
common genotype (0.89 frequency) of 
the ‘contained infection’ group, MUT-
AB, rendered infected wild boars 11 
times less likely to develop 
disseminated bTB (OR = 11.2; 95 % 
CI = 1.04-120.36; p = 0.02) than the 
other MUT genotypes.  
Our results suggest that both 
common MUT variants (A and B 
alleles) are maintained in the wild 
boar population, even if having MUT-
B increases the risk to mycobacterial 
infection because individuals carrying 
both versions will be better able to 
contain the disease spread following 
infection than those with a MUT-AA 
genotype, even if these animals have 
a lower chance of acquiring the 
infection. The possible heterozygote 
advantage of MUT-AB variant against 
bTB might therefore be a balanced 
polymorphism, comparable to the 
presence of high levels of sickle cell 
trait in Africans because of its 
protective effect against malaria 
(Agarwal et al. 2000).  
Although the putative role of MUT for 
bTB remains unknown (Naranjo et al. 
2006a; 2006b), studies conducted in 
humans have shown MUT to be one 
of two cobalamin (B12)-dependent 
enzymes (Banerjee 2006), and the 
key enzyme in intermediary 
metabolism (Kambo et al. 2005). This 
enzyme uses the adenosylcobalamin 
(AdoCbl) cofactor to catalyze the 
isomerization of methylmalonyl-CoA 
to succinyl-CoA, a reaction required in 
the catabolism of methionine, valine, 
threonine, isoleucine, odd-chain fatty 
acids, and cholesterol (Banerjee 
2006). Previous work showed 
overexpression of MUT in non-
tuberculous wild boar, regulated at 
the mRNA level (Naranjo et al. 2006a; 
2006b) and it is possible that the gene 
polymorphisms observed in our study 
could be associated with differences 
in gene expression. While this 
hypothesis remains to be tested, such 
differences in wild boar MUT 
expression may interfere with 
mycobacterial infection by depleting 
macrophages of cholesterol, thus 
limiting the ability of mycobacteria to 
infect and survive within 
macrophages (Koul et al. 2004). 
Additionally, overexpression of MUT 
may be a mechanism by which 
macrophages counteract the inhibition 
of MUT caused by the production of 
nitric oxide (Kambo et al. 2005) as 
part of the macrophage bactericidal 
response to mycobacterial infections 
(Koul et al. 2004).  
A great deal of evidence indicates 
that susceptibility to tuberculosis in 
humans is regulated by various genes 
(Bellamy 2003; Bellamy et al. 2000; 
Casanova & Abel 2002) and it is likely 
that other host species have a similar 
multi-gene regulation of mycobacterial 
disease. Recent studies have found 
evidence of significant effects on bTB 
resistance in wild boars driven by 
neutral heterozygote advantage with 
possible linkage to immune-related 
loci (Acevedo-Whitehouse et al. 2005) 
and differential expression of a 
number of genes (Naranjo et al. 
2006a; 2007b). Our study suggests 
that the MUT gene may play an 
important role in influencing the risk of 
acquiring mycobacterial infection and 
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developing bTB in wild boars. 
Determination of the MUT genotypes 
may help identify wild boar 
populations with high frequencies of 
‘contained-infected’ genotypes likely 
to play a role in the maintenance and 
transmission of bTB to livestock and 
other wildlife species. 
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Table 1. Distribution of MUT genotypic and allelic frequencies among bTB 
infected and healthy control European wild boar. MUT locus was slightly in excess 
of heterozygotes in the bTB infected group (p = 0.032). 
 
Groups MUT genotype number of cases (%) Allele frequencies 
(%) 
 AA AB BB BC CC A B C 
bTB  4 (11) 24 (67) 1 (3) 6 (16) 1 (3) 0.44 0.44 0.11 
Control 13 (35) 19 (51) 1 (3) 4 (11) 0 (0) 0.61 0.34 0.05 
 
 
 
Table 2. Distribution of MUT genotypic and allelic frequencies among infected 
wild boar with successful containment of the disease (contained bTB) and wild 
boar with widespread granulomas (disseminated bTB). 
 
Groups MUT genotype number of cases (%) Allele frequencies 
(%) 
 AA AB BB BC CC A B C 
Disseminated  1 (8) 5 (42) 1 (8) 4 (34) 1 (8) 0.29 0.46 0.25 
Contained 1 (11) 8 (89) 0 (0) 0 (0) 0 (0) 0.56 0.44 0 
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Capítulo 3.3 
Analisis de parámetros bioquímicos séricos en relación con la 
infección por Mycobacterium bovis en jabalí (Sus scrofa) en 
España 
 
Resumen 
 
La tuberculosis bovina (TBb) causada por Mycobacterium bovis (Complejo 
Mycobacterium tuberculosis) es una zoonosis que afecta al ganado y a la 
fauna silvestre. El jabalí (Sus scrofa) es el principal reservorio de M. bovis 
en el sur y centro de España. La identificación de biomarcadores para 
predecir la TBb en jabalíes mediante métodos que no requieran la muerte 
del hospedador podría contribuir a la implementación de programas 
eficaces de control de TBb en esta región. En este estudio se 
caracterizaron parámetros bioquímicos séricos en jabalíes para determinar 
qué valores bioquímicos varían significativamente con la presencia de TBb 
en esta especie. Aunque los niveles de apolipoproteína A y de IgG fueron 
mayores en jabalíes no infectados, los resultados no proporcionaron 
buenos valores predictivos para los parámetros bioquímicos en suero en 
jabalíes en relación a la TBb en España.  
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Abstract Bovine tuberculosis (bTB) caused by Mycobac-
terium bovis (Mycobacterium tuberculosis complex) is a
zoonotic disease that affects cattle and wildlife worldwide.
European wild boar (Sus scrofa) is a major reservoir host of
M. bovis in south-central Spain. The identification of
biomarkers to predict bTB in wild boars by dependable
methods that do not require killing the host would greatly
contribute to the implementation of effective control
programs for bTB in this region. In this study, we have
characterized serum biochemical values in European wild
boars in Spain to determine whether biochemical param-
eters in the serum varied significantly with the presence of
bTB in this species. Although apolipoprotein A1 and IgG
levels were higher in uninfected boars, the results did not
support good predictive value for serum biochemical
parameters studied for European wild boars in relation to
bTB in Spain.
Keywords Tuberculosis . Mycobacterium tuberculosis
complex . Apolipoprotein A1
Introduction
European wild boar (Sus scrofa) is a major reservoir of
Mycobacterium bovis (Mycobacterium tuberculosis com-
plex) in south-central Spain (Gortazar et al. 2003, 2005;
Parra et al. 2003; Aranaz et al. 2004; Segalés et al. 2005;
Vicente et al. 2006; Hermoso de Mendoza et al. 2006).
The presence of common M. bovis genotypes in both
livestock and wild boars poses a threat of interspecies
transmission of the pathogen and increases the risk of
bovine tuberculosis (bTB) in this region (Gortazar et al.
2005).
Control of bTB continues to be a challenge and new
vaccines and therapeutic interventions are necessary to
effectively control and eventually eradicate this disease
(Cousins 2001; Milian Suazo et al. 2003; Buddle et al.
2005). The wide host range ofM. bovis, which infects both
domesticated and wild animals, has affected the success of
the eradication and control programs (Serraino et al. 1999;
Vicente 2004; Donnelly et al. 2006; Corner 2006).
Furthermore, the identification of infected wildlife is
difficult and biomarkers of infection would greatly
contribute to the implementation of effective control
programs for bTB (de Lisle et al. 2002).
Few studies have been conducted on wild pig blood
biochemistry (Williamson and Pelton 1975; Shender et al.
2002) and on serum biochemical parameters of European
wild boars (Williamson and Pelton 1975; Wolkers et al.
1993, 1994a,b; López-Olvera et al. 2006). Particularly
relevant would be the possibility to predict bTB in wild
boars by dependable methods that did not require killing
the host. Serum biochemical parameters may be promising
predictors of bTB as there were shown for other pathogens
and health conditions in wild boar (Wolkers et al. 1993,
1994a,b; López-Olvera et al. 2006) and in other wild host
species (Woolf et al. 1973; Ubelaker et al. 1993; Sartorelli
et al. 1995; Hanni et al. 2003).
The objectives of this study were (1) to characterize
serum biochemical values in European wild boars in Spain
and (2) to determine whether biochemical parameters in the
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serum varied significantly with the presence of bTB in this
host reservoir species.
Materials and methods
European wild boar and sample preparation
In the 2000 to 2005 hunting seasons, 43 hunter-harvested
European wild boars were analyzed from areas in northern
(0% prevalence of bTB) and south-central Spain (>70%
prevalence of bTB). Individuals infected with M. bovis
(TB+, N=22) were diagnosed by pathology, culture, and
spoligotyping of mycobacteria (Gortazar et al. 2005;
Naranjo et al. 2006a). Animals not infected with M. bovis
(TB−, N=21) were negative for pathology and culture.
Wild boars were aged according to a dentition formula
that provided ages corresponding to tooth eruption patterns
(Matschke 1967). Boars classified as 7- to 12-month-old or
below were considered juveniles and boars classified as 13-
to 24-month-old or above were considered adults. Of the 22
TB+ boars, 4 were juvenile females, 4 were adult females,
7 were juvenile males, and 7 were adult males. Of the 21
TB− boars, 6 were juvenile females, 7 were adult females,
4 were juvenile males, and 4 were adult males.
Blood samples were collected from the heart and/or
thoracic cavity into sterile tubes with and without antico-
agulant (lithium heparin) and maintained at 4°C until
plasma and serum were separated after centrifugation and
stored at −30°C.
Determination of serum biochemical parameter
Serum biochemical values were analyzed for apolipopro-
tein A1 (ApoA1), albumin, cholesterol, LDL, HDL,
glucose, triglycerides, total proteins, IgG, IgM, IgA,
complement C3 (C3), and alkaline phosphatase (AP)
with an automatic biochemical analyzer (A25, Biosystems,
Barcelona, Spain) using manufacturer diagnostic reagents.
ApoA1, immunoglobulins, and C3 in the serum sample
precipitated in the presence of goat anti-human antibodies.
The light scattering of the antibody-antigen complexes was
proportional to the concentration of the antigen and was
measured by turbidimetry using the biochemical analyzer.
The other serum variables were evaluated in colorimetric
reactions by spectrophotometry using the biochemical
analyzer.
Means and SD for 13 serum biochemical variables were
calculated by sex and by age for TB− boars, TB+ boars,
and for all boars. Each variable was tested to determine if
there were significant differences between the means of
ages or sexes and between wild boars infected with M.
bovis and those free from the pathogen by one-tailed
Student’s t test for samples with unequal variance or by a
Mann–Whitney U test if the data were not normally
distributed. The number of juvenile and adult females and
males between TB− and TB+ boars was compared using a
chi-square test. A significant value of P=0.050 was used for
all analyses.
Results and discussion
Serum was obtained from 43 hunter-harvested European
wild boars in Spain. From them, 22 were diagnosed to be
Table 1 Comparison of serum biochemical parameters between juveniles and adults and between female and male European wild boars
Variable All animals Juvenilesa Adultsb P value Femalesc Malesd P value
N Range Mean±SD Mean±SD Mean±SD Mean±SD Mean±SD
Total proteins (g/l) 43 21.43–140.24 79.87±27.59 78.85±26.59 80.84±29.11 0.408 72.22±29.64 87.89±23.34 0.030
Albumin (g/l) 43 14.40–70.04 35.73±12.90 33.52±11.21 37.85±14.26 0.137 34.18±15.35 37.36±9.83 0.211
IgG (mg/dl) 43 38.91–281.86 155.25±48.65 152.46±50.42 157.92±47.92 0.359 162.38±40.53 147.78±55.95 0.168
IgM (mg/dl) 22 33.10–286.28 100.62±52.25 90.71±30.12 110.53±67.90 0.196 106.73±65.87 91.84±22.62 0.232
IgA (mg/dl) 43 n.d.–95.62 20.81±25.84 14.42±22.19 26.90±28.06 0.056 17.77±23.14 23.99±28.62 0.220
C3 (mg/dl) 43 31.34–104.23 42.37±12.27 38.67±4.74 45.90±15.90 0.026 42.32±15.19 42.42±8.58 0.490
LDL (mg/dl) 43 9.53–77.98 36.58±16.84 35.34±16.88 37.78±17.11 0.320 36.91±18.62 36.24±15.20 0.448
HDL (mg/dl) 43 4.79–56.86 28.40±14.00 27.57±12.53 29.20±15.52 0.352 27.75±15.24 29.08±12.91 0.379
Cholesterol (mg/dl) 43 22.11–150.64 80.20±33.05 77.88±31.60 82.41±34.97 0.329 80.25±36.00 80.15±30.54 0.496
Triglycerides (mg/dl) 43 13.91–508.45 131.81±100.20 141.87±114.10 122.20±86.50 0.265 143.71±129.60 119.34±55.92 0.213
ApoA1 (mg/dl) 26 1.00–25.18 10.21±7.11 9.46±7.37 10.77±7.12 0.328 9.90±6.48 10.53±7.94 0.414
Glucose (mg/dl) 43 1.79–851.27 166.88±182.39 183.44±211.96 151.06±152.33 0.285 163.55±157.20 170.35±209.49 0.453
Alkaline phosphatase
(U/l)
43 6.30–527.12 95.51±87.19 121.00±114.20 71.18±38.87 0.035 72.81±46.08 119.30±112.10 0.045
aN=11–21
bN=11–22
cN=13–21
dN=9–22
n.d. Not detected
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infected with M. bovis (TB+) and 21 were free from the
pathogen (TB−). The number of juvenile and adult females
and males between TB− and TB+ boars was similar
(P>0.050). Thirteen serum biochemical variables were
evaluated and compared between adults and juveniles,
between females and males, and between TB− and
TB+ boars.
Serum biochemical parameters evaluated for wild boars
had a wide range of values (Table 1). As has been
documented for domestic and wild pigs, this wide range of
serum biochemical parameters may be due to variations in
age, sex, and the physiological, nutritional, and health
status of the animals (Reese et al. 1984; Egeli et al. 1998;
Clemens et al. 1989; Shender et al. 2002; López-Olvera et
al. 2006). Thus, some sensitive serum parameters may have
become affected by some of these factors, which we did not
control because animals were captured in the wild.
The comparison of serum biochemical variables by age
indicated that juveniles had higher levels of AP and lower
levels of C3 than adult animals (Table 1). Furthermore, C3
levels were also higher in TB+ adults than in TB+ juveniles
(mean±SD 43.98±9.41 vs 37.72±2.94, P=0.035). The rest
of the variables were not significantly different between
juvenile and adult boars (Table 1). Egeli et al. (1998)
reported that juvenile pigs have serum enzymes with higher
average values and wider reference ranges than adults and
Shender et al. (2002) found higher AP levels in juvenile
than in adult feral pigs in Texas. Both findings are
consistent with our results for AP in wild boars. In recent
reports, Naranjo et al. (2006a,b) identified that higher C3
levels may correlate with increased resistance to myco-
bacterial infection in adult wild boars. However, Vicente et
al. (2006) have reported that the proportion of wild boars
with generalized lesions is similar between juvenile and
adult animals in Spain.
The comparison of all individuals by sex evidenced that
females had lower levels of AP and total proteins thanmales
(Table 1). The finding of few significant differences in
serum biochemical parameters between sexes was consis-
tent with previous reports (Williamson and Pelton 1975;
Shender et al. 2002). Triglycerides were higher in TB−
females (177.75±140.99 vs 105.21±55.74 mg/dl, P=0.050)
but lower in TB+ females (70.76±57.46 vs 126.40±
56.71 mg/dl, P=0.029) when compared to TB− and TB+
males, respectively. A decrease in the total triacylglycerol
fatty acid content of spleen, liver, and peritoneal macro-
phages from mice infected with Bacille Calmette–Guerin
were reported (Jackson et al. 1989). However, the pos-
sibility that this factor relates to sex was not investigated.
The only difference between TB− and TB+ wild boars
was in the level of IgG, which was higher in TB−
individuals (Table 2). Consistent with this result, we found
in previous studies that IgG heavy-chain mRNA was
differentially expressed in mandibular lymph nodes of TB−
wild boars (Naranjo et al. 2006a). In addition, adult TB−
wild boars had higher levels of serum ApoA1 than adult
TB+ animals (14.52±2.09 vs 7.48±7.43 mg/dl, P=0.026).
In a study in which global protein patterns in mandibular
lymph nodes were compared between TB+ and TB− wild
boars by two-dimensional gel electrophoresis and matrix-
assisted laser desorption/ionization time of flight mass
spectrometry, ApoA1 was found at higher levels in TB−
boars (Naranjo et al. submitted). These results suggest a
role for these molecules in bTB in European wild boars.
However, ApoA1 is one of the proteins that decrease
during acute phase processes in pigs (Carpintero et al.
2005) and therefore it may have little predictive value for
bTB in adult European wild boars.
Serum biochemical parameters were shown to correlate
with some internal parasites and health conditions in feral
pigs and wild boars (Wolkers et al. 1993, 1994a,b; Shender
et al. 2002; López-Olvera et al. 2006). However, different
results were reported on the predictive value of serum
biochemical parameters for parasitic infections in wild
pigs. Shender et al. (2002) found that serum biochemical
parameters do not provide good predictive information on
helminth and ectoparasite infections in wild pigs in Texas.
Recently, López-Olvera et al. (2006) reported that serum
Table 2 Comparison of serum biochemical parameters between European wild boars infected (TB+) and not infected (TB−) with M. bovis
Variable TB− TB+ P value
N Range Mean±SD N Range Mean±SD
Total proteins (g/l) 21 21.43–140.24 76.63±29.30 22 33.17–121.74 83.26±25.96 0.218
Albumin (g/l) 21 14.40–70.04 36.55±13.93 22 16.19–57.05 34.88±12.00 0.338
IgG (mg/dl) 21 38.91–281.86 168.50±53.74 22 57.90–203.16 141.37±39.26 0.033
IgM (mg/dl) 12 33.10–286.28 106.22±67.40 10 54.71–152.55 93.90±26.94 0.285
IgA (mg/dl) 21 n.d.–90.69 20.88±26.23 22 n.d.–95.02 20.73±26.08 0.492
C3 (mg/dl) 21 31.34–104.23 43.96±15.61 22 33.54–65.41 40.70±7.38 0.193
LDL (mg/dl) 21 12.61–60.51 36.16±15.47 22 9.53–77.98 37.03±18.54 0.435
HDL (mg/dl) 21 9.18–56.86 26.67±12.63 22 4.79–54.34 30.22±15.40 0.207
Cholesterol (mg/dl) 21 27.00–122.76 76.55±29.70 22 22.11–150.64 84.02±36.58 0.234
Triglycerides (mg/dl) 21 15.75–508.45 154.67±123.83 22 13.91–217.90 107.86±61.67 0.062
ApoA1 (mg/dl) 12 1.19–18.81 11.65±5.69 14 1.00–25.18 8.98±8.14 0.169
Glucose (mg/dl) 21 2.63–566.61 140.40±168.39 22 1.79–851.27 194.61±196.23 0.169
Alkaline phosphatase (U/l) 21 6.30–187.33 84.40±49.01 22 12.12–527.12 107.14±114.73 0.205
n.d. Not detected
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biochemical parameters changed according to helminth
burden in European wild boars. In general, our results did
not support good predictive value for serum biochemical
parameters studied for European wild boars in relation to
bTB in Spain.
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Capítulo 4.  
 
 
 
 
 
 
 
 
 
 
Discusión  
 
 
Genómica y proteómica comparativa para estudiar la respuesta 
tisular específica y su función en la infección natural por 
Mycobacterium bovis 
 
Resumen 
 
La tuberculosis bovina (TBb) es una zoonosis que afecta al ganado y a la 
fauna silvestre de todo el mundo y para la que se requieren nuevas 
estrategias de control y erradicación. El jabalí (Sus scrofa) es el principal 
reservorio de TBb en España. El objetivo de este trabajo es revisar la 
respuesta tisular específica y la función de linfonodos mandibulares y 
tonsilas en jabalíes infectados de forma natural con Mycobacterium bovis. 
Los resultados de los análisis de genómica y proteómica se usaron para 
comparar la expresión génica diferencial y los patrones globales de 
proteínas expresadas en tonsilas y linfonodos mandibulares de jabalíes 
infectados y no infectados con M. bovis y estos resultados se compararon 
con los reportados en infecciones experimentales de animales de 
laboratorio y domésticos. Los resultados mostraron diferencias específicas 
de tejido en tonsilas y linfonodos en respuesta a infección por M. bovis. Las 
diferencias específicas de tejido en la expresión génica y en el perfil de 
proteínas sugieren diferentes funciones para tonsilas y linfonodos durante 
la infección micobacteriana y proporcionan información para caracterizar la 
patobiología de la infección por M. bovis en jabalí con importantes 
implicaciones para el control de la TBb en España. La caracterización de 
los procesos moleculares en tejidos que tienen diferentes funciones 
durante la infección micobacteriana en individuos infectados de forma 
natural puede ser relevante para entender la patobiología de la infección 
por M. bovis y para diseñar estrategias efectivas para el control de la TBb 
en reservorios silvestres. 
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Abstract
Bovine tuberculosis (bTB) is an established zoonotic disease which affects cattle and wildlife
worldwide and new strategies are required to control and eradicate the disease. The European
wild boar (Sus scrofa) is a major reservoir of bTB in Spain. The objective of this paper was
to review tissue-specific response and function of mandibular lymph nodes (MLN) and
oropharyngeal tonsils (OT) in European wild boar naturally infected with Mycobacterium
bovis. Genomics and proteomics data were used to compare differential gene expression and
global protein patterns in OT and MLN of M. bovis-infected and uninfected European wild boar
and the results were analyzed considering previous reports of experimental infections in
laboratory and domestic animals. The results showed tissue-specific differences in OT and MLN
in response to M. bovis infection. Tissue-specific differences in gene expression and protein
profiles suggested different functions for OT and MLN during mycobacterial infection and
provided information to characterize the pathobiology of M. bovis infection in European wild
boar with important implications for the control of bTB in Spain. The characterization of
molecular events in tissues that play different roles during mycobacterial infection in naturally
infected individuals may be relevant to understand the pathobiology of M. bovis infection and
to design effective strategies for the control of bTB in wildlife reservoirs.
Keywords: bovine tuberculosis, wild boar, mycobacteria, Iberian red deer, vaccine
Introduction
Bovine tuberculosis (bTB), caused by Mycobacterium
bovis (Mycobacterium tuberculosis complex), is an
established zoonotic disease which affects cattle and
wildlife worldwide (Buddle et al., 2006). Several wildlife
species are naturally infected with M. bovis, but European
wild boar (Sus scrofa) is a major reservoir host in Spain
(Gortazar et al., 2005; Vicente et al., 2006). In this species,
most tuberculous lesions are located in the mandibular
lymph nodes (MLN) and oropharyngeal tonsils (OT) and
disseminated lesions are occasionally observed in the
liver, spleen, lungs and other organs (Gortazar et al.,
2003; Marti´n-Hernando et al., 2007). The presence of
common M. bovis genotypes in both cattle and wild boar
suggests a threat of interspecies transmission of the
pathogen (Gortazar et al., 2005).
In European wild boar as in other species, genetic
factors have been associated with resistance to bTB
(Acevedo-Whitehouse et al., 2005; Naranjo et al., 2006a,
b). However, limited information is available on the pro-
tective response of this and other wildlife reservoirs to
mycobacterial infection. Recent studies in cultured cells
and laboratory or domestic animals using functional
genomic analysis have provided data toward under-
standing the mechanisms involved in host–pathogen
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interactions and host cell responses to mycobacteria
(reviewed by Koul et al., 2004). However, little is known
about the immune response and the genes differentially
expressed in naturally infected animal populations
(Naranjo et al., 2006a, 2007; Thacker et al., 2006). Analysis
of genes differentially expressed in tissue biopsies
collected from infected and uninfected individuals ex-
posed to mycobacteria in endemic areas would contribute
to the understanding of the cellular response to natural
mycobacterial exposure (Naranjo et al., 2006a; Orlova
et al., 2006). These results provide information on genes
that may correlate with resistance to tuberculosis and/or
contribute to the development of protective responses in
wildlife reservoirs of infection.
In this paper we review the application of genomic
and proteomic analyses to the study of tissue-specific
response and function in natural wild boar M. bovis
infections and the results were analyzed considering
previous reports of experimental infections in laboratory
and domestic animals. For this study, we used the
comparative analysis between MLN and OT, which may
have different exposure to mycobacteria in wild boar,
a natural reservoir of infection. These analyses may
impact on the understanding of the pathobiology of
M. bovis infection and the control of bTB.
Methodological approach
The wild boar data reviewed herein was obtained from
the genomic and proteomic analyses in OT and MLN of
M. bovis-infected and uninfected European wild boar
(Naranjo et al., 2006a, 2007). The analysis of differential
gene expression and global protein patterns in OT and
MLN of M. bovis-infected (N=4) and uninfected (N=3)
European wild boar was done by suppression-subtractive
hybridization (SSH) and two-dimensional gel electro-
phoresis followed by matrix-assisted laser desorption/
ionization–time of flight mass spectrometry, respectively
(Naranjo et al., 2006a, 2007). Infected animals were
diagnosed by pathology, culture and spoligotyping of
mycobacteria (Naranjo et al., 2006a). The extremely
detailed necropsies performed, in parallel with the
complete histopathology and the immediate culture of
fresh lymphoid and non-lymphoid tissues warrant an
optimal sensitivity to detect mycobacterial infections in
mammals that almost rules out infection in the uninfected
animals (Naranjo et al., 2006a). Some of the differentially
expressed genes and regulated proteins were validated
by quantitative real-time RT–PCR, immunohistochemistry
and protein level determinations in 15–90 samples from
infected and uninfected individuals (Naranjo et al., 2006a,
2007; Vidal et al., 2006). Protein ontology was determined
using protein reference databases (http://www.hprd.
org and http://www.proteinlounge.com). Results were
compared between M. bovis-infected and uninfected
European wild boar and between OT and MLN.
Comparison of the differential gene expression
profiles in MLN and OT of M. bovis-infected
and uninfected European wild boar
The genomic analysis resulted in 270 and 199 genes
differentially regulated in MLN and OT, respectively.
These genes affected cellular functions such as cell
structure, protein and DNA/RNA metabolism, signal
transduction, cell–cell interactions, transport, growth,
inflammation/stress, immune response and enzymatic
processes (Fig. 1A). However, most of the differentially
expressed genes identified were of unknown function
(Fig. 1A).
Differences were observed in the genes differentially
expressed in infected and uninfected animals. The MLN
and OT of infected wild boar showed characteristics
commonly found during mycobacterial infection such as
the inhibition of phagosomal maturation and/or endo-
cytosis and the expression of osteopontin (SPP1), which
correlates with pathologic processes (Naranjo et al.,
2006a). On the other hand, in MLN and OT of uninfected
animals common differentially expressed genes included
the vitamin D receptor (VDR), complement component
C3 (C3) and genes involved in Th1 response, antigen
presentation and prevention of apoptosis, which may
correlate with protective responses to mycobacterial
infection in this species (Naranjo et al., 2006a, b).
The results of the differential gene expression analysis
were also different between MLN and OT. Immune
response genes were differentially expressed predomi-
nantly in MLN (Fig. 1A). Evidence of apoptosis in infected
animals was found in OT only, whereas correlates of
Th2 responses such as arginase I (ARGI) were found
exclusively in MLN (Fig. 1B). Cell structure, protein
metabolism and signal transduction mechanisms were
predominantly affected in MLN of infected boar (Fig. 1B).
Although stress/inflammatory responses were charac-
terized in MLN and OT of wild boar infected with
M. bovis (Fig. 1B), the heat shock protein (HSP) response
was activated in OT while the acute phase protein (APP)
response was increased in MLN of infected animals
(Naranjo et al., 2007).
Comparison of the protein profiles in MLN and OT of
M. bovis-infected and uninfected European wild boar
Proteomic analysis of MLN and OT identified differentially
regulated stress/inflammatory proteins as the main dif-
ference between uninfected and M. bovis-infected boar.
These proteins included annexin V, albumin and apolipo-
protein A1 (ApoA1), which appeared down-regulated,
whereas manganese superoxide dismutase (MnSOD) was
up-regulated in MLN of infected boar (Naranjo et al.,
2007). In OT, NADP-dependent isocitrate dehydrogenase
(IDP), two isoforms of creatine kinase (CK) and MHC
class II (MHC II) were up-regulated in infected animals
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(Naranjo et al., 2007). In accordance with genomic
analysis, evidence of APP response and organ damage
was found in MLN while MHC II up-regulation in OT of
infected animals suggested macrophage activation in
this tissue. The analysis of serum proteins demonstrated
higher levels of MnSOD and serum amyloid A (SAA) in
infected boar and ApoA1, IgG and C3 in uninfected
animals (Naranjo et al., 2006a, 2007; Vidal et al., 2006).
Similarities and differences in the response to
mycobacterial infection between naturally infected
European wild boar and experimentally infected
laboratory and domestic animals
In our studies, we hypothesized that gene and protein
response to mycobacterial infection may be different
between experimentally infected laboratory and domestic
animals and naturally infected wildlife species. The
analysis of gene and protein profiles in MLN and OT of
European wild boar naturally infected with M. bovis did
result in some unique findings in these species. The
differences in the response to mycobacterial infection in
European wild boar when compared to experimental
infections in laboratory and domestic animals may have
resulted from variations in the methodological approach
(global expression analysis versus SSH), or from the use
of different mycobacterial species/strains, tissues (isolated
bone marrow-derived macrophages and peripheral blood
monocytes versus MLN and OT) and stage and condition
of infection (experimental versus natural infections).
Different gene expression profiles have been reported
between different mycobacterial strains (Blumenthal
et al., 2005; Wedlock et al., 2006), infected cell types
(Danelishvili et al., 2003) and time points after infection
(Meade et al., 2006). However, the results of our studies
also suggest that the response in European wild boar and
other wildlife species to natural mycobacterial infection
could differ from cell responses reported previously in
experimental studies. These results also suggest that the
selection of biological samples may be crucial to identify
biomarkers and correlates of pathology and protection in
tuberculosis (Orlova et al., 2006).
Some of the differentially expressed genes that were
identified in European wild boar were reported pre-
viously in other organisms. For example, the lysosomal-
associated protein, which is involved in phagosomal
maturation and is negatively regulated by pathogenic
mycobacteria in human and mouse macrophages
(Clemens and Horwitz, 1995; Koul et al., 2004) was
differentially expressed in European wild boar. The
ubiquitin system, involved in protein degradation and
regulation of the cell cycle, was differentially expressed
in OT of European wild boar as reported previously in
human (Chaussabel et al., 2003; Wang et al., 2003) and
cattle (Weiss et al., 2004) macrophages. Other genes,
such as those encoding MHC II, vascular cell adhesion
molecule 1 (VCAM-1), chemokine receptor 4 (CXCR4),
VDR and C3, were differentially expressed in European
wild boar and in M. tuberculosis-infected mouse and
human macrophages and/or bovine peripheral blood
mononuclear cells (Ragno et al., 2001; Chaussabel et al.,
2003; Velasco-Velazquez et al., 2003; Keller et al., 2004;
Selvaraj et al., 2004; Kim et al., 2006; Meade et al., 2006),
although contradictory results have been reported for
VCAM-1 and CXCR4 expression between different organ-
isms (Ragno et al., 2001; Shalekoff et al., 2001; Chaussabel
et al., 2003; Keller et al., 2004; Naranjo et al., 2006a).
The stress/inflammatory responses to M. bovis charac-
terized in European wild boar, such as those mediated by
annexin, SAA, ARGI, SPP1, MnSOD and MHC II, have
been previously described in macrophages during in vitro
and in vivo experimental infections with mycobacteria
(Nau et al., 1999; Aggeli et al., 2000; Mishra et al., 2000;
Ragno et al., 2001; Koguchi et al., 2003; Keller et al., 2004,
2006; Koul et al., 2004; Meijer et al., 2005). However,
other stress/inflammatory response molecules identified
in European wild boar such as ApoA1, HSPs, CK and IDP
constitute new findings.
Pathobiology of M. bovis infection in European
wild boar
The results of genomic and proteomic analyses may
reflect differences in the role of MLN and OT during
infection and progression of bTB in European wild boar.
The OT may be one of the infection routes in boar,
in which mycobacteria apparently enter through the
respiratory and digestive routes (Vicente et al., 2006). The
OT may act as the first barrier for infection and the heat
shock response in this tissue may be induced to protect
boar from environmental mycobacteria. The finding of
apoptosis in the OT of infected animals is in agreement
with the hypothesis that mycobacteria prevent apoptosis
in the early phase of infection to allow for efficient
bacterial replication, but they may induce or are unable to
prevent cell death in later phase when other organs such
as MLN become infected, which would contribute to their
systemic dissemination via infection of immune cells
(Koul et al., 2004).
The MLN are the most affected tissue by the formation
of granulomatous lesions during progression of bTB in
wild boar (Gortazar et al., 2003; Marti´n-Hernando et al.,
2007). The APP response in MLN of infected animals may
reflect tissue injury in the granulomas. These results are in
agreement with histopathology findings which suggest
that the up-regulation of stress/inflammatory responses in
MLN may contribute to organ damage in M. bovis-infected
animals, resulting in frequent large granulomatous lesions
in more than one anatomical region among juvenile wild
boar (Marti´n-Hernando et al., 2007).
The inflammatory/stress responses in MLN and OT of
M. bovis-infected wild boar suggest active bTB in these
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animals. These findings, together with the histopatholo-
gical characteristics of the tuberculous reaction and the
associated tissue damage in various organs, indicate that
at least those wild boar with large lesions and generalized
infections have the potential to excrete M. bovis by several
routes, which reinforces the suggestion that wild boar is
a true bTB reservoir in Spain (Marti´n-Hernando et al.,
2007).
Implications for the control of bTB in Spain
The genes differentially expressed and the proteins up-
regulated in M. bovis-infected wild boar likely reflect cell
responses to mycobacterial infection. If proven specific
for M. bovis infection, some of these markers could be
used for the development of assays for the identification
of infected animals (Vidal et al., 2006).
However, the genes differentially expressed and
the proteins up-regulated in uninfected wild boar may
represent down-regulation due to mycobacterial infection
in infected animals and/or up-regulation in uninfected
individuals as a result of individual resistance and/or
protective response to infection. Some of the genes
differentially expressed in uninfected animals, such as
C3, methylmalonyl-CoA mutase (MUT) and certain MHC
alleles, have been associated with resistance to bTB in
European wild boar (Acevedo-Whitehouse et al., 2005;
Naranjo et al., 2006a, b). Genetic polymorphisms in these
loci may be identified and correlated with resistance to
bTB, thus providing a tool for the selective genetic
improvement of wild boar and domestic pig populations
when animal translocations and introductions are ap-
proved by regulatory authorities. Additionally, the genes
differentially expressed and the proteins up-regulated in
uninfected wild boar may be used as biomarkers of
protective response against M. bovis infection in experi-
mental trials to identify and characterize new vaccine
candidates and vaccination strategies in this species
(Buddle et al., 2005).
Mycobacterial infections induce antibody production
but the profile of immunoglobulin (Ig) expression in
M. bovis-infected animals is poorly understood (Waters
et al., 2006). Experiments in wild boar provided evidence
of Ig differential expression in OT and MLN of M. bovis-
infected and uninfected wild boar (Naranjo et al., 2006a)
and in mesenteric lymph nodes of Iberian red deer
infected with M. bovis (I. G. Ferna´ndez de Mera et al.,
2007 submitted for publication). Serum IgG levels were
also increased in uninfected boar (Vidal et al., 2006).
These results suggest that antibody responses against M.
bovis may be important in natural infections of wildlife
species and may be used for bTB surveillance and
treatment monitoring (Lyashchenko et al., 2006; Waters
et al., 2006).
Finally, the results discussed here may be relevant for
vaccination strategies against bTB. In addition to systemic
immune response activation, pre-exposure vaccines may
be developed to target tonsil protective response to
prevent infection by the pathogen. Post-exposure thera-
peutic vaccines may need to stimulate immune response
at the lymph node to limit the multiplication, dissemina-
tion and reactivation of mycobacteria. Oral vaccines for
the control of bTB in wildlife may be developed with
these criteria to prevent M. bovis infection and trans-
mission (Cross et al., 2007).
Conclusions
In summary, we have focused our review on research
on the characterization of gene expression and protein
profiles in naturally infected tissues of wildlife reservoirs
of bTB, instead of using experimental infections in
cultured cells or laboratory and domestic animals. The
results reviewed herein show similarities and differences
between naturally M. bovis-infected tissues of wildlife
reservoir species and those reported in cell culture or
laboratory and domestic animals. Very little information is
available on the response of wildlife species to myco-
bacterial infection (Lyashchenko et al., 2006; Naranjo
et al., 2006a, b, 2007; Thacker et al., 2006; Vidal et al.,
2006) although we can anticipate that this information
will increase in the near future (Ballesteros et al., 2007).
Despite difficulties associated with work with naturally
infected wildlife species such as the number of animals
available, the potential presence of other infectious
agents and the differences in the stage of infection
between individuals, the results discussed in this review
support the importance of studying naturally infected
tissues in wildlife species. The understanding of the
response to natural M. bovis infection may be critical to
the development of effective strategies for the control of
bTB. In particular, the response of tissues that play
different roles during mycobacterial infection may be
relevant to understand the pathobiology of M. bovis
infection and to design effective vaccines for the control
of bTB in wildlife reservoirs.
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Capítulo 5 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Conclusiones
 
 
Conclusión 1. Los perfiles de expresión génica son diferentes en jabalíes 
tuberculosos y no tuberculosos expuestos de forma natural a M. bovis. Estas 
diferencias a nivel de expresión génica también tienen lugar entre tonsilas y 
linfonodos mandibulares, lo cual indica que estos tejidos desempeñan 
funciones diferentes durante la infección por M. bovis y en la progresión de la 
enfermedad. 
 
Conclusión 2. Los genes expresados de forma diferencial en jabalíes 
tuberculosos y no tuberculosos están asociados con la regulación de 
importantes procesos celulares como son: transducción de señales, respuesta 
inmune, inflamación/estrés, apoptosis/antiapoptosis, estructura celular, 
adhesión y transporte, metabolismo de ADN/ARN y proteínas y procesos 
enzimáticos. 
 
Conclusión 3. La respuesta inflamatoria y de estrés a la infección por M. bovis 
en jabalí se encuentra regulada a nivel transcripcional y se refleja en los niveles 
de proteína de algunas moléculas en tonsila y linfonodos mandibulares. La 
respuesta de proteínas de choque térmico se encuentra aumentada en tonsilas, 
en tanto que los niveles de las proteínas de fase aguda se incrementan en 
linfonodos mandibulares.  
 
Conclusión 4. Los genes del componente 3 del complemento y de la 
metilmalonil CoA mutasa aparecen sobreexpresados en jabalíes no 
tuberculosos expuestos de forma natural a M. bovis, por lo que son buenos 
candidatos para ser considerados como marcadores de resistencia a la 
tuberculosis bovina en jabalí. 
 
Conclusión 5. El alelo A de la metilmalonil CoA mutasa proporciona protección 
frente a la tuberculosis bovina mientras otros alelos incrementan el riesgo de 
infección. Los jabalíes infectados que son heterocigotos (A/B) poseen una 
mayor capacidad para contener la extensión sistémica de la enfermedad en 
comparación con otros genotipos. La determinación de los genotipos podría ser 
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de importancia para caracterizar poblaciones de cerdos y jabalíes resistentes a 
la tuberculosis. 
 
Conclusión 6. Los parámetros bioquímicos estudiados en suero de jabalí no 
proporcionan buenos valores predictivos en relación con la tuberculosis bovina 
en España. 
 
Conclusión 7. Los genes y proteínas sobreexpresados en jabalíes no 
tuberculosos expuestos de forma natural a M. bovis pueden ser usados como 
marcadores de respuesta protectora frente a la infección por M. bovis,  para el 
desarrollo de nuevas estrategias de vacunas y para la mejora genética en 
ganado porcino. 
 
Conclusión 8. Los genes y proteínas sobreexpresados en jabalíes 
tuberculosos pueden ser usados para el desarrollo de técnicas de identificación 
o diagnóstico de jabalíes infectados por M. bovis si se confirma que son 
específicos para este patógeno.  
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